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Abstract
Proline holds an important position among twenty naturally occurring ammo acids, the building blocks 
of pepudes and proteins It confers particular biological properties upon these physiologically 
important biomolecules due to its unique structural characteristics There has evolved a specialised 
group of enzymes that recognise this residue and can introduce peptide bond cleavage at either its 
carboxyl or ammo terminus within a peptide chain The variety of these specialised peptidases cover 
practically all situations where a proline residue ought occur m a substrate and their action can be of 
biological significance, leading to the inactivation or biotransformation of peptides and proteins
Two distinct proline specific peptidases were detected m bovine serum usmg the substrate Z-Gly-Pro- 
MCA, a reportedly specific fluonmetnc substrate for prolyl endopeptidase (PE) One of these activities 
was inhibited by Z-Pro-Prolinal, a PE specific inhibitor, and was subsequently designated PE Hie 
second activity resisted inhibition by Z-Pro-Prolinal, even at high concentrations and increased 
premcubation tunes This activity was subsequently designated Z-Pro-Prohnal insensitive Z-Gly-Pro- 
MCA degrading peptidase (Z3P)
Both PE and ZIP activities in bovine serum were successfully separated usmg SP-Sepharose cation 
exchange chromatography and were subsequently punfied independently of each other
PE activity was partially punfied, following its separation from ZIP, usmg Phenyl-Sepharose 
hydrophobic interaction, DEAE-Sepharose anion exchange and Sephacryl S-200 HR gel filtration 
chromatographies, with a final yield of 24% and a final purification factor of 30 achieved. The enzyme 
had a native molecular weight of 70,000 Da, as determined by gel filtration chromatography The 
subunit structure of the enzyme could not be determined by SDS PAGE due to the appearance of 
multiple bands following visualisation of the gel by silver staining
A pH optimum of 8 0, with a  preference for phosphate buffer was determined for the partially punfied 
PE. The enzyme was stable over a pH range of 5-9 Optimal activity was obtained from PE at a 
temperature of 37°C with little activity being detected above or below this temperature
The enzyme was inhibited by AEBSF indicating that the enzyme is a member of the serine protease 
family The enzyme was also inhibited by PCMB and activated by DTT, indicating the possible 
presence of an essential cysteine residue, close to the active site
PE hydrolysed the substrates Z-Gly-Pro-MCA and pGlu-His-Pro-MCA, with Km values of 94pM and 
62i*M respectively The enzyme also cleaved a vanety of proline containing bioactive peptides 
including LHRH, bradykinin, substance P and angiotensin II These peptides also competitively
xm
inhibited PE activity towards Z-GIy-Pro-MCA PE demonstrated relatively high specificities towards 
bradykimn and angiotensin n  with Kj values of 136pM and 113[iM respectively
The enzyme was inhibited by a range of PE specific inhibitors with the highest inhibitory activity 
being observed for a-ketobenzothiazole (IC50 = 41 picomolar) and Z-Indohnyl Prolinal (IC50 = 45 
picomolar)
Z-Pro-Prolinal insensitive Z-Gly-Pro-MCA degrading peptidase (ZIP) activity was punfied, following 
its separation from PE, usmg Phenyl-Sepharose hydrophobic interaction , Calcium Phosphate 
Cellulose and Sephacryl S-200 HR gel filtration chromatographies, with a final yield of 14% and a 
final purification factor of 2250 achieved The enzyme had a native molecular weight of 185,000 Da, 
as determined by gel filtration chromatography The subunit structure of ZIP was determined to be 
tetramenc, based on the identification of a major band of 50,000Da by SDS PAGE following 
visualisation of the gel by silver staimng
The enzyme exhibited a pH optimum of 8 5, and was stable over a pH range of 4*9 5 Optimal 
activity was obtained from ZIP at a temperature of 37°C- 40°C with significant activities being 
observed at 4*C and 20aC
The enzyme was inhibited by AEBSF indicating that it is probably a member of the senne protease 
family
ZIP hydrolysed the substrate Z-Gly-Rro-MC A, with a Km value of 267^M The enzyme also cleaved 
proline containing bioactive peptides including LHRH, bradykimn and substance P These peptides 
also inhibited ZIP activity towards Z-Gly-Pro-MCA with bradykimn and LHRH demonstrating 
competitive Kj values of 2 5mM and 475pM respectively
The enzyme was inhibited by some of the PE specific inhibitors tested. Highest inhibitory activity 
was observed for a-ketobenzothiazole (IC50  =15 picomolar)
Bovme serum PE activity, punfied and charactensed dunng this investigation, is similar to PE isolated 
from other sources with regard to its biophysical and biochemical characteristics, and its substrate 
specificity Its localisation in serum, and it activity towards proline containing bioactive peptides 
indicates that it may play and important physiological role in the metabolism of such peptides
ZIP activity may represent a novel profane specific peptidase localised m serum which might also play 
a role m the degradation of proline containing bioactive peptides
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1. Introduction
1 1. Proline
More than two billion years ago, as part of the evolutionary development of protein and peptide 
structure, 20 discrete building blocks emerged as the optimal components of the biosynthetic chain 
Among these 20 a-amino acids a unique position is held by the unino acid proline Amino acids are 
constructed around a single carbon atom, the a-carbon Forming the centre of a tetrahedral array, the 
a-carbon is bound to an ammo group (NH3), a hydrogen atom, a carboxyl group (COOH) and a side 
chain R group (Figure 1 1 a )  Proline differs from other ammo acids in that its side chain R group (- 
CH2 -CH2 -CH3) is bonded to both the amino group and a-carbon, resulting in a cyclic structure 
(Figure l i b )
Chemical modification of the nitrogen atom m this manner, affects its basicity, and the overall polarity 
of the proline residue Furthermore, the cyclic nature of this ammo acid places major constraints on 
structural aspects of the polypeptide backbone
1.2.  Biological Significance o f Proline
1.2 .1 .  Structural Aspects
Due to its unique structural properties, important conformational attributes are observed when proline 
is introduced into a peptide sequence Its cyclic structure limits the angle of rotation about the a- 
carbon and nitrogen within a peptide bond, (0, Figure 1 1 c ) ,  normally only affected by stearic 
hindrance or electrostatic repulsion between the R groups of adjacent residues Consequentially, prolme 
introduces a fixed bend into the peptide chain which has been found to be a potent repeated structure 
breaker It tends to change the direction of peptide chains, resulting in the spherical or globular shape 
of proteins This important structural event, a  reverse turn or haupm bend at the surface of proteins, is 
the most common occurrence of prolme within proteins (Yaron and Naider, 1993, Anfmsen and 
Scheraga, 1975, Crawford el a i , 1973) A second consequence of prolmes’ cyclic nature is that it 
possesses no functional groups This prevents it from participating in hydrogen bonding or resonance 
stabilisation of a peptide bond Prolme is, therefore, the only ammo aad that is not compatible with 
a-hehx or {3-sheet secondary structures It can form a left handed helical structure when multiple 
prolme residues occur sequentially m a protein This is not a common occurrence, but has been reported 
for residues 5 - 7 in bovine pancreas trypsin inhibitor A second helical structure that depends 
specifically on the structural attributes of prolme is collagen, the mam constituent of bone, tendons and 
supporting membranous tissue (Bomstein, 1974)
Steanc hindrance and electrostatic repulsion effects, caused by interactions between the R groups of 
adjacent residues, energetically favour trans isomers of peptide bonds However, due to the close 
association of the R group of prolme and the nitrogen atom of the peptide bond, cis isomers of probne 
and adjoining residues are common (Figure l i d  and l i e )  This allows rotation around the bond 
between the nitrogen and carbonyl groups to occur (©), reducing the structural integrity conferred to
1
biosynthetic chains by the normally fixed planar pepude bond (Figure 1 1 c )  The significance of 
prolmes’ ability to form cis peptide bonds is illustrated by the fact that only four examples of cis 
pepude bonds, not involving a proline residue, have been reliably reported in proteins. Three m 
carboxypepudase A and one in dihydrofolate reductase (Creighton, 1984, Rees, 1981, Koiaskar and 
Ramabrahman, 1982)
1 2.2 Physiological Aspects
A key physiological role played by proline is the protection of biologically active peptides against 
enzymatic degradation This is clearly evident in the regulation of post-translational modifications of 
peptide or protein precursors The biosynthesis and degradation of peptides, such as hormonal peptides 
and neurotransnutters, is recognised to be a highly ordered series of events Generation of an active 
polypeptide involves the action of an endopeptidase(s), which cleaves rts precursor at a specific site(s), 
followed by proteolytic "trimming" by exopeptidases to reduce the polypeptide chain to its correct size 
The peptide chain must possess some structural element to prevent excessive hydrolysis and sobsequent 
loss of biological activity Enzymatic modification of the peptide cham termini by acetylation, or, by 
the formation of a pyroglutamyl residue at the ammo terminus and an amide at the carboxyl terminus, 
can regulate modification of peptides by exopeptidases However, this type of processing occurs after 
proteolytic trimming is complete Prolme residues situated within polypeptide precursors act as 
structural elements limiting the susceptibility of the polypeptide cham to proteolysis They are also 
present at the modification site prior to enzymatic processing of the precursor This has been revealed 
by investigations into the specificity of exopeptidases mvolved in post translational modification of 
peptides and is confirmed by the observation that prolme appears near the ammo tennim of many 
biologically active peptides (Persson et a l , 1985, Bradbury et a l , 1982, Yaron, 1987)
1.3.  Proline Specific Peptidases
As previously discussed, the presence of a prolme residue confers specific properties upon a polypeptide 
cham These structural characteristics give the molecule particular conformational properties and 
influence its interaction with other proteins The interaction between pxolrne containing peptides and 
enzymes is no exception Restriction of the susceptibility of polypeptides to proteolytic cleavage 
conferred by prolme, offers a mechanism of protection against degradation This is primarily true for 
the Xaa-Pro peptide bond, but is also evident for the Pro-Xaa bond These restrictions can also extend 
to amino acid residues not directly attached to the proline and are commonly associated with the 
isomenc configuration of the peptide cham Lm and Brandts, (1983), reported that the sequence -Lys- 
Phe-Pro was only hydrolysed at the Lys-Phe bond by trypsin when the Phe-Pro bond was m trans 
configuration They went on to use this method to determine the ratio of trans-cis proline 
isomensation states m pentapeptide mixtures Because of the varied restrictions applied when dealing 
with prolme containing peptides it is not surprising that nature saw fit to develop range of enzymes to 
deal specifically with this lmino acid. The following pages will endeavour to discuss these enzymes, 
with specific reference to those responsible for the degradation of proline containing peptides
Figure 1 1
h 2
n h 3+ / ' N H
. H 2C v
R C  COO' \  — COO
C ^
H H> H
(a ) Basic amino acid structure (b) Structure o f proline, illustrating the
illustrating carboxyl amino, and R bonded ammo group and R group
groups attached to a chiral a-carbon creating a cyclic structure The
(C) secondary nature o f the nitrogen
containing moiety makes prolme an 
immo acid
H R
(c) Structure o f the peptide bond between two amino acids The a-carbon o f each ammo acid are 
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1 3 1. Prolvl Endopeptidase (EC 3 4 21 26)
Prolyl endopeptidase activity was first observed in homogenates of human utems by Walter et a l , 
(1976) They reported the release of Ieucylglycmamide from the C-tennmus of oxytocin (Cys-Tyr-He- 
Gln-Asn-Cys-Pro-Leu-Gly-NH2) This activity was referred to as post prolme cleaving enzyme by 
Koida and Walter later that year when they punfied the activity frran lamb kidney and determined that 
the enzyme cleaved peptide bonds on the carboxyl side of a proline residue A highly purified bram 
enzyme, which shared similar specificity to post-proline cleaving enzvme, was reported by Orlowskj et 
a l , (1978) The enzyme hydrolysed peptidyl prolyl-peptide and pepadyl prolylammo acid bonds, but 
was inactive towards substrates with an unsubstituted imino group of proline and was therefore 
designated prolyl endopeptidase In 1992, it was recommended thai the enzyme be referred to as prolyl 
oligopepudase, as it does not cleave prolme bonds m proteins (Recommendations of the Nomenclature 
Committee of the International Union of Biochemistry and Molecular Biology, 1992)
1.3.1 .1 .  Biophysical and Biochemical Aspects of Prolyl
Endopeptidase
Early reports as to the molecular weight of prolyl endopeptidase (PE) indicated a dimenc subunit 
structure, with native molecular weights ranging from 115kDa to 140kDa (Mizutani et a l , 1984, 
Koida and Walter, 1976) However, it is generally accepted that the molecular weight of PE ranges 
from 65kDa to 85kDa, with the majonty of reports indicating a molecular weight of 70kDa to 75kDa 
The enzyme is monomenc (Goossens et a l , 1995, O’Leary and 0*Cbnnor, 1995, Kusuhara et a l , 
1993, Yokosawa et a l , 1983) In 1990, Rennex et a l , reported the cDNA cloning of porcine bram 
PE The deduced molecular weight, based on 710 ammo acids sequenced, was 80,751Da. This has 
been confirmed recently for human T-cell PE (Shirasawa et al., 1994) PE from Flavobacterium 
meningosepticum has also been cloned and a molecular weight of 78,705Da was deduced for 705 amino 
aad  residues sequenced (Yoshimoto et a l , 1991) This result was also obtained by Chevaflier et a l , 
(1992), but these workers identified an N-terminal signalling peptide which, when removed, resulted m 
a protein consisting of 685 ammo acids, the molecular weight of which was 76,784 Da The 
identification of an N-tennmal signalling peptide was confirmed by Kanatam et a l , (1993)
Mammalian PE has a pH optimum of 7 5 with a pi of 4 8-4 9 The baceral enzyme has a similar pH 
optimum but its pi is higher at 5 5, with some reports of 6  5 Both forms have an optimum 
temperature of 35°C-40°C (Shanna and Ortwerth, 1994, Makinen etaL, 1994, Goossens et a l, 1995, 
Yoshimoto et a l , 1995)
PE has been classified as a senne protease, based on its inhibition by DFP and to a lesser extent by 
PMSF Sequencing of the protein has confirmed this classification, bat id tandem with biochemical 
charactensation studies, PE has been identified as a member of a distinct family of senne proteases
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The known senne proteases have been classified into three distinct families that are named after the 
representative enzymes trypsin, subtilism and carboxypeptidase Y (Neurath,1989, Breddam, 1986) 
Primary structures of each family differ though these structures are homologous within each family 
A consensus sequence for mammalian senne proteases was proposed by Brenner (1988), where the 
active site senne appears in the sequence Gh -Xaa-Ser-Xaa-GIy This consensus is adhered to by 
trypsin (Gly-Asp-Ser-Gly-Gly) but the carboxyl Gly is not present at the active sites of subuhsin (Gly- 
Thr-Ser-Met-Ala) or carboxypeptidase Y (Glv-Glu-Ser-Tyr-Ala) Rennex et a l , 1990, identified the 
sequence surrounding the active site senne m porcine brain PE as Gly-Gly-Ser-Asn-Gly, which does 
not share homology with the ’classical’ senne protease families It does, however, conform to 
Brenners’ (1988) consensus sequence Bactenal PE active site sequences also share no homology with 
the classical senne proteases and are not in complete agreement with the mammalian sequence 
(Makmen et a l , 1994, Chevallier et a l , 1992, Yoshimoto et a l , 1991)
A second feature setting PE and its family of senne proteases apart from classical forms, is the order m 
which members of the catalytic toad of residues occur Withm the classical enzyme triads of Asp--His- 
-Ser and His~Asp~Ser have been identified. PE, however, contains a catalytic triad sequence of Ser~ 
Asp—His Tins evidence clearly distinguishes PE from classical serine proteases (Goossens et a l , 
1995, Vanhoof et a l , 1995, Yoshimoto et aL, 1995, Kanatam et a l , 1993) The active site is located 
at the C-terminal end of the ammo acid sequence, in a protease domain, the secondary structural 
organisation of which conforms to an a/p hydrolase fold (Goossens et a l , 1995) PE is also widely 
reported to be inhibited by sulphydryl blockmg agents such as PCMB This inhibition is thought to 
be due to the modification of a cysteine residue located near the active site (Goossens et a l , 1995, 
Makmen et a l, 1994)
L£zl6 Polgar has earned out extensive work with regard to the catalytic mechanism of PE In 1991 he 
reported the existence of two pH dependent forms of the enzyme Senne proteases have a catalytically 
competent histidine residue, which facilitates both the formation and the decomposition of the 
intermediate acyl-enzyme and exhibits a pKa of 7 0 The ionisation of this residue governs the pH 
dependence of catalysis However, Polgar observed a second significant ionisation event m pH 
dependent kinetic studies and concluded that a second, low pH (=5 0) form of the enzyme existed 
Further investigations into kinetic deutenum isotopic effects on the two enzyme forms, revealed that 
the rate-determining step of the low pH form was general base/acid catalysis, whrie a physical step was 
rate limiting in catalysis performed by the high pH form. In 1992(b), he confirmed this hypothesis and 
suggested that the physical rate limiting step might be a conformational change, which he confirmed in 
1993 He also reported that in contrast to classical senne proteases, hydrogen bond interaction between 
substrate residue P2 and enzyme subsite S2, made a greater contnbution to catalysis than stabilisation 
of the oxyamon binding site
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1 3.1.2 Substrate Specificity of Prolyl Endopeptidase
Before discussing the substrate specificity of PE, a brief explanation of the terminology used is 
warranted The standard nomenclature for referring to the manner in which various substrates bind to 
complements sites on a peptidase was introduced by Schecbter and Berger (1967) Residues of the 
substrate are denoted according to their distance from the scissile bond and their respective location on 
the C-terminal or N-terminal side of this bond, while the subsites on the enzyme to which these 
residues are hound are similarly designated (Figure 1 2 )
N-tenmnal SubstT<ltC C-terminal
P2 ? !  P i ’ P2
$2 $1 s {  S2’
Enzyme
F igure  1 2 . Standard nomenclature for referrmg to the manner m which various substrates 
bind to complementary enzyme subsites (Schechter and Berger, 1967) Residues o f the substrate 
are denoted according to their distance from the scissde bond and their respective location on the C- 
termmal or N-tenmnal side o f the scissile bond (Pj, Pi'), while the subsites on the enzyme to 
which these residues are bound are similarly designated (Sj, S j ’) The scissile bond is located 
between the Pj and P j’ substrate residues.
PE is an endopeptidase that cleaves a Pro-Xaa bond in a structure that consists of an acyl-Yaa-Pro-Xaa 
sequence Cleavage will not occur if a  free a-amine exists in the N-tenmnal sequence Yaa-Pro-Xaa or 
Pro-Xaa. Pro-Pro bcods and N-blocked peptides of the sequence Z-Pro-Xaa are not cleaved. In peptides 
conforming to these restrictions, the Pj proline can be replaced by alanine but significant losses in 
hydrolytic activity are observed (Walter et aL, 1980) The importance of a Pi prolme was investigated 
by Nomura (1986), usmg a substrate of the sequence Z-Gly-Xaa-Leu-Gly Where Xaa was replaced by 
prolme, alanine, N-methylalanine or sarcosme, good substrates resulted Substitution of Xaa with 
aminobutync aad, hydroxyproline, senne and glycine were not good substrates while substrates with 
N-methylvahne and N-methyleucine in the Pi position were not cleaved Nomura concluded that the 
S] subsite was designed specifically to fit proline This subsite tolerated other residues carrying 
substituent groups, provided they did not exceed the size of prolines' pyrrolidine nng The requirement
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of an unino acid in the P] position of a subsite was confirmed by Makmen et a l , (1994) and Kneg and 
Wolf (1995) There is a preference for a hydrophobic residue at the C-terminal of the scissile bond (Pi') 
with lower specificities for basic and acidic residues respectively (Kneg and Wolf, 1995, Taylor et a l , 
1980, Koida and Walter, 1976) Phosphorylation of this residue leads to increased rates of cleavage 
(Rosen et a l , 1991) The adjoining ?2 residue (located N-terminally with respect to the Pi proline), is 
reported to be bound non-specifically (Kneg and Wolf, 1995) In all, five subsite binding pockets have 
been identified for PE (S3 -S2 ') and the smallest peptide cleaved is a tetrapeptide with residues in 
positions P3~Pi’ The enzyme cannot cleave large proteins and is reported to hydrolyse a maximum 
substrate size of 3,000Da, thus its classification as an oligopepudase The enzyme exhibits high stereo 
specificity for the two bonds spanning the P2-Pl’ substrate positions (Goossens et a l , 1995, Makmen 
et a l , 1994, Sattar et a l , 1990, Yoshimoto et a l , 1988) Prolme containing bioactive peptides, 
conforming to the substrate specificity requirements of PE and subsequently hydrolysed by the enzyme 
are listed in Table 1 1
/
1 3.1 3. Assays for Prolyl Endopeptidase Activity
Following the enzymes discovery m 1976 by Walter et a l , oxytocin and arginine-vasopressin were 
used in native or radiolabelled forms to detect PE activity Koida and Walter (1976), reported the use of 
Z-Gly-Pro-Leu-Gly as substrate for PE detection and quantitation, the product (Leu-Gly) being detected 
by mnhydnn determination (Walto*, 1976)
In 1979, two reports of new synthetic substrates were published Yoshimoto et a l , (1979), 
synthesised Z-Gly-Pro-MCA (7-amino-4-methyl-coumann), a fluonmetnc substrate, while Orlowski et 
a l , (1979), synthesised Z-Gly-Pro-SM (sulphamethoxazole), a colorimetric substrate This basic 
structure of PE substrates (N-blocked dipeptide Gly-Pro- linked to a chromogemc or fluorogenic 
moiety) has changed little since Reports of assay development for PE usmg these substrates, have 
been published relatively recently (Goossens et a l , 1992)
1.3.1.4.  Inhibitors of Prolyl Endopeptidase
In 1983, Fnedman et a l , published the synthesis of Z-Pro-Prolmal, a specific inhibitor of PE which 
was descnbed as being a transition state aldehyde inhibitor of this enzyme Since then, many 
modifications based on this inhibitor have been synthesised There has also been an increase m the 
number of non-peptide based or microbially sourced PE specific inhibitors A list of PE specific 
inhibitors is presented in Table 1 2 with structures presented in Figure 1 3
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Peptide Sequence Reference
Angiotensin I Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu Monyama et a l , 1988
BPP pGIu-Gly-Gly-Tip-Pro-Arg-Pro-Gly-Pro-GIu-Ile-Pro-Pro Koida and Walter, 1976
Bradykmm Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg Greene et a l , 1982
LHRH pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Giy-NH2 Mendez et a l , 1990
Melanotropin Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-VaI-NH2 Tate et a l , 1981
Neurotensin pGlu-Leu-T yr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-T yr-He-Leu Camargo et a l , 1984
Oxytocin Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 Walter e ta l , 1976
Substance P Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met Monyama et a l , 1988
TRH pGlu-His-Pro-NH2 O'Leary and O’Connor, 1995b
Tuftsin Thr-Lys-Pro-Arg Tate et a l , 1980
Vasopressin Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly Monyama et a l , 1988
Table 1 1  Bioactive peptides that are substrates for prolyl endopeptidase The scissile bonds are indicated in bold type 
TRH - Thyrotropin Releasing Hormone, LHRH - Leutemising Hormone Releasing Hormone, BPP - Bradykimn potentiating 
peptide
Inhibitor Details Reference
Poststatin IC50 = 0 03fig/mL Nagai e ta l , 1991
JTP-4819 IC50 = 083nM Toide et a l , 1995
Eurystatin A IC50 = 0 004ng/mL Kamei et a l , 1992
Eurystatin B IC50 = 0 002fig/mL Kamei et a l , 1992
Z-Tbiopropyl-Thyoprolinal Ki = 0 OlnM Tsuru et a l , 1988
Z-Pro-Prolinal Kj = 14nM Wilk and Orlowski, 1983
a-Ketobenzothiazole IC50 = 5nM ( Tsutsumi et a l , 1994
Z-Phe-Pro-Methylketone Ki = 1 8nM Stemmetzer et a l , 1993
Z-Cyclohexyl-Prolinal Kj = 3 0nM Bakker et a t, 1991
Z-Indolinyl-Prolinal Kj = 2 4nM Bakkere/flZ., 1991
Boc-Glu(NHO-Bz)-Pyir Kj = 0 03jjM Demuth et a l , 1993
Table 1 2  PE specific inhibitors Postatin and Eurystatin A and B are prolyl endopeptidase 
specific inhibitors isolated from fermentations of Streptomvces viridnchromopenes MH535-30F3 
and Streptomvces eurvthermus R353-21 respectively Many of the inhibitors presented are 
derivatives o f the original prolyl endopeptidase specific inhibitor, Z-Pro-Prohnal
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<An endogenous inhibitor of PE activity was identified by Yoshimoto et a l , (1982b) These workers 
punfied the compound and reported it to have a molecular weight of 6 500Da It was distnbuted widely 
m both rat and porcine tissues with the highest levels detected in the pancreas Recent studies by 
Salers (1994), have suggested that this inhibitor is present in neonatal rats but that its levels decrease 
as the rat ages, explaining why PE activity in neonatal rats increases over the same penod Ohmon et 
a l , (1994), screened peptides from bovine bram homogenates for inhibitory activity against PE They 
isolated one octadecapepode that demonstrated a K, value of 8 6fiM against PE activity obtained from 
Flavobacterium menmgosepticum
1 3.1.5.  Biological Relevance of Prolyl Endopeptidase
The wide distribution of PE and its activity towards may bioactive pepudes (Table 11) ,  implies that 
the enzyme may have important and/or specific biological functions However, despite the many 
reports mvolvmg in vitro studies concerning PE, it is only when these findings are confirmed in vivo, 
that the true function of PE will be elucidated For this reason, the m w o  implications of PE activity 
will be discussed.
In vivo studies mvolvmg PE can be divided broadly into two categories, those where abnormalities m 
the activity level of the enzyme are linked to a physiological or disease state (comparative activity 
studies) and those where the inhibition of the enzyme in vivo lead to changes m physiological 
parameters (cause and effect studies)
1.3 .1 .5 .1 .  Comparative Activity Studies
By measuring the levels of PE activity m vanous tissues obtained from patients suffenng from vaned 
disease states, and companng these activities to control levels, lmks between PE activity and its 
physiological role can be made In 1994, Maes et a l , reported a significant decrease m serum PE 
levels obtained from patients suffenng from melancholic, minor and simple major depressions The 
greatest reductions m enzyme activity were observed in serum from metanchohcally depressed subjects 
These workers indicated that pepudes known to be involved in the pathophysiology of depression 
included arginine vasopressin, p-endorphin, TRH and LHRH all of which are natural pepude substrates 
for PE This group extended the study in 1995 to mclude manic and schizophrenic patients, confirming 
their earlier work and noting a significant increase m serum PE activity obtained from subjects 
suffering from the psychotic disorders They also suggested that PE may be involved m the activation 
of cell mediated immunity, autoimmune and inflammatory responses, which repeatedly occur in severe 
depression This link between PE and inflammatory or autoimmune syndromes has been made by 
other groups studying quite different physiological events
Shoji et a l , (1989), reported depression of PE activity in inflamed skin, induced m hypersensitive 
guinea pigs with bovme-7-globulm The depressed enzyme activity was caused by an endogenous PE 
inhibitor, generated by the inflammation
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In a mouse model of systemic lupus erythematosus, PE activities were increased in the spleen of 
diseased subjects when compared to controls This increase was progressive with age and indicated an 
important role played by PH m the immunopathological disturbances associated with this syndrome 
(Aoyagi et a l , 1985 and 1987) A further link between PE and immunological disturbances was made 
by Kanon et a l , (1991), when they reported increased PE levels in synovial membrane preparations 
from patients suffenng from rheumatoid arthritis
Abnormally high or low PE activities have also been linked to neurodegenerauve disorders In studies 
evaluating the PE levels m postmortem brains, obtained from subjects who had suffered from 
Alzheimer's disease, significant increases in the levels of enzyme activity were observed (Aoyagi et a l ,
1990) Increases in PE activity were also observed in homogenates of spinal cord obtained from 
patients suffenng from motor neuron disease (Falkous et a l , 1995) However, in studies investigating 
the physiology of Parkinsonian and Huntington’s Chorea patients, lowered PE activities were observed 
m the cerebrospinal fluid and basal ganglia respectively (Hagihara et a l , 1987, Pittaway et a l , 1984)
1.3 .1 .5 .2 .  Cause and Effect Studies
The application of PE specific inhibitors has revealed further physiological possibilities for this 
enzyme
In 1995, Miura et a l , reported that inhibition of PE activity m the to m  of rats, through the oral 
administration of Z-Pro-Prolinal, significantly increased the levels of arginine vasopressin obtained in 
the septum area of the rat brain They deduced from this study that PE may contribute to the 
degradation of endogenous arginine vasopressin m the bram
Amnesia, induced in rats via administration of scopolamine, was reported to be protected against by 
eurystatins A and B, two PE specific inhibitors of microbial origin (Kamei et a l , 1992) This 
confirmed an earlier report by Yoshimoto et aL, (1987), whereby Z-Pro-Prolmal also protected rats 
from scopolamine induced amnesia. It is thought that the inhibition of PE prevents its activity 
towards Pyr-Asn-Cys-Cys-Pro-Arg, a metabolite of vasopressin which was deduced as havmg a direct 
mvolvement w memory and related processes (DeWied et al, 1984)
1.3 .2 .  Dipeptidyl Peptidase IV (EC 3.4.14.5)
Dipeptidyl Peptidase IV was discovered by Hopsu-Havu and Glenner (1966) while studying enzymatic 
activities in rat liver They observed an activity capable of degrading (Hy-Fro-P-naphthylamide and 
called this enzyme glycylprolyl-p-naphthylamidase Further substrate specificity studies earned out by 
McDonald et al (1971), led to its referral as dipeptidyl ammopeptidase IV The distribution of 
dipeptidyl peptidase IV seems to be ubiquitous, with activities punfied from many mammalian, insect 
and bactenal sources (Table 1 3)
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Source Localisation Reference
Flavobactenum memngosepticum Soluble Kabashima et a i f 1995
Porphyromonas gingivahs Soluble Gazi et a l , 1995
Bovine kidney Membrane Brownlees et a l 1992
Bovine uterus Soluble Liu and Hansen, 1995
Canine intestine Membrane Pemberton et a l , 1995
Guinea-pig bram Membrane Smyth and O'Cuinn, 1994
Human lung Membrane Jackman et ai, 1995
Human lymphocytes Membrane Kuiktschiev et a l , 1993
Human oesophagus Membrane Christie et a l , 1995
Human seminal plasma Soluble DeMeester et a l, 1996
Mouse lymphocyte Membrane Bernard et a l , 1994
Porcine oesophagus Membrane Christie et a l , 1995
Porcine seminal plasma Soluble Ohkubo et a l , 1994
Rabbit intestine Membrane Bai, 1993
Rat team Soluble and 
Membrane
Alba et a l , 1995
Table 1 3 Distribution of Dipeptidyl peptidase IV (DPPIV) This table illustrates the 
ubiquitous nature o f DPPIV among micro-organisms and various mammalian tissues DPPIV 
can be localised in the cytoplasm (soluble) but it is more common to find the enzyme 
membrane bound
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The enzyme has been characterised in both membrane and soluble forms and has also been identified as 
an important signalling molecule on T and P lymphocytes, where it is referred to as CD26
1 3  2 1 Biophysical And Biochemical Aspects of Dipeptidyl 
Peptidase IV
Dipeptidyl peptidase IV (DPPIV) is a glycoprotein Nine glycosylation sites have been identified 
within the DPPIV peptide sequence and sugars associated with these sites include sialic acids, mannose 
and galactose (Misumi et a l , 1992, Marguet et a l , 1992, Kyouden et a l , 1992) The mammalian 
form is reported to be a dimer, with subunit molecular weights in the range of 100kDa-130kDa (Abbs 
and Kenny, 1983, Enkson et a l , 1983, Puschel et a l , 1982) There have been reports of 2 different 
molecular weight versions of DPPIV m human serum with monomenc values ranging from 105kDa to 
175kDa and native values of 250kDa-550kDa (Duke-Cohan et a l , 1996, Krepela et a l , 1983) The 
structure of DPPIV has been deduced from its cDNA obtained from a variety of sources cDNA from 
Flavobactenum memngosepticum, human, murine and rat DPPIV code for 711, 766, 760 and 767 
amino acids respectively The bacterial protein had a deduced subunit molecular weight of 80,626Da 
while the mouse and rat values were 87,500 and 88,107 Daltons respectively These values do not 
consider the added weight of glycosylation (Kabashima et al ,„1995, Misumi et al, 1992, Tanaka et al,
1992, Marguet et a l , 1992, Ogata et a l , 1989) The gene coding for human DPPIV has been located 
on the long arm of chromosome 2 (2q24) (DarmouJ et aL, 1994, Abbott et a l , 1994)
The pH optimum of DPPIV, though dependent to some degree on the substrate used, ranges from 8 0- 
9 0, with a general consensus of maximum activity obtained at pH 8 5 Similarly, pi values range 
from 3-5, with the majority of reports quoting pi figures of 4 7 Interestingly, conflicting reports as to 
the effect of neuraminidase, an enzyme that removes neuraminic aad from protein glycosylation sites, 
on the pi of DPPIV have been published, with workers observing both increased and decreased pi values 
for DPPIV following neuraminidase treatment (Liu and Hansen, 1995, DeMeester et a l , 1992, 
Mmeyama and Saito, 1991, Yoshimoto et a l , 1982)
DPPIV has been classified mechanistically as a senne protease due to its inhibition by DFP and its 
resistance to inhibition by sulphydryl blocking agents and chelators (Ohkubo et al f 1994, Schon,
1993, Hama et a l , 1982) Sequencing and cDNA studies have revealed more specific details regarding 
the active site of this protease The catalytic site is located at the C-terminal region of the polypeptide 
This has been described as the protease domain, which is attached to a non-catalytic structural domain 
(Loster et a l , 1995, Polgar and Szabo, 1992) The active site catalytic triad has been identified as 
Ser624, Asp702 and His734 in murine DPPIV but the active site same residue in the human enzyme 
is identified as Ser631 (David et a l , 1993, Fujiwara et a l , 1992) In humans, the consensus sequence 
for the active site senne residue is Gly-Xaa-Ser-Xaa-Gly This sequence is identified in DPPIV as 
Gly629-Trp-Ser-Tyr-Gly633 Substitution of senne or either of the glycine residues in this sequence 
and subsequent expression of the mutated protein results in the production of inactive enzyme (Fujiwara
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et a l , 1992, Ogaia et a l , 1992) The novel topology of the catalytic tnad (Ser, Asp, His) residues and 
the lack m sequence homology between DPPIV and classical senne proteases (eg trypsm) indicates that 
this enzyme is a member of a recently identified subclass of senne proteases (David et a l , 1993) 
Detailed thermodynamic analysis of the reaction mechanism of DPPIV has led Brandt et al (1996), to 
propose a novel mechanism for senne protease catalysis They suggest a stabilisation of the tetrahedral 
intermediate by oxazohdme nng formation with the P2 - Pi non-scissile bond and trans-cis 
lsomensation of this bond m the final steps of bond cleavage
1 3.2 2. Substrate Specificity of Dipeptidyl Peptidase IV
DPPIV cleaves dipeptides from substrates consisting of three or more ammo acid residues or dipeptides 
linked to C-terminal chromogenic or fluorogemc compounds such as 2-naphthylamides or 
methylcoumann amides (Yaron and Naider, 1993) Proline is the preferred residue at position Pi, but 
it may be substituted by alanine or hydroxyprolroe, resulting m lower activities against these 
substrates It should also be noted that the catalytic mechanism by which DPPIV cleaves dipeptides 
with Pi alanine is different to the mechanism where P i is a proline residue (Hems et a l , 1988) Bonds 
where both ?\ and P i’ residues are proline, are not cleaved and there is an absolute requirement for the 
Pi-Pi* bond to be m trans configuration (Puschel et a l , 1992, Fischer et a l , 1983)
Bovine growth hormone releasing factor (GRF) has been studied extensively with regards to DPPIV 
specificity The N-tenninal sequence of this peptide, Tyr-AIa-Asp-, is cleaved quite efficiently by the 
enzyme However, substitution of the Tyr-Ala- moiety by His-Val-, protects GRF from DPPIV 
hydrolysis, retaining the peptides potency and indicating the importance of the Pi residue (Campbell et 
a/,1994)
t
Bongers et al (1992), earned out extensive studies into the specificity of DPPIV for GRF and its 
analogues They observed no differences in the rates of hydrolysis obtained for GRF(l-44), GRF(l-29) 
and GRF(l-20) Lower rates of cleavage were observed for G RF(l-ll) and GRF(l-3) indicating that 
substrate binding by the enzyme extends beyond the Si* subsite Substitution of D configuration 
residues in positions P2 , P i or P i’ resulted in no hydrolytic activity, demonstrating DPPIV's stnct 
requirement for L-residues in these positions Indeed, the requirement for L-residue configuration 
extends to P4\  indicating an S4  subsite These workers also investigated the kinetic effects observed 
when alanine in the P i position was substituted The results obtained were as follows
Km Abu<Ala<Pro<Val<Ser<Gly«Leu and kcat Abu>Pro>Ala>Ser>Gly=Val»Leu
where Abu is a-aminobutync acid The position of proline and alanine is particularly interesting As 
stated earlier, high hydrolytic activities are obtained when the Pi position is occupied by proline 
However, DPPIV demonstrates greater specificity towards GRF with alanine m this position
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Bongers et a l , concluded that the ethyl side chain of a-aminobutync acid was close to the optimal Pi 
specificity of DPPIV which they described as being a hydrophobic residue, 0 25nm m length
Other substrates of interest are substance P and p-casomorphin The acuon of DPPIV on substance P 
(Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met), produces des[Arg^-Pro^] substance P which is 
subsequently hydrolysed to des[Arg^-Pro^] (Conlon and Sheehan, 1983) p-casomoiphin (Tyr-Pro-Phe- 
Pro-Gly-Pro-De) is cleaved sequentially at Pro^ and Pro^ (Kreil et a l , 1983)
1.3 2.3.  Assays for Dipeptidyl Peptidase IV Activity
Assays for the enzyme are based primarily on substrates whereby a chromophore or fluorophore is 
attached to the C-tenmnus of the dipepbde Gly-Pro- (Shibuyu-Saruta et a l , 1995) An alternative 
assay for the enzyme was developed by Hoffman et al (1995), when capillary electrophoresis was used 
to analyse the fragments produced following the action of DPPIV on the N-termmal dodecapeptide of 
interleukin-2
1.3.2.4* Specific Inhibitors of Dipeptidyl Peptidase IV
Diprotin A (Ile-Pro-Ile) and diprotm B (Val-Pro-Leu) are well known specific inhibitors of DPPIV 
activity and have been used extensively in the identification of this enzyme (Sedo and Revoltella, 
1995, Umezawa et a l , 1984)
Anunoacylpyrrohdme-2-mtnles have been recently developed to specifically inhibit DPPIV The 
carboxyl group of prolrne is replaced by a mtnle which is thought to interact with the active site 
senne, forming an imidate adduct These compounds are synthesised easily, yet remain potent and 
stable DPPIV inhibitors (Li et al, 1995)
Some of the most effective DPPIV inhibitors are of the type Xaa-boroPro, where boroPro is an ammo 
boromc acid analogue of prolrne In 1993, Gutbeil and Bachovchm reported that the L-L-chastereomer 
of Pro-boroPro inhibited DPPIV with a Ki of 16 picomohr
1.3 .2 5. Physiological Relevance of Dipeptidyl Peptidase IV
The ubiquitous distribution o f DPPIV, implies that it may play an important role m different in vivo 
physiological processes It is likely that the localisation of the enzyme will influence the particular 
function is performs
1 3 .2  5.1.  Absorption Of Proline Containing Peptides.
The absorption or recycling of prolrne containing peptides is a vital process DPPIV's contribution to 
this process is twofold due to its brush border localisation in the small intestine and the kidney The 
functional role of DPPIV in the intestinal hydrolysis and assimilation of prolyl peptides was
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investigated by Tirupathi et a l , (1993), using rats which were genetically deficient in this enzyme 
When a reference diet, where proteins were normal in proline content, was fed to DPPIV deficient rats 
(DDR) and an appropriate control group, no difference in the growth rates of either group was observed 
When the protein source was changed to a proline nch protein, gliadin, the control groups maintained 
their weights, while the DDR group experienced significant weight loss Similarly, when Suzuki et 
a l , (1993), fed high proline content diets to rats, the expression of intestinal brush border DPPIV 
increased dramatically, confirming the proteases role in the hydrolysis and assimilation of prolyl 
peptides and proline nch proteins Similar experiments earned out on DDR rats, but concentrating on 
the renal absorbtion of proline containing peptides, led workers to conclude positively with regards to 
the physiological role played by DPPIV (Miyamoto et a l , 1987, Tirupathi et a l , 1990)
1.3.2.5.2.  Immunological Relevance
The role of DPPIV in the immune system became of interest when its presence on the surface of 
human penpheral lymphocytes as an ectoenzyme was demonstrated (Lojda, 1977, Sedo et a l , 1989) It 
was soon concluded that a T-lymphocyte surface antigen, designated CD26, and a leukocyte activation 
marker (Tpl03) were m fact DPPIV (Fox et a l , 1984, Hegen et a l , 1990) The enzyme is now known 
to be an activation marker on T-cells, natural killer cells and 6-cells (Buhling et a l , 1995) The precise 
details on the mechanism and nature of its interaction with physiological substrates, and it subsequent 
activation of lymphocytes are unclear It is known that substrate or mitogemc interaction with CD26 
can cause lymphocyte differentiation, increases m the rate of DNA synthesis and increased cytokine 
production It is also known that, although activation molecules need not be targeted directly to the 
active site of DPPTV, its enzymatic activity is required for signal potentiation (Dong et a l , 1990, 
Kahne et a l , 1995, Reinhold et a l , 1994)
1.3.3.  Dipeptidvl Peptidase II (EC 3.4.14.2)
Dipeptidyl peptidase II (DPPII) is, m may ways, similar to DPPIV, in that it catalyses the removal of 
N-terminal dipeptides from substrates Detailed biochemical and substrate specificity studies, however, 
distinguish this enzyme from DPPIV
The enzyme is primarily lysosomally located and is widely distnbuted It is a dimenc protein with 
reported molecular weights of between 80kDa and 130kDa for the native enzyme The protein is 
glycosylated (approximately 2% w/w) with mannose representing most of the attached sugar moieties 
Reported pH optima for DPPII range from 5 5 to 6 3, with a consensus among most reports that the 
pH optimum is 5 5, which is appropriate to its subcellular localisation The enzyme has a pi of 4 8- 
5 0, with no change being observed following treatment with neuraminidase, indicating that there are 
no sialic acids taking part m its glycosylation The enzyme has been classed as a senne protease, based 
on its inhibition by DFP and its resistance to sulphydryl blocking and chelating agents
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DPPII removes N-terminal dipepudes from substrates of the general sequence Xaa-Pro-Yaa 
Substitution of the Pj proline with alanine is accepted and results in comparable hydrolvtic rates which 
is unusual among the proline specific enzymes discussed thus far Favoured residues m the P2 position 
are basic and neutral ammo acids, with 100 fold decreases in hydrolytic activity being observed with 
acidic residues at this position Another unusual aspect of the substrate specificity of DPPII is its 
ability to cleave Xaa-Pro-Pro bonds Tnpepudes are the preferred chain length, with decreased activity 
towards tetrapeptides Substrates with more than four residues are not cleaved (Lynn, 1991 Mentlein 
and Struckhoff, 1989, Scott et a l , 1988, Lampelo et a l , 1987, Eisenhauer and McDonald, 1986, 
Fukusawa et a l , 1983)
Lys-Ala-MCA was synthesised by Nagatsu et a l , (1985), for the specific determination of DPPII 
activity in rat tissues This substrate and variations on the Lys-Ala theme are still used as the preferred 
substrate for DPPII activity determinations (Smyth and O Cuinn, 1994)
DPPII is commonly used as a lysosomal marker enzyme It is thought to play a physiological role in 
peptide catabolism and post-translational modification, with suggestions that it plays an important role 
m the catabolic processes of cell differentiation (Roberts et a l , 1990, Duve et a t, 1995, Struckhoff,
1993) Significant increases in DPPII activity have been reported m the brain and cerebrospinal fluid of 
patients suffering from Parkinson's and Huntington's disease (Mantle et aL, 1995, Hagihara et a l , 
1987b)
1.3 .4 .  Aminopeptidase P (EC 3.4.11.9.)
Ammopeptidase P was first isolated from the soluble fraction of Escherichia coli by Yaron and Mlynar, 
(1968) These workers were studying prolrne containing polypeptides and the specificity of their 
enzymatic hydrolysis Using polymers of proline as substrates, several proteolytic enzymes were 
detected and isolated from bacteria. Aminopeptidase P was isolated and characterised during these 
investigations and was found to be responsible for the specific cleavage of N-termmal Xaa-Pro peptide 
bonds in both short and long peptides (Yaron and Berger, 1970) The enzyme is widely distributed 
among mammalian and microbial sources (Table 1 4 )
1 .3 .4 .1 .  Biophysical and Biochemical Characteristics of
Aminopeptidase P
The molecular weight of Ammopeptidase P (APP) and its subunit structure are source dependent 
Bacterial APP has been the best studied to date, and is reported to be multimenc with tbe molecular 
weight of the inactive monomer ranging from 50kDa to 60kDa. A cloned and sequenced APP from E 
coh had a monomenc molecular weight of 49,650 Da, deduced for 440 ammo aad  residues 
Subsequent expression of this gene revealed a native molecular weight of 200kDa, indicating a 
tetramenc subunit structure (Yoshimoto et a l , 1988b and 1989) Oyama et al., (1989) obtained 
similar results when E colt APP was expressed in Bacillus subtilis
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Source Enzyme localisation Reference
Bovine adrenal medulla Soluble Vanhoof et a l , 1992b
Bovine lung Membrane Orawski et a i, 1987
Escherichia coh Soluble Yaron and Mlynar, 1968
Guinea pig serum Soluble Ryan et a l , 1990
Human erythrocytes Soluble Sidorowicze/fli, 1984b
Human kidney Membrane Hooper and Turner, 1988
Human leukocytes Soluble Rnsu and Yaron, 1992
Human lung Membrane Sidorowicz et a i , 1984
Human serum Soluble Holtzman et a l , 1987
Lactococcus lactis Soluble Mars and Monnet, 1995
Rat bram Soluble Harbeck and Mention, 1991
Streptomyces Imdans Soluble Butter etaL, 1993
Table 1 4 Distribution o f Ammopeptidase P This table is not an exhaustive list 
but rather a means to illustrate the ubiquitous nature o f Ammopeptidase P among micro­
organisms and mammals o f different species
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Mammalian APP, however, vanes with regard to its native molecular weight and subunit makeup 
Soluble forms of the enzyme, isolated from rat bram and human leukocytes, were dimers with a native 
molecular weight of 140kDa (Harbeck and Mentlein 1991, Rusu and Yaron, 1992) The rat bram 
soluble APP, however, was revealed to be trunenc when the native molecular weight was estimated by 
gel filtration chromatography in the absence of salt, indicating that its native molecular weight was 
dependent on salt concentration (Harbeck and Mentlein, 1991) Tnmenc forms of soluble APP were 
also reported for guinea-pig serum and human platelets with native molecular weights of 220kDa (Ryan 
et al, 1992, Vanhoof et al, 1992) Similarly, a tnmer of 280kDa was observed when membrane bound 
APP was isolated from porcine kidney by Hooper et a l , (1990) APP from bovine lung was found to 
be tetramenc with a monomenc molecular weight of 95kDa. It is not suipnsing that the mammalian 
APP subunit molecular weight is considerably larger than that of the bacterial enzyme as recently, 
Vergas Romero et al, (1995), reported that the ammo acid sequence of mammalian APP from porcine 
kidney consisted of 623 ammo acids
Bactenal and, soluble and membrane mammalian APP, have been classified as metalloproteases based 
on their inhibition by metal chelators (Yo&himoto et a l , 1989; Simmons and Orawski, 1992, Harbeck 
and Mentlein, 1991) This inhibition is caused by the removal of an essential metal atom from the 
active site of the enzyme Hooper et al, (1992), have recently identified the APP active site metal atom 
as zmc The metal atom provides an electrophilic "pull", co-ordinating the nucleophilic attack by water 
on the peptide bond It is co-ordinated tetrahedrally within the active site, being bound to two 
histidines residues A third attachment is to a water molecule which remains in the active site 
following substrate binding and may take part in the nucleophilic attack on the substrate A fourth 
interaction occurs between substrate and metal ion subsequent to binding (Dunn, 1989) The anchoring 
of the metal atom by two histidine readues m the active site is relevant as Lun and Turner, (1996), 
have recently identified two histidine residues in porcine kidney APP that are cntacal for enzyme 
activity Some confusion arises in the hterature as to the effect of different divalent metal ions on APP 
activity Zmc is reported to be inhibitory towards APP from vaned sources including porcine kidney, 
rat brain, human platelets and leukocytes (Harbeck and Menttem, 1991, Hooper et aL, 1990, Rusu and 
Yaron, 1992, Vanhoof et a l , 1992) Zinc has also been reported as been acdvatory towards APP 
isolated from guinea-pig serum (Ryan et a l , 1992) Divalent metal ions commonly associated with 
the activation of APP, or its reactivation following exposure to chelators, are Mn^+ and Co^+ (Rusu 
and Yaron, 1992, Hooper et a l , 1990; Orawski and Simmons, 1995, Fleminger and Yaron, 1984) 
Only one report concerning human lung APP (Sidorowicz et a l , 1984) showed no inhibition of the 
enzyme by chelators These workers did observe a decrease in APP activity but concluded that this 
decrease was due to the chelation of activating metal ions that were loosely associated with the enzyme
The inhibition of APP by thiol functional reagents has also been widely reported (Mars and Monnet, 
1995, Ryan et a l , 1992, Sodorowicz et a l , 1984b) These results concur with the identification of 
four cysteme residues per subunit in the cloned E colt APP (Yoshimoto et a l , 1989) The cysteine
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residues might not be located m the active site, yet retain a functional significance The inhibition of 
APP b\ Lhiol reagents, such as DTT may be a competitive interaction between the reagent and 
substrate for the fourth metal atom co-ordination position (Campbell et a l , 1988) Care must be taken 
when interpreting the inhibition of APP by metal ions or thiol functional reagents as these observed 
characteristics may be substrate dependent (Lloyd and Turner, 1995)
Optimal APP activity is obtained at pH 7 0 - pH 8 5 at an optimum temperature of 43°C (Rusu and 
Yaron, 1992, Orawski and Simmons, 1995) One interesting point, with regards to the biophysical 
and biochemical attributes of APP, was reported by Orawski and Simmons (1995) who observed that a 
membrane bound rat lung APP was inhibited by NaCl, complete inhibition being observed at 2M 
NaCl This may relate to the salt dependent nature of mulumenc APP forms discussed earlier 
Considering that monomeric forms of the enzyme are reported to be inactive, the inhibition of APP 
activity by high salt might indicate that cooperativity between subunits is essential for substrate 
hydrolysis.
1.3.4.2.  Substrate Specificity of Aminopeptidase P
Although substrate specificity studies on mammalian APP are not as complete as those of the bacterial 
enzyme, both lead to similar conclusions APP is an exopeptidase which hydrolyses a variety of 
peptides ranging m size from dipepDdes to proteins It cleaves between an N-termmal ammo acid (Pj) 
and a penultimate proline (P jf) The N-termmal amino acid must have a free ammo group, the 
penultimate residue must be proline and the scissile bond must be m the trans configuration (Lin and 
Brandts, 1979)
In 1983, Flemmger and Yaron reported the cleavage of bradykmin (Arg-Pro-Pro-Gly-Pbe-Ser-Pro-Phe- 
Arg) by nmnobOised bacterial APP, with arginine and proline being released sequentially from the N- 
termmus. Reports of mammalian APP cleaving bradykmin followed (Sidorowicz et a l , 1984, Ward et 
a l , 1991, Hooper et a l , 1992) These workers also observed the cleavage of dipeptides such as Phe- 
Pro, Arg-Pro and Ala-Pro Harbeck and Mentlem, (1991), reported that APP isolated from rat brain 
cytosol, selectively liberated all unblocked ultimate (Pi) residues from di-, tn- and oligopeptides with 
N-terminal Xaa-Pro- sequences, where Xaa (Pi) was preferentially a hydrophobic or basic residue 
Replacement of the penultimate residue (P i’) by alanine or any residue other than proline, led to 
decreased or no hydrolysis being observed
Bioacdve peptides cleaved include bradykmin, substance P and melanostatm (Simmons and Orawski, 
1992) Peptide-YY (PYY) cleavage by APP has also been reported (Medeiros and Turner, 1994) 
Yoshimoto et aL> (1988c), identified a third subsite (S2*) m bacterial APP which preferentially bound 
aromatic ammo acids at the P? position This preference was confirmed when Gly-Pro-pNA, Gly-Pro- 
pNA and Gly-Pro-MCA were observed as excellent substrates for the enzyme
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In 1994, Yoshimoto et al., carried out detailed substrate specificity studies on APP isolated from E. 
coli. These workers found that dipeptides were hydrolysed very slowly relative to longer substrates and 
a fourth enzyme subsite was identified (S3*). S\ and Si' were highly stereospecific with preferential 
binding of hydrophobic residues at S\. They also noted that bacterial APP could accommodate most 
amino acid residues in the S2' subsite. This was in contrast to mammalian APP which could not 
accommodate bulky P2’ residues. The presence of four substrate binding sites for mammalian APP 
was confirmed by Orawski and Simmons, (1995), who also reported that the Si, S]' and the S2* 
subsites had to be occupied for substrate hydrolysis to occur.
1.3 .4 .3 .  Assays for Aminopeptidase P Activity
The original assay procedures used to detect APP activity were developed by Yaron and Berger, (1970), 
and were based on the cleavage of polyproline. These substrates proved insufficient however, as they 
were neither sensitive nor specific, and were only hydrolysed slowly by purified mammalian APP 
(Rusu and Yaron, 1992; Harbeck and Mentlein, 1991). Specific substrates of the sequence Xaa-Pro-Pro 
were developed as they were resistant to dipeptidyl aminopeptidase and carboxypeptidase hydrolysis. 
Fleminger et al., (1982), developed an intramolecularly quenched fluorimetric substrate, Lys-(Dnp>Pro- 
Pro-Eda-Abz. The fluorophore, 2-aminobenzoyl (Abz), was quenched by the dinitrophenol (Dnp) 
moiety. Following the removal of Lys(Dnp) by APP, Abz could be detected fluorimetrically, resulting 
in a sensitive and specific assay for the enzyme.
Coupled enzyme assays have also been developed and used successfully for the detection of APP. 
These include colorimetric and fluorimetric substrates such as Gly-Gly-Plro-pNa (Lasch et a l , 1988) and 
Gly-Pro-MCA (Yoshimoto et al., 1988), coupled with the enzymes dipeptidyl aminopeptidase IV or 
proline iminopeptidase respectively.
Radiolabelled assays are also in use, including radiolabelled bradykinin (^H-Bradykinin) and a 
radiolabelled bradykinin fragment, (Arg-Pro-Pro-3H)-benzylamide (Ryan et aL, 1992b).
1.3.4.4.  Specific Inhibitors of Aminopeptidase P
Prechel et a l (1995), designed the APP inhibitor, apstatin, based on an N-blocked tripeptide (Pro-Pro- 
Ala-NH2). It was synthesised specifically to facilitate the inhibition of APP during investigations into 
the degradation of bradykinin, and was reported to have no inhibitory effect on angiotensin converting 
enzyme (ACE) or other known bradykinin degrading enzymes. It inhibited APP with a Kj of 2.6pM.
1.3 .4 .5 .  Physiological Relevance of Aminopeptidase P
A single report of a disease linked to human APP deficiency has been published by Blau et al. (1988). 
These workers discovered a new inborn error of metabolism, whereby a deficiency in APP led to the 
development of peptiduria.
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However, the specificity of APP suggests that this enzyme may have a unique biological role Table 
1 5 lists a number of bioactive polypeptides that contain N-termmal Xaa-Pro- bonds (Yaron and 
Naider, 1993) These include hormones, toxins and enzymes Because of the N-termmal Xaa-Pro 
bond, these peptides are ideal substrates for APP Their hydrolysis might lead to a loss or alteration in 
biological activity, or initiate a cascade of events leading to the eventual termination of biological 
activity and subsequent peptide/protein turnover For example, the action of APP on peptide-YY 
regulates the mterconversion of this peptides’ receptor selectivity (Medeiros and Turner, 1994)
It is also possible that APP plays an important role m the tnmming of biosynthetic precursors during 
post-translational modification The specificity of APP makes it ideal for the final post-translauonal 
modification steps involving peptides containing an N-termmal proline
The high APP activity found m various blood components may also be of physiological significance 
Scharpe et al (1990) and Hendnks et a l , (1991) reported that the majority of APP found m blood was 
located inside platelets, unlike other exopeptidases such as ACE and DAP IV These findings support 
the hypothesis that APP is involved in the regulation of cardiovascular and pulmonary functions 
Ryan et a l , (1990) observed that APP can act in vitro on the anuanhythmic peptide (Gly-Pro-Hyp- 
Gly-Ala-Gly) and substance P, peptides that are associated with cardiovascular physiology In 1995, 
Prechel et al reported that APP and ACE working together, fully accounted for the degradation of 
bradykimn in the rat pulmonary vascular bed Also, m 1995, Kitamura et al reported that blood 
pressure responses to administered bradykimn following treatment of rats with apstatm, were doubled 
They concluded that APP was an important in vivo kminase To combat the effects of APP on 
bradykimn activity, Ward et a l , (1991), have developed bradykimn receptor agonists and antagonists 
resistant to APP attack B7644, an agonist of bradykimn, was found to be resistant to APP hydrolysis 
and more potent than the natural peptide
1.3 .5 .  Prolidase (EC 3.4.13.19.)
Prolidase was first discovered by Bergmann and Fruton, (1937), while studying aminopeptidase and 
carboxypepddase activities in porcine intestinal mucosal extracts It was subsequently purified and 
characterised from porcine kidney, and porcine and bovine intestine (Davis and Smith, 1957, Sjostrom 
et a l , 1973, Yoshimoto et a l , 1983)
Prolidase is closely related to ammopeptidase P in that it removes N-terminal amino acids from 
substrates with prolrne m the penultimate P i' position yet it is manifestly dipeptide specific Like 
APP, the enzyme is widely distributed among mammalian and microbial sources (Table 1 6 )
1 3 .5  1 Biophysical and Biochemical Aspects of Prolidase
The molecular weight of prolidase, like the molecular weight of aminopeptidase P, is difficult to state 
definitively In previous reviews on proline specific peptidases, the native molecular weight of a
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Polypeptide N-terminal sequence
Basic tiypsin inhibitor Arg-Pro-Asp-Phe-Cys-
Bradykimn Arg-Pro-Pro-Gly-Phe-
P-casomorpliiD Tyr-Pro-Phe-Pro-Gly-
Cathepsin B Leu-Pro-Ala-Ser-Phe-
CathepsinD Gly-Pro-Iie-Pro-Glu-
CathepsmH Gly-Pro-Tyr-Pro-Gly-
CathepsmL Leu-Pro-Asp-Ser-Val-
Eledoisin pGlu-Pto-Ser-Lys-Asp-
Erythropoietin Ala-Pn>Pro-Leu-Leu-
Factor Xll De-Pro-Pro-Tip-Glu-
Growth hormone Phe-Pro-Ala-Met- Pro-
Interleukin 2 Ala-Pro-Thr-Ser-Ser-
Neurotensin 9-13 Arg-Pro-Tyr-He-Leu-
Papain De-Pto-Glu-Tyr-Val-
Plasminogen Glu-firo-Leu-Asp-Asp*
Prolactin Leu-Pro-De-Cys-Ser-
Streptavidm Asp-Pro-Ser-Lys-Asp-
Substance P Arg-Pro-Lys-Pro-Gln-
Thyrotropm Phe-Pro-Asp-GIy-Glu-
Trypsinogen AIa-Pro-Asp-Asp*Asp-
Table 1 5 .  List o f  bioacnve peptide sequences that contain proline in the N- 
temunal penultimate position These peptide sequences are ideal substrates for  
Ammopeptidase P (Yaron andNaider, 1993)
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Source Reference
Bovine intestine Yoshimoto et a l, 1983
Human erythrocytes Ohhashi et a l , 1990
Human fibroblasts Oono e ta l, 1990
Human kidney Myaraera/., 1994
Human liver Endo et al, 1987
Human plasma Cosson et aL, 1992
Human prostate Masuda e ta i, 1994
Lactobacillus delbruecku Stucky etaL, 1995
Porcine intestine Sjostrom et a l , 1973
Porcine kidney Mock and Liu, 1995
Rabbit kidney Endre and Kuchel, 1985
Rat brain Middlehurst et a l, 1989
Rat liver Miech et a l, 1988
Xanthomonas mahophilia Suga et a i, 1995
Table 1.6 Distribution o f Prolidase This table is not an exhaustive list but rather a 
means to illustrate the ubiquitous nature o f Prolidase among micro-organisms and various 
mammalian tissues Prolidase is localised in the cytoplasm (soluble) There have been no 
reports regarding a membrane form o f the enzyme
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dunenc prolidase was reported as 1 lOkDa (Yaron and Naider, 1993, Waller et a l , 1980) Yaron and 
Naider based this value on the results of Endo et a l , (1989) A combination of human prolidase gene 
cloning and Edman sequence determination allowed these workers to deduce a monomenc molecular 
weight of 54,305 Da, which agreed with an estimation of 56kDa for human erythrocyte prolidase and 
more recent results (Richter et a l , 1989, Ohhashi et a l , 1990, Myara et al 1994 Suga et a l , 1995) 
However, m 1985, Butterworth and Pnestman reported the separation of two dunenc forms of prolidase 
(I and II) from human tissues with native molecular weights of 112kDa and 185kDa- This was later 
confirmed by Oono et a l , (1990) and Masuda et a l , (1994)
With the exception of one report (Suga et a l , 1995), the pi of mammalian and bacterial prolidase is 
4 6 A pH optimum of 7 5 has been observed for all forms of the enzyme (Stucky et a l , 1995, Myara 
et al , 1994, Oohashi et a l , 1990)
Biochemical characterisations of prolidases in general indicate that they are Mn++ activated yet 
inhibited by sulphydryl group reagents, indicating that the enzyme is a cysteine or metallo-protease 
Prolidase type II however was reported to be inhibited by Mn++ ions (Butterworth and Pnestman, 
1984, Sjostrom and Noren, 1974, Masuda et a l , 1994, Cosson et a l , 1992) King et a l , (1989), 
identified an active site Mn++ ion and concluded that prolidase is a metalloenzyme dimer whose 
subunits exhibited selective co-operative interaction pH dependent kinetic studies of prolidase activity 
towards picohnylprohnes suggested an active site mechanism involving the participation of two acidic 
metal ions positioned adjacently within the active site (Mock and Green, 1990, Mock and Liu, 1995) 
A functional group within the active site having a pKa of 6  6 has been widely reported This 
functional group is essential for catalytic activity and has been identified as a water molecule, rendered 
acidic through its co-ordination with the active site metal ion Productive chelation to this metal ion 
by the Pi substrate residue was observed with subsequent displacement of the functional water 
molecule (Mock and Liu, 1995, Radzicka and Wolfenden, 1991, Mock et a l , 1990) Active site 
arginine and aspartic acid functional residues have also been identified (Mock and Zhuang, 1991)
1.3 5 2 Substrate Specificity of Prolidase
Prolidase hydrolyses dipepudes in which the C-tenmnal residue is prolrne and the N-terminal residue is 
an amino acid with a free a-amino group Prolrne can be replaced by hydroxyprolme (Hyp), resulting 
m significant losses in hydrolytic activity Tissue culture studies illustrated that an auxotrophic 
Chinese hamster ovary (CHO) cell line could utilise Gly-Pro as a prolrne source through the action of 
prolidase Inability to similarly utilise Gly-Hyp was observed, indicating prolidase's poor activity 
towards this substrate (Emmerson and Phang, 1993) When proline is replaced at the C-terminus by 
Thi, a proline analogue whereby a sulphur atom is substituted into the pyrrolidine nng, the dipeptide 
Gly-Thi was hydrolysed at 2 7 times the rate of Gly-Pro (Yaron and Naider, 1993) It was also 
discovered that Z-pipecohc acid exerted the same level of inhibition towards prolidase as Z-Prohne, 
indicating that the prolrne binding S jf subsite could bind a six-membered piperodine nng as well as thet
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five-membered pyrrolidine ring of proline. This led workers to conclude that the S j' subsite was a 
hydrophobic cleft and could explain the observation that prolidase exhibited low rates of hydrolysis 
towards the substrates Leu-Ala and Ala-Leu (King et al.y 1989; Hui and Lajtha, 1980; Sjostrom et al., 
1973).
The requirement for a free a-amino group residue in the Pj position has been questioned by some 
workers. Mock et al., (1990), studied the specificity and pH dependence for acylproline catalysis by 
prolidase and found that at pH 6.6, significant hydrolysis of alkylthioacetyl prolines and haloacetyl 
prolines was evident.
Lin and Brandts, (1979b), concluded that prolidase had an absolute specificity for the substrate dipeptide 
bond to be in trans isomeric form. This was later confirmed using NMR analysis of Ala-Rro hydrolysis 
by the enzyme (King et al., 1986).
1.3.5.3.  Assays for Prolidase Activity
The prolidase assay is based on its hydrolysis of Gly-Pro, and methods used for product detection are 
primarily HPLC based with some reports of the use of isotachophoresis (Harada et al., 1990; Mikasa et 
al., 1985).
1.3.5.4.  Specific Inhibitors of Prolidase
In 1989, King et al. reported the competitive inhibition of prolidase by N-blocked proline (Z-Proline - 
Kj = 9.0 x 10'^M) and Z-pipecolic acid. Mock and Green (1987) reported the use of trans- 
cyclopentane-1,2, dicarboxylic acid as a prolidase inhibitor. This compound is a substituted Xaa-Pro 
dipeptide, where the Pi substrate position is replaced by dicarboxylic acid. A Kj value of 9.0 x 10'^M 
was reported for the interaction between this inhibitor and prolidase.
The most potent prolidase inhibitors reported to date are derivatives of phosphoenolpyruvate. 
Phosphoenolpyruvate is a metabolic intermediate which inhibits prolidase with a Kj of 8.0 x 10"^M. 
A bromophosphoenolpyruvate derivative inhibited prolidase with a Kj value of 4.0 x 10‘^ M (Radzicka 
and Wolfenden, 1991).
1.3.5.5.  Physiological Relevance of Prolidase
The primary biological function of prolidase is thought to be the metabolism of collagen degradation 
products and other Xaa-Pro dipeptides, with the subsequent recycling of proline. Prolidase deficiency 
(PLD-D) results in an inability to recycle proline from dipeptides and leads to abnormalities of the skin 
and other collagenous tissues, sometimes leading to mental retardation. Massive amounts of Xaa-Pro 
dipeptides are excreted by individuals suffering from PLD-D with Gly-Pro being the most prominent of 
these (Freij et al., 1984).
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PLD-D may be the result of biochemical alterations within prolidase rather than a marked reduction in 
the levels of the enzyme In 1984 and 1985, Butterworth and Pnestman compared the characteristics of 
prolidase in cultured skin fibroblasts from healthy and PLD-D individuals Using Gly-Pro as substrate, 
there was a marked loss of prolidase activity in PLD-D cells which could not be restored by the addition 
of Mn++ However only slight reductions m PLD-D prolidase activity were observed when Phe-Pro, 
Ala-Pro and Leu-Pro were used as substrates Usmg these substrates, normal prolidase activity was 
stable dunng prolonged incubation with Mn++ while the PLD-D activity was progressively 
inactivated In 1986, Lombeck et a l , reported that patients suffenng from PLD-D were found to have 
significantly increased Mn++ levels m their blood cells, yet their argmase and prolidase activity levels 
were almost halved They concluded that an altered form of prolidase rendered the Mn++ ions 
inaccessible to the active site, preventing the enzymes activation This altered prolidase was also 
observed by Ohhashi et a l , (1988), when prolidase from PLD-D serum could not be activated by 
Mn++> but was activated by Co++
The hereditary nature of PLD-D is classified as an autosomal recessive disorder (Bonght et a! , 1989) 
The structural organisation of the human prolidase gene was elucidated by Tanoue et a l , (1990), and in 
PLD-D patients, several hundred base pair deletions were evident, including the whole of exon 14 A 
guanine to adenosine substitution at position 826 in exon 12, resulting m the replacement of an 
aspartic acid by asparagine m the polypeptide cham, was also observed The human prolidase gene and 
the arginine substituted PLD-D gene were expressed m mammalian cell cultures, and although both 
genes produced a prolidase polypeptide, the substituted protein was inactive It was also demonstrated 
that active prolidase could be recovered from PLD-D cells following transfection with the normal 
prolidase gene They concluded that gene replacement might be an appropriate therapeutic regime for 
individuals suffering from PLD-D It is also interesting to restate that an essential aspartic acid residue 
in the active site of prolidase was identified by Mock and Zhuang, (1991)
Although the deletion of exon 14 was confirmed by other groups, these mutations were not found in all 
patients tested, indicating that the molecular defects in PLD-D were heterogenous This was confirmed 
by Ledoux et a /,  (1994), when cDNA samples from five patients suffenng from PLD-D were 
examined A wide vanety of different genetic mutations were evident in all five subjects They 
concluded that PLD-D is caused by mutations m multiple prolidase alleles
1-3.6.  HIV 1 Protease (EC 3.4.23.-)
HIV produces a small protease (HIV 1 protease) that specifically cleaves the polyprotein precursor in 
which structural proteins and enzymes of the virus are contained This enzyme is becoming one of the 
most important proteins m medicine as it is absolutely required for the production of mature, infectious 
vinons It is therefore the most attractive target for the development of anu-HIV therapeutic drugs
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The relevance of the HIV 1 protease to this discussion is that it has a high specificity for Xaa-Pro 
sequences in the middle of a polypeptide chain As an endopepudase that cleaves the Xaa-Pro ternary 
amide u is a rarity among proteases
1 3.6 1. Biophysical and Biochemical Aspects of HIV 1 Protease
The HIV 1 protease (HIVIP) has been purified from virions isolated from HIV positive patients 
However, the development of recombinant and total chemical synthesis methodologies have led to the 
production and purification of large quantities of the protein Most published investigative work into 
the varied biochemical aspects of HIV IP has been earned out on these "artificial” forms of the enzyme
In type I human immunodeficiency virus (HIV-1), the capsid and nonstructural proteins are synthesised 
as a single polypeptide precursor The polypeptide is coded by two genes, gag and pot and includes the 
protease HIV IP (Figure 1 4 a )  HIV IP autocatalytically excises itself from the precursor polypeptide 
by cleaving a Phe-Pro bond at its C- and N- termini at cleavage sites V and VI respectively (Figure 
1 4 b )  (Debouck et a l , 1987, Graves et a l , 1988)
A model was developed to examine the sequence of events leading to production of mature HIV1P, 
whereby, the protease polypeptide was flanked at its C- and N- termini by native sequences from the 
gag-pol precursor, the C- terminal sequence being fused to the maltose binding protein of £. coh 
(MBP) In its dunenc form, this polypeptide cleaved itself mtramolecularly between the C- terminal 
flanking sequence and HIV IP, releasing a HIV IP + N- terminal flanking sequence as a short hved 
intermediate This intermediate possessed activity similar to that of the mature protease The dimeric 
intermediate mtermolecularly removed the N-terminal flanking sequence producing the mature HIV IP 
(Wondrak et aLt 1996, Louis et a l , 1994, Boutelje et a l , 1990)
Mature HIV IP is a dimer of 2 identical subunits, each with a molecular weight of 11 kDa and 99 
ammo acid residues Monomeric HIV IP is inactive (Stnckler et a l , 1989, Tomasefli et a l , 1993) 
The rates of association of HIV IP  from monomeric to dimenc form woe found to be within the range 
commonly associated with protein-protem interaction (4 x lO^M^s"*), while the dissociation erf the 
dimer was found to be strongly pH dependent and governed by a dissociation constant m the picomolar 
range The enzyme exhibits maximal activity between pH 4 0 and 6 0, with an observed optimum pH 
of 5 5 (Darke et a l, 1994, Jordan et a l , 1992, Menendez-Anas et aL, 1992)
HIV IP is strongly inhibited by pepstatin and 1,2-epoxy-(3-(4-mtrophenoxy)propane) indicating that it 
is an aspartyl protease Indeed, its ammo acid sequence of 99 residues has shared homology with other 
aspartyl proteases such as renin, pepsin and chymosin (StrakalaiUs et a l , 1991, Meek et a l , 1989)
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Figure 1 3  HIV-1 Genome, (a) Schematic of the genome of HIV-I LTR-iong terminal
repeats gag-group specific antigen gene encodes viral nucleopcapstdproteins p24 a nucleoid shell 
protein p7t p i5, p l7  and p55, pol-polymerase gene, encodes the viral enzyme, proteose (plO), 
reverse transcriptase (p66/55, alpha and beta subunits) and integrase (p32), env-envelope gene, 
encodes the viral envelope glyocproteins gpl20 and gp41 ta t encodes transactivator protein, rev 
encodes a regulator o f expression of viral protein, vif associated with viral infectivity, vpu encodes 
viral protein U, vpr encode viral protein R, ne f encodes a ’so-called' negative regulator protein (b) 
Schematic illustrating HIV IP  cleavage sites (I-VII) on the gag and pol protein precursors
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An active site mechanism proposed by Hyland et al in 1991, was updated and detailed by Silva et a l , 
1996 Essentially, the substrate is asymmetrically bound to one active site aspartate residue Proton 
exchange between the aspartate and carborn I group of the scissile bond with simultaneous hydration of 
the bond to introduce flexibility, facilitates optimised binding Further proton movement from the 
hydroxyl of the scissile bond to an aspartate residue with concerted proton exchange between the second 
aspartate and the ammo group of the N-termmal product, introduces a bond break and regenerates the 
initial protonation state of the active site aspartates The active site aspartate residues have been 
identified at position 25 in each monomer Modification or substitution of these residues leads to 
inactivation of the protease (Lab et a l , 1991 Gnnde et a l , 1992)
Two cysteine residues have been identified among the 99 ammo acids of each monomer Although 
neither are required for enzyme activity, modification of Cys 67 leads to inactivation of the enzyme 
(Karlstrom et a l , 1993)
The dunenc interface between identical subanus is composed of 4 well ordered p-strands from both the 
C- and N-termim of the 99 ammo acid sequence with residues 86-94 having a helical formation 
Substitution of Asp-88 or Arg-87 with Lys lead to inactivation of HIV IP Further analysis of the 
protease domain surrounding these residues, revealed that their substitution affected the proteins' ability 
to form an active homo-dimenc complex (Wlodawer et a l , 1989, Quenet et a l , 1989, Louis et a l , 
1989)
In 1991, Hyland et aL noted the non-specific activation of HIV IP m increasing ionic strength It was 
later revealed that at similar lomc strengths, different salts activated HIV IP activity with respect to 
their position m the Hofmeister series, a measurement of their salting out effect (Wondrak et a l ,
1991) Szeltner and Polgar (1996) confirmed that the increase m conformational stability and catalytic 
activity of HIV IP was due to stabilisation of itoe protease by preferential hydration
1 3 6.2.  Substrate Specificity of HIV 1 Protease
The natural substrates for HIV IP are the seven cleavage sites that are involved in the maturation of the 
viral protein (Table 17),  coded for by the gag and pol genes (Figure 1 4 b )  Three of these cleavage 
sites are Xaa-Pro bonds and also form part of a consensus sequence, 1 e sequences that are also required 
recognition sites for other retroviral pxoteases (jterl and Taylor, 1987) Sites V and VI are hydrolysed 
by the enzyme during its auto-excision from the polypeptide precursor
The substrate specificity of HIV IP is not only determined by the residues present at the scissile bond, 
but extends to many of the C- and N-tenninai substrate residues flanking the cleavage site However, 
close scrutiny of the flanking ammo acids presented in Table 1 7 , provides little insight into the 
subsite requirements of the enzyme
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Cleavage site HTV-l sequence cleaved Ammo acid sequence of cleavage site
I gag 124-138 -Ser-Gln-Ans-Tyr— Pro-Ile-Val-Gln-
Q gag 357-370 -Ala-Arg-Val-Leu- - -Ala-Glu-Ala-Met-
m gag 370-383 -Ala-Thr-De-Met— Met-Gln-Arg-Gly-
IV gag 440-453 -Pro-Gly-Asn-Phe— Leu-Gln-Ser-Arg-
V pol 59-72 -Ser-Phe-Asn-Phe— Pro-Gln-IIe-Thr-
VI pol 162-174 -Thr-Leu-Asn-Phe— Pro-Ile-Ser-Pro-
vn pol 721-734 -Arg-Lys-De-Leu— Phe-Leu-Asp-Gly-
Table 1 7 Identification o f the positions within the gag-pol polypeptide precursor that represent 
cleavage sites for the viral protease, HIV1P It ts o f interest to note that excluding the Phe-Pro scissile 
bonds present m sites V and VI, all sites vary in their amino acid sequence The ability o f HIV IP to cleave 
sites I-VII reveals little regarding the substrate specificity o f this enzyme Sites V ands VI represent the 
amino acids that are cleaved by HTV1P during its auto-excision from the polypeptide precursor Scissile 
bond are represented by - - -
A definitive picture of HIV IP specificity is difficult to portray and is complicated by the various 
models used for determining this specificity These include the enzymes’ ability to cleave synthetic 
substrates, to autobydrol>se itself in native or substituted form and to auto-excise itself from 
polypeptide precursors where the equivalent V and VI site have been modified Because of these varied 
permutations and combinations, only the basic substrate specificity requirements of this enzyme will 
be discussed
The specificity of the enzyme for the Tyr-Pro and Phe-Pro cleavage sites (I,V,VI, Table 1 7 )  are 
different with respect to the influence of flanking residues Smgle ammo acid substitutions m these 
sites revealed that cleavage of Tyr-Pro (I) is severely inhibited by substitutions at the P4 , ?2> Pi and 
P2 * positions The Phe-Pro site exhibits far greater tolerance to ammo acid substitution at these 
positions (Partin et al t 1990) The P i' residue of the Tyr-Pro cleavage site (Prolme) could be 
substituted by hydrophobic amino acids such as Leu, Val and Phe, without greatly affecting the activity 
of HIV IP agamst this site (Kassel et a l , 1995) These results confirmed an earlier statistical analysis 
by Poorman et a l (1991), in which an extended viral substrate data base was used to predict that the 
highest stringency for particular amino acid residues were at P2 , Pi and P2' positions It is also 
interesting to note, however, that the subsites of the substrate binding pocket of HIV IP are capable of 
acting independently in their interaction with substrate ammo acids (Cameron et a l , 1994)
1.3 .6 .3 .  Assays for HIV 1 Protease Activity
Various methods for the detection of HTVIP activity have been developed including ELISA, HPLC and 
fluonmetnc substrate assays Two ELISA*s have been developed that are based on the specificity of 
HIV IP for the pl7/jp24 cleavage site (I) They are both based on the reduced immunoreactivity of a 
fusion proton containing the p24 polypeptide following the action of HIV IP (Mansfield et a l , 1993, 
Sarubbi et aL, 1991)
The pl7/p24 cleavage site is also the focus of HPLC based assays A polypeptide containing the 
pl7/p24 cleavage site (-Tyr-Pro-) is incubated with HIV1P samples and the cleavage products are 
separated and identified using HPLC (Louis et a l , 1989, Cole et a l , 1991)
A commercially available tetradecapeptide that includes the peptide sequence of angiotensin I plus N- 
terminally added Leu-Val-Tyr-Ser, is cleaved by HIV IP at the Leu-Leu bond, producing angiotensin I 
which can be subsequently quantified using HPLC or RIA methods (Sharma et a l , 1991, Wilkinson et 
a l , 1993, Evans et a t, 1992, Hyland and Meet, 1991)
A fluonmetnc substrate, N-a-b2-Arg-Gly-Phe-Pro-HeO-PNa was developed by Tyagi and Carter, 
(1992) Cleavage at the Phe-Pro bond by HIV IP releases Pro-MeO-pNa which can be detected 
fiuonmetncally
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Inhibitor Details Reference
Resistomycin Isolated from Actinomycetes cultures, IC50 = 21|iM Roggo et a l , 1994
Spirodihydrobenzofuranlactams Isolated from Stachybotrys sp , IC50 = 11 pM Roggo e ta l,  1996
A-98881 A synthesised azacyclic urea, Kj =5 5pM Sham et a l , 1996
SB-206343 P l’-P2’ inhibitor site bond is an isotenc acylimidazole ring, Kt = 0 6nM Thompson et a l , 1994
BILA-398 Synthetic competitive inhibitor of HIV IP, K, = 0 5pM Pargellis et a l , 1994
RPI-856A Isolated from Streptmocyes sp AL-322, Kt = lOnM Asano et a l , 1994
GR123976 A penicillin derivative, asymmetnc inhibitor, IC50 = 2 3|iM Jhoti et a l , 1994
Z-OVCA-NH-Bun A peptide substrate derivative, Kj = 8nM Sakurai et a l , 1994
Table 1 8. Specific inhibitors against HIV1P activity Due to the significant rise in the levels o f interest 
expressed in HIV IP  and its specific inhibitors, only those citations from 1994 onwards are included Inhibitors 
vary in type from modifications o f peptide substrates fo r the protease, to novel compounds isolated from  
microbial cultures Much emphasis has been placed on the screening o f microbial cultures for inhibitors o f this 
protease
1.3 6.4.  Specific Inhibitors of HIV 1 Protease
It is understandable that, due to this enzymes function m HIV-1 infection, a proliferation of 
publications have arisen describing the synthesis and use of HIV IP specific inhibitors A brief list of 
recently published HI VIP specific inhibitors is presented in Table 1 8
1.3 6.5.  Physiological Relevance of HIV 1 Protease
As stated earlier, HIV1P is absolutely required for the maturation of HIV-1 vinons It is also thought 
to have some function in the assembly of vinon particles Inhibitors of HIV IP have been shown to 
block the early steps of HIV-1 replication In H9 and HeLa CD4-LTR/p-gal cells infected with HIV-1, 
the protease was thought to be responsible for the cleavage of the nucleocapsid (NC) protein This 
cleavage may be required for the proper formation of a pre-integration complex and/or its transport to 
the cell nucleus (Nagy et a l , 1994) However, apart from the role of this protease in the replication of 
new vinons, interesting interactions between HIV1P and native cellular proteins have been identified 
NF-K-p is a factor required by HIV-1 for transcription It is produced by native cells as a 105kDa 
precursor, located in the cytoplasm In its active form, it is translocated to the cell nucleus where it is 
mvolved in transcription Riviere et a l , (1991) discovered that HIV1P can process the inactive 
precursor of NF-K-p into its active form, suggesting that this function may also be part of HTVIPs 
role m vinon replication
HIV IP can also cleave native cellular cytoskeleton proteins such as actin, spectrin and tropomyosin 
This weakening of the cytoskeleton of an infected cell may serve some purpose with regards to cell 
infection or vinon expulsion (Shoeman et a l , 1991, Adams et aL, 1992) However, recent proposals 
suggest that elements within the cytoskeleton may play an important role in the regulation of large 
scale genetic regulation Therefore, the cleavage of cytoskeletal proteins by HTV IP may perturb the 
regulation of gene expression by these proteins and m turn, account for the increased incidence of cancer 
m HTV-1 infected patients (Shoeman et a l , 1992)
1.3  7. Prolvl Carboxvpeptidase (EC 3 4.16.2)
Prolyl carboxypeptidase (FCP) was first detected in the lysosomal fraction of porcine kidney by Young 
et a l , (1968) and characterised by these workers as an enzyme capable of removing the C-tennmal 
phenylalanine residue from angiotensin H Reports of the molecular weight of this enzyme vary 
greatly Human kidney FCP has a native molecular weight of 115kDa and is dunenc, while the 
porcine kidney enzyme is reported to have a native molecular weight of 210kDa (Walter et a l , 1980) 
Recently, a tetramenc form of the enzyme was purified from Xanthomonas maltophiha with a native 
molecular weight of 330kDa (Suga et a l , 1995b) Tan et a l , (1993), cloned and sequenced human 
PCP The enzyme was found to consist of 451 ammo acid residues with a calculated weight of 
51,043Da. It was also identified as a glycoprotein with an estimated 12% carbohydrate (w/w) reported. 
The human enzyme has a pH optimum of 5 0-5 5, whereas, the bacterial PCP’s pH optimum is 8 5
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This enzyme is a senne protease, based on its inhibition by DFP (Suga et a l , 1995) The enzyme 
cleaves C-terminal residues from peptides with proline being the preferred Pi residue (Suga et a l , 
1995, Walter et a l , 1980) Z-Pro-prolinal, the prolyl endopeptidase specific inhibitor, also inhibits 
PCP with a K, of 2 6 X 10'7M (Tan et a l , 1993)
1 3.8 Carboxypeptidase P (EC 3.4.12-)
Carboxypeptidase P (CPP) was first discovered by Dehm and Nordwig, (1970), while investigating the 
cleavage of prolyl peptides by kidney peptidases The enzyme is a dimenc glycoprotein with a native 
molecular weight of 240kDa and a single, asparagine linked, mannose carbohydrate moiety being 
reported (Walter et a l , 1980, Zieske et a l , 1992) The pH optimum for CPP ranges from 6 0 to 7 8 
Confusion persists over the mechanistic classification of this enzyme It is widely reported to be 
activated by Mn++ ions In 1985, Hedeager-Sorensen and Kenny identified one zinc atom present in 
each subunit of the dimer Enckson et a l , (1989), reported subsequently that the enzyme was inhibited 
by chelators and suggested it to be a metalloprotease However, m 1992, Zieske et a l , identified a 
senne residue that they determined to be necessary for catalytic activity The enzyme is responsible for 
the removal of C-terminal residues from peptides and proteins, with a preference for prolme residues in 
the Pi position Alanine and glycine substitutions of prolme are also cleaved (Hedeager-Sorensen and 
Kenny, 1985) A general peptide and/or protein processing role has been suggested for CPP 
(Hoedemaeker et a l , 1994) and it is therefore not surpnsing that the enzyme features regularly m the 
literature as part of peptide and/or pro tern sequencing methodologies (Thiede et a l , 1995, Gray et a l ,
1994)
1.3.9.  Summary
Prolme holds an important position among twenty naturally occurring ammo acids, the building blocks 
of pepudes and proteins It confers particular biological properties upon these physiologically 
important biomolecules due to its unique structural charactenstics There has evolved a specialised 
group of enzymes that recognise this residue and can introduce peptide bond cleavage at either its 
carboxyl or ammo terminus within a peptide cham The vanety of these specialised peptidases cover 
practically all situations where a proline residue might occur in a substrate and their action can be of 
biological significance, leading to the inactivation or biotransformation of peptides and proteins
The role played by prolme specific peptidases in physiological processes has been discussed, and, 
because of their unique role within these processes, their continued investigation is warranted.
Prolme specific peptidases have been implicated in a vanety of disease states based on (a), 
abnormalities m their levels or modes of action or (b), abnormalities associated specifically with their 
natural substrates In the latter case, therapeutic regimes often focus on the administration of the 
natural peptide to compensate for its deficiency or defect Administration of such compounds often
fails to alleviate symptoms or cure ailments due to their short lived efficacy, primarily doe to
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degradation by pepudases This has led to the development of peptide analogues as therapeutic agents, 
designed specifically to elicit the natural activity of the pepude yet resist enzymatic degradation
It is obvious that administration of such agents as part of a therapeutic regime will inevitably lead to 
their exposure to the degradative processes contained in serum To date, the physiochemical properties 
of proline specific peptidases in the blood/serum fraction has been poorly studied Although some 
work has been earned out on serum aminopeptidase P, prolidase and prolyl endopeptidase, the extent to 
which they have been studied vanes from purification and detailed characterisation (e g aminopeptidase 
P and prolidase) to simply reporting the presence of the peptidase m serum
Therefore, more detailed studies are essential, in order to better understand the nature of these enzymes, 
and to identify links between them and their tissue counterparts The continued investigation into the 
biochemical characteristics and substrate specificity of serum proline specific peptidases is vital in 
overcoming problems associated with drug delivery
I
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2. Materials & Methods
2 1 Materials
Sigma Chemical Company (Poole. Dorset. England)
2-Iodoacetamide 
2 Mercaptoethanol 
8-Hydroxyqumohne 
1,10-Phenanthrolme 
Ala-MCA
Ammonium Persulphate
Angiotensin II
Aprotimn
Arg-MCA
Bacitracin
Baizamidme
Bisacrylamide
Blue Dextran
Bovine Serum Albumin
Bradykmin
Cadmium Sulphate
Calcium Sulphate
CDTA
Cellulose Type 50
Chymotrypsm Inhibitor
Cobalt Sulphate
Coomassie Brilliant Blue G
Dithiothreitol
DTOB
EOTA
EGTA
Glycine
Imidazole
Iodoacetate
Leupeptm
LHRH
Magnesium Sulphate 
Manganese Sulphate 
MCA
Mercuric Sulphate 
MES
MW-GF-200 Marker Kit
N-Acetylimidazole
N-Decanoyl Co-A
N-Ethylmaleimide
Nickel Sulphate
PCMB
pGlu-His-Pro
Phenylmethylsulphonylfluonde
Potassium Phosphate (dibasic)
Potassium Phosphate (monobasic)
Proline
Pro-MCA
Puromycm
SDS
Sephadex G-25
Silver Stain High MW Standard Kit
Silver Stain Kit
Sodium Chlonde
Substance P
TEMED
TRH-OH
TnzmaBase
Trypsm Inhibitor from Soybean 
Zinc Sulphate
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Bachem Feinchemikalein AG (Bubendorf. Switzerland)
Alamne TRH-OH
Gly-Gly-Pro-Ala Z-Gly-Pro-MCA
Gly-Pbe-Ala Z-Gly-Pro-Ala
Gly-Pro-MCA Z-Pro-Ala
Leu-Gly Z-Pro-Gly
Lys-Ala-MCA Z-Pro-Leu-Giy
pGlu-His-Pro-MCA Z-Pro-Pro
Thyroliberin
BDH Chemicals Ltd (Poole. Dorset. England)
Acetone Dimethylsulpboxide
Aaylamide Dioxane
Ammonia Solution Glacial Acetic Aad
Biuret Reagent Glycerol
Bromophenol Blue Hydrochloric Aad
Calcium Chlonde Methanol
Citnc Aad Polyethylene Glycol 6000
Copper Sulphate Urea
Dimethylformamide Zinc Chlonde
Merck Chemical Company (Frankfurt, Germany)
Ammonium Sulphate Sodium Hydrogen Phosphate
Potassium Chlonde Sodium Hydroxide
Pharmacia Fine Chemical Company (Uppsala. Sweden).
Activated Thiol Sepharose CL-4B Q-Sepharose High Performance
Blue Sepharose Fast Flow Sephacryl S-200HR
DEAE-Sepharose Fast Row SP-Sepharose Fast Flow
Phenyl Sepharose CL-4B
Bio-Rad Laboratories (Hercules. California. USA)
Biogel HT Hydroxy lapatite
Keypak Meats (Clonee. Co Meath. Ireland)
Bovine whole blood
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Aldrich Chemical Company (Poole. Dorset. England)
1,7-PhenanthroIine 
4,7 -Phenanthroline 
Tnfluoroacetic Acid
Calbiochem-Novabiochem (UK) Ltd (Nottingham. England)
AEBSF
Pepstatin
Pierce Chemical Company (Illinois. USA)*
BCA Reagent
Mount Sinai School of Medicine (New York. Courtesy of Dr S Wilk)
Fmoc-Pro-Pro-Nitnle
Z-Pro-Prolinal
University College Galway (Courtesy of Dr G O'Cmnn)
Gly-Ala-Phe Pro-Gly
Gly-Pro-Ala Z-Pro
Lys-Ala-Ala
Dublin Citv University (Conrtesv of Dr J  Dalton)
Boc-Val-Leu-Lys-MCA Suc-Gly-Pro-Leu-Gly-Pro-MCA
Boc-Val-Pro-Aig-MCA Z-Aig-MCA
Glu-Phe-MCA Z-Arg-Arg-MCA
Gly-Arg-MCA Z-Phe-Arg-MCA
Suc-Ala-Phe-Lys-MCA Z-Phe-Val-Arg-MCA
University Rene Descartes (Paris. France. Courtesy of Prof B Roques) 
Kelatorphan
Institute of M icrobial Chemistry (Tokyo. Japan. Courtesy of Dr M NagaO 
Poststatin
Pfizer (Groton. CT. USA. Courtesy of Dr S F arad )
Z-Indohnyl Prolinal 
Z-Cyclohexyl Prolinal
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Meiji Seika Kaisha. LTD (Yokohama, Japan. Courtesy of Dr S Tsutsumi)
a-Ketobenzothiazole 
Z PrO'Prolinai
Hans-Knoell Institute of N atural Product Research (Germany. Courtesy of Prof 
H U Demuth)
Z-Phe-Pro-Metbylketone
Boc-Glu(NHOBz)-PyiT
Nagasaki University (Japan. Courtesy of Prof T Yoshimoto)
Z-Thiopropyl Thioprobnal
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2 2 Fluorescence Spectrophotometry using 7-Amno-4-Methvl-Coumarin 
(MCA) 
2 21. MCA Standard Curves
5mM MCA in 100^ DMSO was diluted to 200pM MCA using lOOmM potassium phosphate, pH 7 4, 
at 37 C This stock solution was stored at 4 C Lower MCA concentrations could be achieved using 
lOOmM potassium phosphate, pH 7 4, as diluant Standard curves were prepared by combining IOOjiL 
lOOmM potassium phosphate, pH 7 4, 400jiL appropriate MCA concentration and lmL 1 5M acetic 
acid Ranges of 0-2 5pM, 0-10|iM and 0-20|iM MCA were prepared in triplicate Fluonmetnc 
analysis of these samples was achieved using a Perkin Elmer LS-50 Fluorescence Spectrophotometer at 
excitation and emission wavelengths of 370nm and 440nm respectively Excitation slit widths were 
main tamed at lOnm while emission slit widths were adjusted to produce fluonmetnc intensities 
appropriate for the range being analysed
2.2.2. Inner Filter Effect
The inner filter effect of enzyme samples was determined by combining IOOjiL enzyme sample, 400^L 
appropriate MCA solution and lmL 1 5M acetic acid These samples, prepared m tnphcate, were 
analysed fluonmetncally as described m section 2 2 1
2.3 Protein Determination
2.3 1 Absorbance at 280nm
The absorbance of proteins based on the ^max of tryptophan residues at 280nm was used as a non- 
quantitative method of determining protein concentrations in post-column chromatography fractions 
A Shimadzn UV 160A Spectrophotometer was used to determine this absorbance
2.3.2 Biuret Assay
The Biuret assay was used to quantify pro tern concentrations in samples of approximately 2mg/mL 
protein or greater Samples were dialysed for 12 hours against lOOmM potassium phosphate, pH 7 4, 
to remove possible mterfenng substances where necessary Samples with a protein concentration 
outside the limits of the Biuret assay (2-10mg/mL) were diluted with lOOmM potassium phosphate, pH 
7 4, to achieve a suitable protein concentration with respect to the assay limits 200^L Biuret reagent 
was added to 50|iL sample in tnphcate m a 96 well microplate and incubated for 30 minutes at 37‘C 
BSA standard corves m the range O-lOmg/mL were mcluded on each plate in tnphcate The 
absorbance of each well at 560nm was determined using a Titertek Multiscan PLUS plate reader
2 3.3. Standard BCA Assay
The standard BCA assay protocol, based on the method of Smith et a l , (1985), was used to quantify 
protein concentrations of samples that could not be determined accurately usmg the less sensitive
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Biuret assay Samples were prepared as described for the Biuret assay 200nL BCA reagent was 
added to 50j±L sample in triplicate in a 96 well microplate and incubated for 30 minutes at 37 C BSA 
standard curves in the range 0-14 mg/mL were included on each plate m triplicate Plates were read as 
described in section 2 3 2
2.3.4. Enhanced BCA Assay
The Enhanced BCA assay protocol was used to quantify protein concentrations of samples that could 
not be determined accurately by the less sensitive standard BCA assay The assay was performed as 
described m section 2 3 3 using an incubation temperature of 60°C The included BSA standard 
curves were m the range 0-100|ig/mL and were prepared in triplicate on each plate
2 4 Serum Preparation
Whole blood was collected from a freshly killed bovme The whole blood was transported to a 4°C 
cold room and the clot allowed to shrink for 24 hours The remaining unclotted whole blood was then 
decanted and centrifuged at 6000 rpm (4100 x g) for 1 hour using a Beckman J2-MC refrigerated 
centrifuge fitted with a JA-21 rotor at 4°C The serum thus produced was divided into 20mL aliquots 
Aliquots were stored at -20°C
2.5. Enzvme Assays
2 5.1. Measurement of Z-Gly-Pro-MCA Degrading Activities
Z-Gly-Pro-MCA degrading activity was determined according to a modification of the original 
procedure of Yoshimoto et a l, (1979) lOmM Z-Gly-Pro-MCA substrate stock m 100% DMSO was 
prepared lOOmM potassium phosphate, pH 7 4, at 37°C, was added slowly to 300^L DMSO + IOOjiL 
substrate stock to a final volume of lOmL resulting in a final concentration of 0 ImM substrate, 4% 
DMSO (v/v) 400)iL 0 ImM substrate was added to 100|iL sample to be tested in triplicate and the 
reaction mixture was incubated for 1 hour at 37°C Both enzyme and substrate were premcubated at 
37 C to allow them to reach thermal equilibrium The reaction was terminated by the addition of lmL 
1 5M acetic acid Negative controls were prepared by adding lmL 1 5M acetic aad to enzyme sample 
prior to substrate addition and incubation at 37°C MCA liberated from the substrate was determined 
fluonmetncally as described m section 2 21  Fluonmetnc intensities obtained for each sample were 
converted to picomoles (pmoles) MCA released per mm per mL usmg standard curves described in 
section 2 21 Enzyme units were defined as pmoles MCA released per minute
2.5.2. Z-Pro-Prolinal Insensitive Activity
Z-Pro-Prolmal insensitive residual Z-Gly-Pro-MCA degrading activity m serum was determined as 
described m section 2 51 with the excepuon that 20j±L of 10'^M Z-Pro-Prolinal was added to each 
sample prior to substrate addition The sensitivity of residual Z-Gly-Pro-MCA degrading activity m 
serum to varied concentrations of Z-Pro-Prolmal was investigated by adding 20|iL Z-Pro-Prolinal (that
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varied in concentration from 10'^M to 10"4M to serum pnor to substrate addition The effect of 
increased premcubation time with Z-Pro-Prohnal on residual Z-Gly-Pro-MCA degrading activity was 
also investigated by preincubating lOO^L serum with 20\iL 10'^M Z-Pro-Prolinal for 0-30 minutes at 
37 C, prior to substrate addition All determinations were carried out m triplicate with suitable 
negative controls
2.5 3 Microplate Assay
A non-quantitative microplate fluonmetnc assay was developed to facilitate the rapid identification of 
Z-Gly-Pro-MCA degrading activities ra post-column chromatography fractions 200pJL 0 ImM 
substrate ra lOOmM potassium phosphate, pH 7 4, 4% (v/v) DMSO (+ 15mM DTT, 15mM EDTA for 
PE type activity) was added to lOOpL sample m each well The plate was incubated for 30 minutes at 
37 C MCA liberated from the substrate in each well was determined using the Perkin Elmer LS-50 
Fluorescence Spectrophotometer with microplate reader accessory attached
2.6. Purification of Serum Z-Gly-Pro-MCA Degrading Activities
All procedures were earned out at 4°C unless otherwise stated
2.61. SP Sepharose Fast Flow Cation Exchange Chromatography
r
2 6.1.1. Separation of 2 Z-Gly-Pro-MCA Degrading Activities from 
Serum using SP Sepharose Fast Flow Cation Exchange 
Chromatography
A 20mL aliquot of serum was thawed at 37 C and dialysed against 4L 20mM MES, pH 4 5, for 12 
hours The post-dialysis serum was centrifuged at 20,000rpm (48,500 x g) for 20 minutes using a 
Beckman J2-MC refrigerated centrifuge fitted with a JA-20 rotor to remove post-dialysis precipitate 
A 25mL SP Sepharose column (2 5cm x 5cm) was equilibrated with lOOmL 20mM MES, pH 5 5, at a 
flowrate of lmL/min Dialysed serum supernatant was loaded followed by a 200mL wash with 20mM 
MES, pH 5 5 Bound protein was eluted isocratically with lOOmL lOOmM potassium phosphate, 1M 
ammonium sulphate, pH 7 4 5mL fractions were collected throughout the run Loading, washing and 
elution steps were earned out at a flowrate of 2mL/min Fractions were assayed for Z-Gly-Pro-MCA 
degrading activity using the microplate assay procedure described in section 2 5 3 Protein 
determinations for each fraction were achieved using absorbance readings at 280nm as described in 
section 2 31 Fractions containing Z-Gly-Pro-MCA degrading activity were combined to form the 
post-SP Sepharose PE and ZIP pools
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2 612.  Identification of PE Activity m Post-SP Sepharose 
Fractions
PE activity in the post SP Sepharose fractions could be distinguished from residual Z-Pro-Prohnal 
insensitive Z-Gly-Pro-MCA degrading peptidase (ZIP) activity by the addition of 20^L 10'^M Z-Pro- 
Prohnal into each well pnor to substrate addition
2 6.2, Phenyl Sepharose Hydrophobic Interaction Chromatography 
(PE)
The post-SP Sepharose PE pool was salted by addition of 50mL 200mM potassium phosphate, 2M 
ammonium sulphate, pH 7 4 The final volume was brought to lOOmL with distilled water resulting m 
a final concentration of lOOmM potassium phosphate, 1M ammonium sulphate 
A 17mL Phenyl Sepharose column (2 5cm x 3 5cm) was equilibrated with lOOmL lOOmM potassium 
phosphate, 1M ammonium sulphate, pH 7 4, at a flowrate of lmL/mm The salted post-SP Sepharose 
pool was loaded followed by a 200mL wash with lOOmM potassium phosphate, 800mM ammonium 
sulphate, pH 7 4 Bound pro tern was eluted with a 200mL Linear gradient from lOOmM potassium 
phosphate, 800mM ammonium sulphate, pH 7 4, to lOOmM potassium phosphate, pH 7 4 5mL 
fractions were collected throughout the run Loading, washing and elution steps were earned out at a 
flowrate of 2mL/mm Fractions collected were assayed for PE activity using the microplate assay 
procedure described m section 2 5.3 Protein determinations for each fraction were achieved using 
absorbance readings at 280nm as described in section 2 3 1 Fractions containing PE activity were 
combined to form the post-Phenyl Sepharose PE pool
2.6 3. DEAE Sepharose Fast Flow Anion Exchange 
Chromatography (PE)
The post-Phenyl Sepharose PE pool was dialysed against 2L 50mM Tns-HCl, pH 8 0, for 12 hours 
with buffer changes at 3, 6 , and 9 hours The conductivity of the sample was measured before 
application onto DEAE Sepharose
A 20mL DEAE Sepharose column (2 5cm x 4cm) was equilibrated with lOOmL 50mM Tns-HCl, pH 
8 0, at a flowrate of lmL/min The dialysed post-Phenyl Sepharose PE pool was loaded followed by a 
200mL wash with 50mM Tns-HCl, pH 8 0 Bound protein was eluted with a 200mL linear gradient 
from 50mM Tns-HCl, pH 8 0, to 5GmM Tns-HCl, lOOmM NaCl, pH 8 0 A further lOOmL wash with 
50mM Tns-HCl, lOOmM NaCl, pH 8 0, was applied to the column to complete elution 5mL fractions 
were collected throughout the run Loading and washing steps woe earned out at a flowrate of 
2mL/mm Elution was carried out at a flowrate of lmL/mm Fractions collected were assayed for PE 
activity using the microplate assay procedure desenbed in section 2.5.3 Protein determinations for 
each fraction were achieved using absorbance readings at 280nm as desenbed in section 2 3 1 
Fractions containing PE activity were combined to form the post-DEAE Sepharose PE pool
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2.6 4 Sephacryl S-200 HR Sepharose Gel Filtration 
Chromatography (PE)
Tbe post-DEAE Sepharose PE pool was concentrated via reverse osmosis using polyethylene glycol 
Glycerol was added to the concentrated sample to a final concentrauon of 10% (v/v)
A 220mL Sephacryl S-200 Sepharose column (2 5cm x 45cm) was equilibrated with 400mL lOOmM 
potassium phosphate, 200mM KCl, pH 7 4, at a flowrate of lmL/mm The concentrated sample was 
loaded under the buffer head and the column was washed with 300mL equilibration buffer at a flowrate 
of lmL/mm 5mL fractions were collected and assayed for PE activity using the microplate assay 
procedure described in section 2 5 3 Protein determinations for each fraction were achieved using the 
BCA assay described in section 2 3 3 Fractions containing PE activity were pooled and stored on ice
2.6 5. Phenyl Sepharose Hydrophobic Interaction Chromatography
(ZIP)
A lOmL Phenyl Sepharose column (2 5cm x 5cm) was equilibrated with lOOmL lOOmM potassium 
phosphate, 1M ammonium sulphate, pH 7 4, at a flowrate of lmlVmin The post-SP Sepharose ZIP 
pool was loaded followed by a 200mL wash with lOmM potassium phosphate, 50mM ammonium 
sulphate, pH 7 4 The bound protein was eluted isocratically with lOOmL distilled water 5 mL 
fractions were collected throughout the run Loading, washing and elution steps were earned out at a 
flowrate of 2mL/mm Fractions collected were assayed for ZIP activity usmg the microplate assay 
procedure described m section 2 5 3 Protein determinations for each fraction were achieved usmg 
absorbance readings at 280nm as described in section 2 31 Fractions containing ZIP activity were 
combined to form the post-Phenyl Sepharose ZIP pool
2.6 6. Calcium Phosphate Cellulose Chromatography (ZJP)
Calcium Phosphate Cellulose was prepared according to the method of Tiselius et a l , (1956) with the 
exception that the cellulose used was SigmaCell 50
A 7mL Calcium Phosphate Cellulose column (1 5cm x 4cm) was equilibrated with 50mL lOmM 
potassium phosphate, pH 7 4, at a flowrate of 0 6mL/min The post-Phenyl Sepharose ZIP pool was 
loaded followed by a 50mL wash with lOmM potassium phosphate, pH 7 4 The bound protein was 
eluted with a lOOmL linear gradient from lOmM potassium phosphate, pH 7 4, to 500mM potassium 
phosphate, pH 7 4 6mL fractions woe collected throughout the run Loading, washing and elution 
steps were earned out at a flowrate of 0 6mLJmm Fractions collected were assayed for ZIP activity 
usmg the microplate assay procedure described m section 2 5 3 Protein determinations for each 
fraction were achieved usmg the BCA assay desenbed m section 2 3 3 Fractions containing ZIP 
activity were combined to form the post-Calcium Phosphate Cellulose ZIP pool
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2 6 7 Sephacryl S-200 HR Sepharose Gel Filtration 
Chromatography (ZIP)
The post-Calcium Phosphate Cellulose ZIP pool was concentrated \ia reverse osmosis using 
polyethylene glycol Glycerol was added to the concentrated sample to a final concentration of 10%
(v/v)
A 220ml Sephacryl S-200 HR Sepharose column (2 5cm x 45cm) was equilibrated with 400mL 
lOOmM potassium phosphate, 200mM KC1, pH 7 4, at a flowrate of lmL/mm The concentrated 
sample was loaded under the buffer head and the column was washed with 150mL equilibration buffer 
at a flowrate of lmL/min 5mL fractions were collected throughout the nin Fractions collected were 
assayed for ZIP activity using the microplate assay procedure described m section 2 5 3 Protein 
determinations for each fraction were achieved using the enhanced BCA assay described in section 
2 3 4 Fractions containing ZIP activity were pooled and stored on ice
2.6 8. Alternative Chromatographic Regimes Used to Further 
Purify PE
The following chromatographic media woe used to develop further steps as part of 
the PE purification
2.6.8.1. Q Sepharose Fast Flow Anion Exchange Chromatography
Post-Phenyl Sepharose PE activity was produced as outlined m section 2 6.2. and dialysed as outlined 
in section 2 63  A 20mL Q Sepharose column (2 5cm x 4cm) was equilibrated with lOOmL 20mM 
Tns-HCL, pH 8 0, at a flowrate of lmL/mm The dialysed post-Phenyl Sepharose PE pool was loaded 
followed by a 200mL wash with 20mM Tns-HCl, pH 8 0 Bound protein was eluted with a lOOmL 
linear gradient from 20mM Tns-HCl, pH 8 0, to 20mM Tns-HG, 500mM NaCl, pH 8 0 5mJL 
fractions were collected throughout the run Loading, washing and elution steps were earned out at a 
flowrate of 2mL/min Fractions collected were assayed for PE activity usmg the microplate assay 
procedure desenbed m section 2 5 3 Protein determinations for each fraction were achieved usmg the 
Biuret assay as desenbed m section 2 3 2
2 6 8.2. Calcium Phosphate Cellulose Chromatography
The Calcium Phosphate Cellulose column outlined in section 2 6 6  was used. Post-Phenyl Sepharose 
PE activity was dialysed against 2L lOmM potassium phosphate, pH 7 4, for 12 hours with buffer 
changes at 3, 6 and 9 hours The Calcium Phosphate Cellulose column was equilibrated as outlined in 
section 2 6 6 at a flowrate of 0 5mL/min The dialysed PE pool was loaded followed by a 50mL wash 
with lOmM potassium phosphate, pH 7 4 The bound protein was eluted with a lOOmL linear gradient 
from lOmM potassium phosphate, pH 7 4, to 500mM potassium phosphate, pH 7 4 5mL fractions 
were collected throughout the run Loading, washing and elution steps were earned out at a flowrate of 
0 5mL/mm Fractions collected were assayed for PE activity using the microplate assay procedure
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descnbed m section 2 5 3 Protein determinations for each fraction were achieved usmg the Biuret 
£ assay as descnbed in section 2 3 2
2.6 8 3, Biogel HT Hydroxylapadte Chromatography
Post-Phenyl Sepharose PE acuvity was diahsed as outlined in section 2 6  8 2 A lOmL Biogel HT 
Hydroxylapatite column (2 5cm x 2cm) was equilibrated with lOOmL lOmM potassium phosphate, pH 
7 4, at 0 5mL/min The dialysed PE acuvity was loaded followed by a lOOmL wash with lOmM 
potassium phosphate, pH 7 4 Bound protein was eluted with a 200mL linear gradient from lOmM 
potassium phosphate, pH 7 4, to 500mM potassium phosphate, pH 7 4 5mL fractions were collected 
throughout the run Loading, washing and elution steps were earned out al a flowrate of 0.5mL/mm 
Fractions collected were assayed for PE activity usmg the microplate assay procedure as outlined m 
section 2 5 3 Protein determinations for each fraction were achieved usmg the Biuret assay as 
descnbed in section 2 3 2
2.6.8.4. Blue Sepharose Fast Flow Chromatography
Post-Phenyl Sepharose PE pool was dialysed against 2L 20mM potassium phosphate, pH 7 4, for 12 
hours with buffer changes at 3, 6  and 9 hours* A 40mL Blue Sepharose column (2 5cm x 8cm) was 
equilibrated with 150mL 20mM potassium phosphate, pH 7 4, at a flowrate of lmL/min The dialysed 
PE activity was loaded followed by a lOOmL wash with 20mM potassium phosphate, pH 7 4 Bound 
protein was eluted with a 150mL linear gradient from 20mM potassium phosphate, pH 7 4, to 20mM 
potassium phosphate, 2M NaCl, pH 7 4 Loading, washing and elution steps were earned out at a 
flowrate of lmL/min 5mL fractions were collected throughout the run. Fractions collected were 
assayed for PE activity usmg the microplate assay procedure as outlined in section 2 5 3 Protein 
determinations for each fraction were achieved using the Biuret assay as descnbed in section 2 3 2
2.6 8 5. Activated Thiol Sepharose 4B Chromatography
PE activity was eluted from the Phenyl Sepharose column as descnbed m section 2 6 2 with the 
exception that 5mM DTT was incorporated into both elution buffers DTT removal from the enzyme 
sample was an important step before application onto the Activated Thiol Sepharose column This was 
achieved by two different methods
2.6 8.5.1. Removal of DTT by Dialysis
The post-Phenyl Sepharose PE pool, containing 5mM DTT, was dialysed for 6  hours against 1L 20mM 
potassium phosphate, pH 7 4, with buffer changes at 2 and 4 hours
2 6.8.5 2. Removal of DTT usmg Sephadex G-25 Chromatography
The post-Phenyl Sepharose PE pool, containing 5mM DTT was concentrated via reverse osmosis usmg 
polyethylene glycol Following concentration, glycerol was added to a final concentration of 10% 
(v/v) A 25mL Sephadex G-25 column (1.5cm x 15cm) was equilibrated with lOOmL 20mM
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potassium phosphate, pH 7 4 at a flowrate of 0 5mL/min The concentrated PE pool was loaded under 
the buffer head and the column was washed with 150mL 20mM potassium phosphate, pH 7 4, at a 
flowrate of 0 5mL/mm 5mL fractions were collected and assayed for PE activity using the microplate 
assay procedure outlined in section 2 5 3 Protein determinations for each fraction were achieved using 
the Biuret assay as desenbed in section 2 3 2 DTT elution from the column could also be determined 
due to its interference with the Biuret assay Fractions containing PE activity were pooled for 
application onto Activated Thiol Sepharose
2 6.8.5.3. Application of PE onto Activated Thiol Sepharose
A 5mL Activated Thiol Sepharose column (1 5cm x 3cm) was equilibrated with 50mL 20mM 
potassium phosphate, pH 7 4, at a flowrate of 0 5mL/min The PE activity, having had the DTT 
removed by dialysis or de-salung usmg Sephadex G-25, was loaded followed by a 25mL wash with 
20mM potassium phosphate, pH 7 4 Flow was stopped for 30 minutes to allow protein to bmd to the 
column A further wash of 25mL 20mM potassium phosphate, pH 7 4, was followed by isocratic 
elution of bound protein usmg 50mL 2GmM potassium phosphate, 5mM DTT, pH 7 4 5mL fractions 
were collected throughout the run Loading, washing and elution steps were earned out at 
0.25mL/min Fractions collected were assayed for PE activity usmg the microplate assay procedure as 
outlined m section 2 5 3 Protein determinations for each fraction were achieved usmg absorbance 
readings at 280nm as described m section 2 31
2.7. Polyacrylamide Gel Electrophoresis
SDS polyacrylamide gel electrophoresis was used to determine the success of the purification of both 
enzymes It was also used to determine the subunit structure of both enzymes and the molecular 
weight of these subunits A non-native, discontinuous SDS PAGE system based on the method of 
Laemmli, (1970) was used
2.7.1. Sample Preparation
Samples to be electrophoresed were dialysed extensively over a 24 hour period against 2L 62 5mM 
Tns-HCl, pH 6 8 , at room temperature with buffer changes at 6 and 12 hours Dialysed samples were 
then diluted with an equal volume of sample solubilisation buffer which consisted of 62 5mM Tns- 
HCl, pH 6  8 ,20% v/v glycerol, 8% w/v SDS, 10% v/v 2-mercaptoethanol and 0 01% w/v bromophenol 
blue A molecular marker cocktail, containing six known molecular weight markers, was prepared 
from a Sigma MW-SDS-200 marker k it This included carbonic anhydrase (29,000Da), ovalbumin 
(45,000Da), BSA (66 ,OOODa), phosphorylase B (97,400Da), B-galactosidase (116,000Da) and myosm 
(205,000Da) For gels that were subjected to Silver Staining, a specific Silver Stain Molecular Weight 
Marker kit was obtained from Sigma. This kit contained no myosm or ovalbumin marker, but did 
contain a Fumarase marker (48,500) Samples and markers thus prepared were incubated in a boiling 
water bath for 2  minutes pnor to application onto the gel
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2 7 2 Preparation of SDS Gels
The following slock solutions were prepared in deionised water
Resolving Gel Buffer 
Stacking Gel Buffer 
Acryl / Bis-Aery 1 Stock 
Ammonium Persulphate
3M Tns-HCl, pH 8 8
0 5M Tns-HCl, pH 6 8
30% w/v acrylamide, 0 8% bisacrylamide
1 5% w/v AP freshly prepared 
10% w/v
0 025M Tns-HCl, 0 192M Glycine, 0 1% SDS, pH 8 3
SDS
Running Buffer
Table 2 1 outlines how these stock solutions were combined to produce a 10% resolving gel overlayed 
with a 3 75% stacking gel Gels were prepared in an ATTO vertical electrophoresis system (160mm x 
160mm x 1mm) The system was filled with running buffer and 20|iL of the appropriately prepared 
samples were loaded into the wells under the buffer The gels were then electrophoresed using a 
current of 25mA per gel for approximately 3 hours
2.73. Visualising Proteins in Polyacrylamide Gels 
2.73.1 Staining Polyacrylamide Gels with Coomassie Brilliant
Following electrophoresis as outlined m section 2 7 2 , gels were fixed for 30 minutes in a solution of 
40% v/v methanol, 7% v/v glacial acetic acid Gels were then stained for 1 hour m a solution of 0 1% 
w/v Coomassie Brilliant Blue G, 25% v/v methanol and 5% v/v acetic acid Following staining, the 
gels were destamed for 12-24 hours m a solution of 25% v/v methanol, 10% v/v glacial acetic acid
Polyacrylamide gels were stained with silver using a Silver Staining kit obtained from Sigma. The kit 
operates according to the method of Heukeshoven and Dernick, (1985) Table 2 2 outlines the steps 
involved
2 7.4. Recording and Storage of Polyacrylamide Gel Images
Digital unages of gels were obtained using a UVP ImageS tore 7500 This incorporated a UVP 
White/UV Transilluminator/Camera unit dnven by ImageS tore 7500 software Images acquired were 
either stored digitally on disk, or printed using a Sony Videographics Printer UP-860 CE
Blue
2.132. Silver Staining Polyacrylamide Gels
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Solution 10% Resolving gel (mL) 3 75% Stacking gel (mL)
Acryl / Bisacryl Stock 10 2 5
Resolving Gel Buffer 3 75
Stacking Gel Buffer 5
SDS 0 3 0  2
Water 1445 113
Ammonium Persulphate 15 1
TEMHD 0015 0 015
Table 21  Volumes required for SDS PAGE resolving and stacking gels All solutions with the exception 
o f TEMED were prepared in deionised water (refer to section 2 7 2 )  Quantities indicated sufficient to 
cast 2 x (160mm x 160mm x 1mm) gels
Step Solvent Reagent Duration
Fixing 30% v/v Ethanol, 10% v/v Glacial Acetic Acid 60 minutes
Rinsing Deionised Water 30 minutes
Silver Staining Silver Nitrate 30 minutes
Rinsing Deionised Water 20 seconds
Developing Sodium Carbonate, Formaldehyde 30 minutes
Development Stop 1% Glacial Acetic Acid 5 minutes
Rinsing Deionised Water 30 minutes
Reducing Sodium Thiosulphate, Sodium Carbonate 30 seconds
Rinsing Deionised Water 24 hours
Table 2 2 Steps involved in Silver Staining polyacrylamide gels Solutions used for Silver Staining, 
Developing and Reducing were supplied as part o f Sigma Silver Staining Kit No AG-25 Durations of 
each step were appropriate for a 1mm thick polyacrylamide gel
2 8. Assay Development for Purified Serum Z-GlvPro-MCA
Degrading Activities
2.8.1. Substrate Solvent Determination
lOmM Z-Gly-Pro-MCA stocks were prepared in 100% DMSO, DMF and dioxane Purified enzyme 
(PE or ZIP) was assayed in triplicate with suitable negative controls using 0 ImM Z-Gly-Pro-MCA 
(+15mM DTT, 15mM EDTA in the case of purified PE), prepared from each stock as descnbed in 
section 2 5 1, to determine the effect of different substrate solvents on enzyme activity
2.8.2 Solvent Concentration Determination
0 ImM Z-GIy-Pro-MCA in 2%, 4%, 6 %, 8% and 10% dioxane (v/v) were prepared in lOOmM 
potassium phosphate, pH 7 4 Purified enzyme (PE or ZIP) was assayed in tnplicate with these 
substrates as descnbed in section 2 5 1 to determine the effect of solvent concentration on enzyme 
acuvity Suitable negative controls woe prepared
2.8.3. Linearity of Enzyme Assays with respect to Time
300pL purified enzyme (PE or ZIP) and 1 2mL 0 ImM Z-Gly-Pro-MCA were preincubaied separately 
at 37’C to allow each to attain thermal equilibnum The liberation of MCA from the reaction of 
substrate and enzyme combined was monitored continuously over a 2 hour penod m an incubated 
cuvette holder to determine the lmeanty of enzyme activity over tune The experiment was repeated 
for serum in the presence and absence of 20|iL 10^M Z-Pro-Prolmal
2 8.4 Lmeanty of Enzyme Assays with respect to Enzyme 
Concentration
A range of punfied enzyme concentrations (PE or ZIP) were prepared using lOOmM potassium 
phosphate, pH 7 4, as diluant These samples were assayed in tnpfacate as descnbed m section 25 1 
Suitable negative controls were prepared The experiment was repeated on punfied ZIP activity as 
descnbed here, with the exception that 200mM KC1 was incorporated into substrate and diluant The 
lmeanty of observed ZIP activity with respect to enzyme concentration was also repeated on ZIP 
activity that had been dialysed extensively against lOOinM potassium phosphate, pH 7 4, to remove 
post-gel filtration KCL
2.8.5. DTT Activation of Punfied Z-Gly-Pro-MCA Degrading 
Activities
0 ImM Z-Gly-Pro-MCA was prepared in a range of DTT concentrations from 0 to 25mM Punfied 
enzyme activity (PE or ZIP) was assayed m tnplicate with these substrates as descnbed in section 
2 5 1 Suitable negative controls were prepared This experiment determined the DTT concentration at 
which punfied enzyme was maximally activated under assay conditions where DTT was present in 
substrate only
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2 8 6. Salt Activation of Punfied Z-Gly-Pro-MCA Degrading 
Activities
0 ImM Z-Gly-Pro-MCA was prepared in a range of NaCl concentrations from 0 to 1M Punfied 
enzyme activity (PE or ZIP) was assayed with these substrates in tnphcate as desenbed in section 
2 5 1 Suitable negative controls were prepared This experiment determined the NaCl concentration 
at which the punfied enzyme was maximally activated under assay conditions where NaCl was present 
in substrate only
2.8.7. Optimised Assay for Z-Gly-Pro-MCA Degrading Activities
The optimised assay used to determine PE and ZIP activities, based on the results from the assay 
development experiments, was as desenbed in section 2 51 with the following modifications lOmM 
stock substrate was prepared in 100% dioxane and the final concentration of dioxane in 0 ImM Z-GIy- 
Pro-MCA prepared in lOOmM potassium phosphate, pH 7 4, was 2% (v/v) PE activities were assayed 
with substrate incorporating 15mM DTT, 15mM EDTA while ZIP activities were assayed with 
substrate incorporating 500mM NaCl unless the presence of these agents interfered with a particular 
study It should be noted that the optimised assays for each enzyme were used to evaluate the success 
of each purification protocol
29. Characterisation of Purified Z-Gly-Pro-MCA Degrading Activities
2.9.1. Relative Molecular Mass Determination
The relative molecular masses of punfied PE and punfied ZIP were determined by Gel Filtration 
Chromatography, Size Exclusion Chromatography using HPLC and SDS Polyacrylamide 
Electrophoresis
2.9.11. Sephacryl S-200 HR Gel Filtration Chromatography
The S-200 gel filtration column, similar to the column previously mentioned m sections 2 64  and 
2 6 7 , was calibrated for relative molecular mass determination
2 9.11.1. Void Volume Determination
The S-200 column was equilibrated with 300mL lOOmM potassium phosphate, pH 7 4 ,200taM KC1 at 
ImL/min lmL of a 2mg/mL dextran blue solution, containing 10% v/v glycerol, was loaded onto the 
S-200 column under the buffer bead The column was washed with equilibration buffer al lmL/mm 
and 2mL fractions were collected Dextran blue elution was determined by monitoring the absorbance 
at 620nm m fractions collected The void volume (V0) of the column was calculated to be the volume 
at which the absorbance at 620nm reached a maximum.
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2 9 1.1.2. Calibration of the S-200 Column with Molecular Mass
Standards
The S-200 column was equilibrated as outlined m section 2 9 1 1 1  lmL of each standard at a 
concentration of 2mg/mL, containing 10% v/v glycerol, were loaded onto the S-200 column under the 
buffer head The column was washed with equilibration buffer at lmL/min and 2mL fractions were 
collected The elution volume (Ve) of each standard was monitored by assaying the fractions for 
protein using the BCA assay described m section 2 3 3 Cytochrome C elution was monitored at its 
Xmax of 405nm Standards applied to the column included cytochrome C (12,400Da), carbonic 
anhydrase (29,000Da), BSA (66,000Da), alcohol dehydrogenase (150,OOODa) and 6-amylase 
(200,OOODa) A plot of Log molecular mass versus Ve/V0  of each standard, was prepared, and a 
calibration curve for the column was thus constructed.
2 9.1 1.3. Estimation of Relative Molecular Mass of Purified Enzymes
The S-200 column was equilibrated as outlined m section 2 9 1 1 1  lmL of each enzyme, containing 
10% v/v glycerol, was loaded onto the S-200 column under the buffer head The column was washed 
with equilibration buffer at lmL/min and 2mL fractions were collected Elution of each enzyme 
activity was monitored using the microplate assay described m section 2 5 3 The elation volume for 
each enzyme (Vg) was analysed usmg the calibration curve produced m section 2 9 1 1 2  to determine 
a relative molecular mass
2 9.1.2. Biosep SEC-3000 High Performance Size Exclusion
Chromatography
A Beckman System Gold HPLC system was used to carry out high pressure size exclusion 
chromatography The system was fitted with a Beckman Autosampler for sample injection, a Beckman 
Programmable Solvent Module for solvent delivery, and a Beckman Photo Diode Array (PDA) 
detection system The column used was a Phenomenex Biosep SEC-3000 (7 8mm x 300mm)
2.9.1.2.1. Calibration of the Biosep SEC-3000 Column with Molecular 
Mass Standards.
The Biosep SEC-3000 column was equilibrated with 50mL lOOmM potassium phosphate, pH 7 4, at a 
flowrate of 0 5mL/mm The standards used to calibrate the S-200 column m section 2 9 1 1 2  were 
also used to calibrate the Biosep SEC-3000 column with the exception that apofemtin (443,000Da) 
was included. 5|iL injections of 2mg/mL of each standard were applied and eluted from the column 
with 15mL equilibration buffer at a flowrate of 0 5mL/min. The elution of each standard was 
monitored at 214nm, 280nm and by continuous scanning of the column eluant usmg the PDA. Peak 
detection and retention time determination for each standard was achieved usmg Beckman System 
Gold peak integration software The elution volume (Ve) was calculated as the retention time
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(minutes) of each standard multiplied by the flowrate (0 5mL/min) A plot of Log molecular mass 
versus Ve of each standard, was prepared, and a calibration curve for the column was thus constructed
2 91 2 2 Estimation of Relative Molecular Mass of Purified Enzymes
Punfied PE and ZIP samples were concentrated 10 fold via reverse osmosis as outlined in section 
2 6 4 and 2 6 7 respectively 5jiL injections of concentrated enzvme were applied and eluted from the 
column with 15mL equilibration buffer at a flowrate of 0 5mL/min while 0 2min fractions were 
collected The fractions collected were assayed for Z-Gly-Pro-MCA degrading activity as outlined in 
section 28 7 and the elution volume (determined as outlined m section 2 9  1 2 1 ) was analysed using 
the calibration curve produced m section 2 9 1 2 1  The relative molecular mass of each enzyme was 
thus determined
2.9.1.3. SDS Polyacrylamide Gel Electrophoresis
The SDS electrophoresis of enzyme samples and molecular weight markers has been described m 
section 2 7 The distance migrated by each of the standards, punfied enzyme bands and bromophenol 
blue dye front was determined by measuring the distance from the stacker-reslover interface to the 
appronate band/dye front The relative mobility (Rf) of the molecular weight standards and the 
punfied protein samples were calculated by dividing the distance migrated by each standard or enzyme 
sample, by the distance migrated by the bromophenol blue dye front. A plot of Log molecular mass of 
each standard versus the Rf calculated for each standard was prepared and a calibration curve for the 
gel was thus constructed This calibration curve was then used to determine the molecular weight of 
the punfied enzyme samples based on their respective Rf values
2.92. Temperature Effects on Purified Enzymes
The effect of assaying punfied PE and punfied ZIP at vanous temperatures was determined Punfied 
enzymes were premcubated at 4°C, 20*C, 37°C, 45°C, 60°C and 80 C for 10 minutes to achieve thermal 
equilibnum after which enzyme activities were determined m triplicate as desenbed in section 2 8 7 at 
each temperature Activities were determined over assay times of 15, 30 and 45 minutes Substrate 
was premcubated at each temperature to achieve thermal equilibnum and suitable negative controls 
were prepared
2.9.3. pH Effects on Punfied Enzymes
2.9.3 1. pH Activity Profiles
20mL punfied PE and punfied ZIP w oe dialysed for 12 hours against 4L distilled water at 4°C 
0 ImM Z-Gly-Pro-MCA was prepared m a range of 20mM buffer systems at vanous pH values 
Enzyme activities were determined m tnphcate as outlined m section 2 8 7 usmg substrate prepared 
over a pH range of 2.5 to 10 5 Suitable negative controls were prepared The buffer systems used
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were citnc acid/potassium phosphate basic species (pH 2 5-7 5), potassium phosphate (pH 6  0-8 0), 
Tns/HCl (pH 7 0-9 0) and glycine/NaOH (pH 8 5-105)
2 9 32. pH Inactivation Profiles
50 i^L punfied enzyme samples prepared as descnbed in section 2 9 3 1 were premcubated with 50|iL 
40mM buffer at vanous pH for 15 minutes at 37°C The buffer systems used are descnbed m the 
preceding section 2 9 3 1 Enzyme activities were determined in tnplicate as described in section 2 8 7 
usmg substrate prepared in lOOmM potassium phosphate, pH 7 4 Suitable negative controls were 
prepared
2.9.4. Effect of Functional Reagents on Punfied Enzyme 
Activities
The effect of vanous functional reagents on punfied PE and ZIP activities were investigated The 
reagents tested and details on stock preparations of these reagents are listed in Table 23 50}iL of each 
reagent to be tested were incubated with 50jil of punfied enzyme for 15 minutes at 37°C pnor to 
substrate addition Samples were assayed as outlined in section 2 8 7 , with the exception that neither 
DTT nor NaQ woe included in the substrate used Each reagent was tested m tnplicate with suitable 
negative controls Fluonmetnc standard curves were prepared for each reagent to account for any 
inner filter effect produced (filtered standard curves) Where functional reagents were prepared m 
acetone or 0 1M NaOH, suitable positive controls were also prepared
2.9.5. Effect of Divalent Metal Salts on Punfied Enzyme Activities
The effect of vanous divalent metal salts on punfied PE and ZIP activities were investigated The 
metal salts used were N1SO4 , MnSO^ ZnSC>4 , CdS0 4 , C0SO4 , HgSC>4 , 0 1 SO4 , CaSC>4 and MgSC>4 
Each salt was used at a concentration of ImM 50*iL of each metal salt to be tested were incubated 
with 5tyU of punfied enzyme for 15 minutes at 37°C prior to substrate addition Samples were assayed 
as outlined in section 2 8 7 ,  with the exception that neither DTT nor NaCl were included in the 
substrate used. Each metal salt was tested in tnplicate with suitable negative controls Fluonmetnc 
standard curves were prepared for each reagent to account for any inner filter effect produced
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Functional reagent Concentration Preparation
DTT 20mM Dissolved in buffer(a)
DTNB 20mM Dissolved in buffer with heating W
Iodoacetamide 20mM Dissolved in buffer(a)
Iodoacetate 20mM Dissolved in basic phosphate buffer(c)
NEM 20mM Dissolved in buffer(a)
Leupeptin 2mM Dissolved in buffer(a)
2-Mercaptoethanol 20mM Dissolved in buffer(h)
PCMB lOmM Dissolved in 10% v/v 0 1M NaOH <d>
EDTA 20mM Dissolved in buffer(a)
CDTA 20mM Dissolved in buffer(a)
EGTA 20mM Dissolved in buffer <a)
Imidazole 20mM Dissolved in buffer M
8-Hydroxyquinohne 20mM Dissolved m 5% v/v acetone with heating <e>
1,10 Phenanthrohne 20mM Dissolved in 5% v/v acetone(f)
1,7 Phenanthroline 20mM Dissolved m 5% v/v acetone(0
4,7 Phenanthroline 20mM Dissolved m 5% v/v acetone with heating <c)
PMSF 2mM Dissolved in 5% v/v acetone
AEBSF 20mM Dissolved in buffer(a)
Puromycm 2mM Dissolved m buffer <fl>
N-Acetylunidazole 20mM Dissolved in buffer
Benzamidine 20mM Dissolved in buffer(fl)
Trypsin inhibitor 2mg/mL Dissolved in buffer <a)
Chymotrypsin inhibitor lmg/mL Dissolved in buffer <a)
Pepstatin lmg/mL Dissolved in 5% v/v acetone ®
Aprotmm lmg/mL Dissolved in buffer(a)
Bacitracin 2mg/mL Dissolved in buffer (a)
N-Decanoyl Co A 2mg/mL Dissolved in buffer <a>
Table 2 3 Preparation o f Junctional reagent stock solutions <a)100mM potassium phosphate, pH 
74, at S7aC lOOmM potassium phosphate, pH 7 4, with subsequent heating m a boiling water bath. 
WlOOmM potassium phosphate basic species at 37 °C to aid solubility and to maintain a final pH o f 70  
^Dissolved initially in 0 IM NaOH followed by dilution with appropriate lOOmM basic or acidic 
potassium phosphate species at 37'C to maintain pH at 70  (e)Dissolved initially in 100% acetone 
followed by dilution with lOOmM potassium phosphate, pH 7 4, with subsequent heating in a boiling 
water balh. <f>Dissolved initially in 100% acetone with subsequent diltuion with lOOmM potassium 
phosphate, pH 7 4 <*>Asfor <f> with the exception that preparation was carried out 10 minutes prior to 
preuiCubatiOft ^ 2 OuL 2-mercaptoethanol diluted with lOmL lOOmM potassium phosphate pH 7 4
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2.9.6. Substrate Specificity Studies on PE and ZIP
The substrate specificity of punfied PE and punfied ZIP activities was determined using 
Reverse Phase HPLC , fluonmetnc and kinetic analysis methodologies
2.9 6 1 Substrate Specificity Determination Using Reverse Phase
HPLC
A Beckman Gold HPLC system, as previously descnbed in section 2 9 1 2 ,  was used The column 
used was a Beckman Ultrasphere C-8 (Octyl) Reverse Phase Column (4 6mm x 250mm) which was 
fitted with a Beckman Ultrasphere Reverse Phase Guard Column (4 6mm x 45mm),
2.9 6.1 1 Preparation of Stock Substrates and Standard Fragments
All stock substrates and standard fragments used were prepared m a similar manner They were 
initially dissolved m 0 5mL 100% MeOH (filtered and degassed), followed by dilution to lOmL with 
lOOmM potassium phosphate, pH 7 4 (filtered and degassed) Table 2 4 lists the substrates and 
standard fragments that were used
2.9.6.1.2. Reaction of Substrates and Punfied Enzyme Activities
200nL of each substrate (ImM) was added to 50pL punfied enzyme acuvity (PE or ZIP) The reacuon 
between substrate and enzyme was allowed to continue for 24 hours at 37°C Suitable buffer, enzyme, 
substrate and fragment controls were prepared Substrate specificity studies on PE were performed m 
the presence and absence of 15mM DTT, 15mM EDTA , and m the presence and absence of Z-Pro- 
Prohnal
2.9.6.1.3. Reverse Phase HPLC of Samples
Following the compleuon of the enzyme-substrate reactions, and preparation of suitable controls, 
samples were transferred to HPLC vials and positioned in the Beckman Autosampler Running buffers 
for the reverse phase chromatography were A 100% MeOH + 0.2% TFA (v/v) and B Ultrapure 
water + 0 2% TFA (v/v) Both buffers were filtered and degassed pnor to use The reverse phase 
column was equilibrated with lOmL 15% buffer A / 85% buffer B at a flowrate of lmL/mm 20pJL 
injections of each sample to be analysed were applied followed immediately by a lOmL linear gradient 
from 15% buffer A / 85% buffer B to 70% buffer A / 30% buffer B Following a 5mL wash at 70% 
buffer A / 30% buffer B and a subsequent 5mL wash with 100% buffer A to clean the column, the 
column was re-equilibrated pnor to application of the next sample Eluant from the column was 
monitored using the Beckman PDA detector previously described in section 2 9 1 2  Wavelengths used 
were 214nm, 280nm and continuous scanning from 190nm to 590nm at 4nm intervals Scans were 
performed twice every second
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Substrate / Solubility in Solubility id Stock conc
Fragment 100% MeOH * buffer** Heanng needed^ (m M )^
LHRH Yes Yes No 1 0
TRH Yes Yes No 2 0
TRH-OH Yes Yes No 35
Bradykimn Yes Yes No 0 35
Substance P Yes Yes No 015
Angiotensin U No Yes No 0 20
Pro-Gly No Yes No 7 0
Pro No Yes No 14 0
Gly No Yes No 56 0
Z-Pro-G ly Yes Yes No 6 5
Gly-Pro-Ala No Yes No 3 5
Gly-Pro Yes Yes No 6 0
Ala No Yes No 15 0
Z-Gly-Pro-Ala Yes Yes No 55
Gly-Gly-Pro-Ala No Yes No 6 5
Gly-Ala-Phe No No Yes 80°C 5 0
Lys-Ala-Ala No Yes No 8 0
Gly-Phe-Ala No Yes No 4 5
Z-Pro-Pro No Yes No 55
Z-Pro-Ala Yes Yes No 5 0
Z-Pro-Leu-GIy Yes Yes No 4 5
Leu-Gly Yes Yes No 55
Z-Pro Yes Yes No 6 0
Table 2 4 Preparation o f  stock substrates and fragments for substrate specificty studies usmg 
reverse phase HPLC * Indicates whether substrate/ fragment was solubilised in initial 0 5mL 100% 
MeOH ** Indicates whether (a) substrate/fragment that failed to dissolve in MeOH was finally 
dissolved upon addition o f lOOmM potassium phosphate, pH 7 4y or (b) substrate/fragment that was 
dissolved in MeOH remained m solution following addition o f buffer 1 1ndicates whether heating was 
needed to dissolve substrate /fragment f t  ImM stock substrate/fragment was the intended final 
concentration however some substrates were in short supply and had to be made up at lower 
concentrations Those substrates that were made up to a final concentration greater than ImM were 
diluted appropriately prior to use in substrate specificity studies Those peptides listed in bold type 
were also used in kinetic analysis studies as desenbed in section 2 9 6 3  S
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2962 .  Substrate Specificity Determination Using Fluonmetnc
Substrates
Vanous substrates, to which MCA was attached, were used for this study
2 9.6 2 1 Preparation of Stock Substrates and Standard Fragments
All stock substrates used were prepared in a similar manner They were initially dissolved m 100% 
dioxane followed by dilution with lOOmM potassium phosphate, pH 7 4, at 37°C so that the final 
concentration of each substrate stock was ImM in a final dioxane concentration of 20% (v/v) Table 
2 5 lists the substrates that were used
2 9.6.2.2. Reaction of Substrates and Punfied Enzyme Activities
The activity of punfied PE and ZIP activities against the vanous substrates was determined in a similar 
manner to that descnbed previously m section 2 8 7 Each substrate stock, prepared as outlined in 
section 2 9 6  2 1 , was diluted 10 fold with lOOmM potassium phosphate, pH 7 4, (+15mM DTT for PE 
activity determination or +500mM NaCl for ZIP activity determination) to a final concentration of 
0 ImM The final dioxane concentration present in each substrate was 2% (v/v) 400^tL of each 
substrate to be tested was added to lOOpL of punfied PE or ZIP activity The reaction mixture was 
then incubated for 1 hour at 37°C followed by the addition of lmL 1 5M acetic acid to terminate the 
assay Substrates were tested in tnplicate and suitable negative controls were prepared MCA 
liberated from each substrate was determined fluonmetncally as outlined in section 2 2 1
29.7. Substrate Specificity Studies on PE and ZIP Based on 
Kinetic Analysis
Kinetic analyses of PE and ZIP activities against Z-Gly-Pro-MCA and pGlu-His-Pro-MCA, coupled 
with the effects of prolrne containing peptides on the kinetic parameters obtained, were investigated.
2 9.7.1. Determination of Km for Z-Gly-Pro-MCA (PE and ZIP)
The Michaclis-Menten Constant (Km) of punfied enzymes (PE or ZIP) for the substrate Z-Gly-Pro- 
MCA was determined Stock substrates for PE and ZIP studies were 0 2mM Z-Gly-Pro-MCA, 5% 
dioxane (v/v), 15mM DTT, 15mM EDTA and 0 5mM Z-Gly-Pro-MCA, 10% dioxane (v/v), 500mM 
NaCl respectively A range of substrate concentrations from 0-100% stock substrate were prepared 
usmg an appropriate diluant. Enzyme activities were determined in tnplicate as outlined in section 
2 8 7 Suitable negative controls were prepared The results were subjected to Michaelis-Menten, 
Lmeweaver-Burk, Eadie-Hofstee, Hanes-Woolf and Direct Linear Plot analysis to determine Km 
(Michaelis and Menten, 1913, Lineweaver and Burk, 1934, Hofstee et a l , 1959, Hanes, 1932, 
Eisenthal and Cormsh-Bowden, 1974)
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Substrate Typical activity detected Reference
AJa-MCA Alanine Ammopeptidase Mantle et aL ,(1983)
Arg-MCA Arginine Ammopeptidase Bairett et aL ,(1981)
Z-Arg-MCA Trypsin Nishikata et aL ,(1985)
Pro-MCA Prolme Ammopeptidase Yoshimoto et aL ,(1983)
pGlu-MCA PAP Type I Cummins and O’Connell996)
Glu-Phe-MCA Chymotrypsin Zimmerman et aL ,(1977)
Gly-Arg-MCA DPP I Chan et aL ,(1985)
Gly-Pro-MCA DPPIV Checler et ai ,(1985)
Lys-AJa-MCA DPPn Nagatsu et aL ,(1985)
Z-Arg-Arg-MCA CathepsmB Hiwasa et aL ,(1987)
Z-Phe-Arg-MCA Plasma Kallikrein BarrettetaL  ,(1981)
Z-GIy-Pro-MCA Prolyl Endopeptidase Yoshimoto et aL ,(1979)
pGlu-Hjs-Pro-MCA * PAP type II O'Leary and O'Connor ,(1995)
Boc-Val-Leu-Lys-MCA Plasmrn Kaio et aL ,(1980)
Boc-Val-Pro-Arg-MCA Thrombin Kawabata et aL ,(1988)
S uc-AJa-Phe-Lys-MC A Plasmm Pierzchala et aL ,(1979)
Z-Phe-Val-Aig-MCA Trypsin Somorm et aL ,(1978)
Suc-Gly-Pro-Leu-Gly-Pro-MCA Collegenase Shop et aL ,(1989)
Table 2  5. Fluorimetric substrates used to determine the substrate specificity o f punfied PE and 
ZIP activities The enzymes which are normally associated with activity against these substrates are 
also listed * This substrate can also be used to detect Prolyl Endopeptidase activity PAP - 
Pyroglutamyl ammopeptidase, DPP - Dipeptidyl Peptidase
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2 9 7 2. Determination of Km for pGIu-His-Pro-MCA (PE)
The Michaelis-Menten Constant (Km) of punfied PE for the substrate pGIu-His-Pro-MCA was 
determined 0 5mM pGIu-His-Pro-MCA, 15mM DTT, 15mM EDTA was prepared in lOOmM 
potassium phosphate, pH 7 4 A range of substrate concentrations from 0-100% of this stock substrate 
was prepared m lOOmM potassium phosphate, pH 7 4, 15mM DTT 15mM EDTA Enzyme activities 
towards pGIu-His-Pro-MCA were determined in tnphcate m a similar manner to that desenbed in 
section 2 8 7 Suitable negative controls were prepared The results were subjected to Michaehs- 
Menten, Lmeweaver-Burk, Eadie Hofstee, Hanes-Woolf and Direct Linear Plot analysis to determine 
Km
2,9 73. Determination of Kj Values for Proline Containing Peptides
(PE and ZIP)
The effects of proline containing pepudes on the Km values obtamed for PE and ZIP activities towards 
the substrate Z-Gly-Pro-MCA were investigated The peptides used are listed in Table 2 4 in bold 
type Stock substrates for PE and ZIP studies were 0 2mM Z-GIy-Pro-MCA, 5% dioxane (v/v), 15mM 
DTT, 15mM EDTA and 0 5mM Z-Gly-Pro-MCA, 10% dioxane (v/v), 500mM NaCl respectively A 
range of substrate concentrations from 0 -100% stock substrate were prepared usmg an appropriate 
diluant. A fixed concentration of each proline con taming peptide to be tested was incorporated into the 
substrate ranges Where possible the concentration of each peptide m the substrate was maintained at 
ImM Enzyme activities were determined in tnphcate as described m section 2 8 7 Suitable negative 
controls were prepared The results were subjected to Michaelis-Menteo, Lmeweaver-Burk, Eadie- 
Hofstee, Hanes-Woolf and Direct Linear Plot analysis to determine Km and apparent Km values The 
relationships between the Km and apparent Km values thus obtained, and the nature of the inhibition 
observed, were investigated usmg Lmeweaver-Burk, Eadie-Hofstee and Hanes-Woolf analyses Kj 
values were thus determined
2.9.8. Effect of PE Specific Inhibitors on Punfied PE and ZIP 
Activities
The effect of vanous PE and proline specific peptidase inhibitors was investigated Table 2 6  lists 
these inhibitors and details of their preparation and use Stock substrates for PE and ZIP studies were 
0 2mM Z-Gly-Pro-MCA, 4% dioxane (v/v), 30mM DTT, 30mM EDTA and 0 2mM Z-Gly-Pro-MCA, 
4% dioxane (v/v), 500mM NaCl respectively lmL of each inhibitor al vanous concentrations was 
added to lmL of substrate pnor to enzyme addition Thus the final concentration of substrate used was 
0 ImM, 2% dioxane (v/v) Enzyme activities against these substrates woe determined in tnphcate as 
outlined in section 2 8 7 Suitable negative and positive controls were prepared
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Inhibitor Reference Preparation Concentration range used (M)
Fmoc-Pro-Pro-Nitnle Dr Sherwm Wilk (PC) 20% (v/v) Dioxane(a) 2  6x l0*15 - 2  6x l0’6
Z-Thiopropyl-ThyoprolinaJ Tsuru eta l (1988) 50% (v/v) Dioxane(a) 1 9xl0 ' 14 - 1 9xl0 ' 5
Z-Pro-ProlinaJ Wilk and Orlowski (1983) 20% (v/v) Dioxane(a) 2  8x 1 0 - , 2 - 2  8 x 1 0 -3
a-Ketobenzothiazole Tsutsumi et a l (1994) 50% (v/v) Dioxane(a) 6 9x10 '15-6  9x10' 6
Posts taun Nagai et a l (1991) 20% (v/v) Dioxane(a) 8 lxlO*13 - 8 lxlO"4
Z-Phe- Pro-Mcthylkctone Stclnmetzer et al (1993) Buffer (M 1 OxIO*15 - 1 OxIO' 6
Z-Cyclohexyl-Prolinal Bakker et al (1991) 50% (v/v) Dioxane(a) 2  0 x 1 0 - 1 5 - 2 0 x 1 0 '6
Z-Indolinyl-Prolinal Bakker et a l  (1991) 50% (v/v) Dioxane(a) 1 lxlO' 13 -1 lxlO"4
Boc-Glu(NHO-Bz)-Pyir Demuthetal (1993) 20% (v/v) Dioxane(a) s e x i o - ^ - s e x i o -4
Kelatorphan Barelh et al (1993) Buffer W 1 OxIO' 10 -1  OxIO-2
T able  2 6  PE specific inhibitors used to characterise purged PE and ZIP activities as described in section 2 9 7  (a) Inhibitors were 
initially dissolved in 100% dioxane to which lOOmM potassium phosphate, pH 7 4, at 37°C was added resulting in the final dioxane 
concentration presented (b) lOOmM potassium phosphate, pH 74, at 37°C (PC) - Personal Communication
3, Results
Note Error bars on all graphs represent the standard deviation values determined for triplicate 
observations
3 1. MCA Standard Curves and the Inner Filter Effect
MCA standard curves were prepared as outlined m section 2 2 1 Plots of fluonmetnc intensity 
observed versus MCA concentration are presented in Figures 3 1 1 , 3 1 2 ,  and 3 1 3  These plots also 
include standard curves prepared as desenbed m section 2.2.2 to demonstrate the inner filter effect 
observed when using serum as the enzyme sample Table 3 1 lists the slopes obtained from each 
curve It should be noted that the expression of MCA concentration on the X-axis of Figures 3 1 1 ,  
3 1 2 and 3 1 3 represent the concentration contained in 400|iL used to construct the curve (refer to 
section 2 2 1 )
3.2. Protein Standard Curves
Protein standard curves woe prepared using BSA as outlined in section 2 3 2 , 2 3 3  and 2 3 4  Plots 
of Absorbance at 560nm versus BSA concentration are presented in Figures 3 2 1 , 3 2 2  and 323  for 
the Biuret, Standard BCA and Enhanced BCA assays respectively
3.3. Serum Preparation
Serum was prepared as desenbed in section 2 4 From 9L whole blood collected, 2L unclotted blood 
was removed following 24 hours at 4°C and 1 6L serum were produced following centrifugation
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Curve Slope * (No filter effect) Slope including filter effect
0 - 2 5  |iM (Figure 3 1 1) 321 07 F I^iM  MCA 277 61 F I / ^ M  MCA
0 - 1 0  fiM (Figure 3 1 2 )  7085FI /nM M CA  6191FI /nM M C A
0 - 2 0  pM (Figure 3 1 3 )  11 16FI/^iMMCA 9 8 5 F I /n M M C A
Table 3.1 Slopes obtained from MCA standard curves * F I  -  Fluorimetric Intensities MCA 
standard curves were constructed as outlined in section 2 2 1  This table clearly indicates Inner Filter 
effect observed when serum ts incorporated into the MCA standard curves with slopes reduced by an 
average o f approximately 12 5%
MCA concentration* (pM)
MCA concentration* (jiM)
Figures 3 1 1  e n d  3 1 2  MCA S ta n d a rd  Curves Plots o f fluonmetnc intensity versus 
M CA concentration demonstrating the inner filter effect lOOfjL buffer (o-o) or lOOfjL serum 
were combined with 400fiLMCA and lmL 15M acetic acid before being analysed fluorimetncally as 
outlined in section 2 2 1  Emission slit widths were set to lOnm and 5nm for Figures 3 1 1  and 3 1 2  
respectively * MCA concentrations represented as desenbed m section 31
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MCA concentration* (jiM)
Figure 3 1 3  MCA Standard Curve Plot offluorimetnc intensity versus MCA concentration 
demonstrating the inner filter effect of serum ( • - • )  compared to that o f buffer (o-o)  Curve 
constructed as outlined in section 2 2 1  and 2 2 2  Emission slit width set to 2 5nm. * MCA 
concentrations represented as desenbed m section 31
BSA concentration (mg/mL)
Figure 3.2 A, BSA Standard Curve Plot o f absorbance at 560nm versus BSA concentration 
obtained using the Biuret assay Curve constructed as outlined m section 2 3 2  Absorbances at 
560nm determined usmg a Taertek Multiscan PLUS plate reader
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BSA concentration (mg/mL)
BSA concentration (jig/mL)
Figures 3 2 2  and 3 2 3  BSA Standard Curves Plots of absorbance at 560nm versus BSA 
concentration obtained using the Standard BCA and Enhanced BCA assays respectively SOfjL BSA 
was combined with 200ftL BCA reagent in a 96 well plate, which was mcubated for 30 minutes at 37°C 
or 60°Cfor the Standard BCA or Enhanced BCA assays respectively as outlined in sections 2 3  3 and 
2 3 4  Absorbances at 560nm were determined using a Titertek Multiscan PLUS plate reader
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3 4. Measurement of Z-Glv-Pro-MCA Degrading Activity in Serum
Serum Z-GIy-Pro-MCA degrading activities were determined as outlined in section 2 5 1 Z-Pro- 
Prohnal insensitive Z-Gly-Pro-MCA degrading activity <ZIP) in serum was determined a* desenbed m 
section 2 5 2 Figure 3 4 1 demonstrates the presence of Prolyl Endopepudase (PE) and ZIP in bovine 
serum Figure 3 4 2 and Figure 3 4 3 confirm that Z-Gh -Pro-MCA degrading activity in serum could 
not be further inhibited by increasing Z-Pro-Prolinal coocentration, or by increasing the preincubation 
time of serum with Z-Pro-Prolinal at 37°C pnor to substrate addition, respectively It should be noted 
that the Z-Pro-Prolinal concentrations expressed on the X-axis of Figure 3 4 2 represent the inhibitor 
concentration present m the 20jjL added to serum pnor to substrate addition (refer to section 2 5 2)
3 5 Conversion of Fluorimetric Intensities to Enzyme Units
Conversion of fluonmetnc intensities to enzyme units, defined as pmoles MCA released per minute, 
were accomplished usmg the following formula.
Enzyme Units =—E i — x 6 67 
SLOPE
where F J  is the fluonmetnc intensity observed, SLOPE is the slope of an appropnate standard curve 
and 6 67 is a factor that considers how the standard curves were constructed (refer to section 2 2 1 )  
The conversion from pM to pmoles and from hours to minutes is also considered Usmg this formula 
and multiplying by a factor of 10 to convert to Units per mL, the PE and ZIP activities presented in 
Figure 3 4 1 are 342 Enzyme Units per mL and 222 Enzyme Units per mL respectively
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F ig u re  3 .4 1 . D em onstra tion  o f  2 d istinc t Z -G ly-P ro -M C A  d egrad ing  activities in  
bovine  se ru m  Plot o f bovine serum enzyme activity against Z-Gly-Pro-MCA in the presence and 
absence o f  Z-Pro-Prolinal (ZPP) PE activity is represented by the disappearance o f ZGly-Pro-MCA 
degrading activity in the presence o f Z-Pro-Prohnal ZIP activity is represented by the residual 
activity against Z-Gly-Pro-MCA in the presence o f Z-Pro-ProhnaL Activities determined as outlined 
in sections 2 51 and 2 52  * Enzyme activity expressed as fluorimetric intensities
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Figures 3 42  and 3 4 3  Resistance o f residual Z^Gly-Pro-MCA degrading activity 
in bovine serum to Z-Pro-Prohnal inhibition Plots o f bovine serum enzyme activity against 
Z-Gty-Pro-MCA versus Z-Pro-Prohnal concentration (Figure 3 4 2 )  or increased preincubation time 
with Z-Pro-Prohnal (Figure 3 4 3 )  Plots demonstrate that residual Z-Gly-Pro-MCA degrading 
activity in serum is resistant to Z-Pro-Prohnal inhibition regardless o f inhibitor concentration or 
pretncubation time used PE activity in serum is completely inactivated by Z-Pro-Prohnal 
concentrations o f lQr^M or greater * Enzyme activity expressed as fluonmetnc intensities t  Z-Pro- 
Prolmal concentrations in Figure 3 4  2 areas descnbed in section 3 4
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3 6. Purification of Z-Glv-Pro-MCA Degrading Activities from Bovine 
Serum
3 6 1 SP Sepharose Fast Flow Cation Exchange Chromatography
Following dialysis of 20mL bovine senim, post-dialysis precipitate was removed by centrifugation as 
outimed in section 2 6  11 producing 21 5mL clear supernatant, pH 5 5 85% PE and 73% ZIP 
activities were recovered following dialysis and centrifugation lmL of the dialysed supernatant was 
retamed for enzyme activity and protein determinations while the remainder was applied to an SP 
Sepharose column as desenbed m section 2 6 1 1  Two activity peaks were detected from this column 
The first peak eluted dunng the wash and a second peak was eluted following the application of an 
isocratic salt wash to the column as illustrated in Figure 3 6 1 1  These activities are distinguished 
according to their sensitivity towards Z-Pro-Prolinal which is illustrated m Figure 3 6 1 2  Fractions 4- 
12 and 51-56 were combined as the post-SP Sepharose PE (41 5mL) and ZIP (27 5mL) pools 
respectively lmL of each pool was retained for enzyme activity and protein determinations
3 6.2 Phenyl Sepharose Hydrophobic Interaction Chromatography (PE)
The post-SP Sepharose PE pool was salted and applied to the Phenyl Sepharose column as outlined in 
section 2 6 2 PE acuvity was eluted from the column by application of a linear decreasing salt 
gradient (Figure 3 6  2 )  Fractions 74-91 were combined as the post-Phenyl Sepharose PE pool 
(84mL) lmL of this pool was retamed for enzyme activity and protein determinations
36  3. DEAE Sepharose Fast Flow Anion Exchange 
Chromatography (PE)
The post-Phenyl Sepharose PE pool was dialysed as outlined infection 2 6  3 Following dialysis the 
volume of the pool had increased to llOmL and its conductivity had reached 3 98 millisiemens (mS) 
The conductivity of the DEAE Sepharose equilibration buffer was recorded as 3 84mS The pool was 
applied to the column as desenbed in section 2 6  3 PE was eluted from the column with an linear 
increasing salt gradient and final salt wash as illustrated in Figure 3 6  3 Fractions 94-111 were 
combmed as the post-DEAE Sepharose PE pool (82mL) lmL of this pool was retamed for enzyme 
activity and protein determinations
3 6.4. Sephacryl S-200 HR Sepharose Gel Filtration 
Chromatography (PE)
The post-DEAE Sepharose PE pool was concentrated to 2mL via reverse osmosis 200j±L glycerol 
were added to the concentrated enzyme which was loaded and eluted from the S-200 column as 
outlined in section 2 6 4 86mL were washed through the column before fractions were collected 
Figure 3 6 4  illustrates the elution profile of PE from the column Fractions 11-23 were pooled 
(6  lmL) and stored on ice lmL of this pool was retained for enzyme activity and protein 
determinations The effectiveness of the PE purification strategy is presented in Table 3 2
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Figure 3 6 LI. Elution o f PE and ZIP activities from SP Sepharose cation 
exchange chromatography Plot o f absorbance at 280nm ( ), Z-Gly-Pro-MCA degrading
activity ( o~0) and ammonium sulphate concentration (—-—) versus elution volume Plot illustrates 
run through and bound Z-Gly-Pro-MCA degrading activities in bovine serum being separated by 
cation exchange chromatography Pool I (fractions 4 - 12, 41 5mL) represents PE activity Pool 2 
(fractions 51 - 56, 2 1 5mL) represents ZIP activity SP Sepharose chromatography performed as 
desenbed in section 2 6 1 1  * Enzyme activity expressed as fluonmetnc intensities
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Figure 3 6 1 2  Sensitivity of post-SP Sepharose fractions to Z-Pro-Prohnal 
inhibition Plot o f enzyme activity versus elution volume Plot illustrates Z-Gly-Pro-MCA 
degrading activity infractions assayed in the presence (o-o) and absence ( • - • )  o f Z-Pro-Prolinal 
Run through activity (-20 - 60mL) was totally inhibited by ZrPrO'Pwhnal while bound activity (**250 - 
280mL) was totally insensitive to ZrPro-Prolmal inhibition Fractions assayed as outlined m sections 
2 6 1 1  and 2 6 1 2  * Enzyme activity expressed as fluorimetric intensities
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Figure 3 62  Elution of PE activity from Phenyl Sepharose hydrophobic 
interaction chromatography Plot o f absorbance at 280nm ( ), PE activity ( • - • )  and
ammonium sulphate concentration (------ ) versus elution volume Bound PE activity was eluted usmg
a linear decreasing ammonium sulphate gradient Fractions 74 - 91 were combined to form the post- 
Phenyl Sepharose PE pool (84mL) Phenyl Sepharose chromatography was performed as desenbed m 
section 2 62  * Enzyme activity expressed as fluorimetric intensities
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Figure 3 6 3 Elution of PE from DEAE Sepharose anion exchange 
chromatography Plot o f absorbance at 2S0nm ( ), PE activity (0-0) and NaCl concentration 
(—*— ) versus elution volume Bound PE activity was eluted using a linear increasing NaCl gradient 
Fractions 94 - 111 were combined to form the post-DEAE Sepharose PE pool (82mL) DEAE 
Sepharose chromatography was performed as desenbed in section 2 6 3  * Enzyme activity expressed 
as fluonmetnc intensities
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Figure 3 6.4. Elution of PE from Sephacryl S-200 HR Sepharose gel filtration 
chromatography. Plot o f absorbance at 560nm ( ) and PE activity (*-*)  versus elution volume 
Protein was determined using the Standard BCA assay as descnbed m section 23  3 Fractions 11-23  
were combined to form the post-Sephacryl S-200 pool (61mL) and were stored on ice fo r  
charactensation studies Sephacryl S-200 HR Sepharose chromatography was performed as outlined 
in section 2 6.4 * Enzyme activity expressed as fluonmetnc intensities
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Purification stage Total protein (mg) Total activity (Units)* Specific activity (Umts/mg) Purification factor Recovery (%)
Serum 1,420 10,228 7 20 100 100
Dialysis pH 5 5 1,084 8,716 804 1 12 85
SP Sepharose 422 4,994 1183 1 64 49
Phenyl Sepharose 31 4,243 137 21 19 05 41
DEAE Sepharose 12 2,420 205 88 28 59 24
Sephacryl S-200 HR 11 1,197 104 29 1448 12
Table 3 2 Purification o f prolyl endopeptidase from bovme serum. * Units are expressed as pmoles 
MCA released per minute Pools representing each purification stage were assayed for PE activity as 
outlined m section 2 8 7 , with 15mM DTT\ J5mM EDTA incorporated into substrate
3 6.5 Further Purification of ZIP Using Phenyl Sepharose 
Hydrophobic Interaction Chromatography (ZIP)
The post-SP Sepharose ZIP pool was applied to the Phenyl Sepharose column as desenbed in section
2 6 5 ZIP activity was eluted with an isocraUc distilled water wash as illustrated in Figure 3 6 5 
Fractions 53-56 were combined as the post-Phenyl Sepharose ZIP pool (18mL) lmL of this pool was 
retained for enzyme activity and protein determinations
3 6.6 Calcium Phosphate Cellulose Chromatography (ZIP)
The post-Phenyl Sepharose ZIP pool was further punfied usmg a Calcium Phosphate Cellulose column 
as desenbed m section 2 6 6  The enzyme was eluted from the column following application of an 
linear increasing phosphate gradient as illustrated in Figure 3 6 6  Fractions 20-24 were combined as 
the post-Calcium Phosphate Cellulose pool (29mL) lmL of this pool was retained for enzyme activity 
and protein determinations
3 6.7. Sephacryl S-200 HR Sepharose Gel Filtration 
Chromatography (ZIP)
The post-Calcium Phosphate Cellulose ZIP pool was concentrated via reverse osmosis to 2mL 200|iL 
glycerol were added to the concentrated enzyme which was loaded and eluted from the S-200 column 
as desenbed in section 2 67  and illustrated m Figure 3 6 7 85mL were washed through the column 
before fractions were collected. Fractions 7-12 were pooled (28 5mL) and stored on ice lmL of this 
pool was retained for enzyme activity and protein determinauons The effectiveness of the ZIP 
purification strategy is presented in Table 3 3
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F ig u re  3 6 5  E lu tio n  o f  Z I P  f r o m  P h e n y l Sepharose  hydrophob ic  in teraction  
chrom atography Plots o f absorbance at 280nm ( ), ZIP activity ( • - • )  and ammonium sulphate 
concentration (— ■—) versus elution volume Bound ZIP activity was eluted isocratically with a 
distilled water wash Factions 53 - 56 were combined to form the post-Phenyl Sepharose ZIP pool 
(18mL) Phenyl Sepharose chromatography was performed as desenbed in section 26 5 * Enzyme 
activity expressed as fluonmetnc intensities
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Figure 3 6 6  Elution of ZIP from Calcium Phosphate Cellulose chromatography
Plots o f absorbance at 560nm ( ), ZIP activity ( • - • )  and potassium phosphate concentration
(-------) versus elution volume Bound ZIP activity was eluted with a linear increasing phosphate
gradient Protein determined usmg the Standard BCA assay as described in section 23  3 Fractions 
20 - 24 were combined to form the post-Calcium Phosphate Cellulose ZIP pool (29mL) Calcium 
Phosphate Cellulose Chromatography was performed as descnbed m section 2 6 6  * Enzyme activity 
expressed as fluonmetnc intensities
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Figure 3.6 7 Elution of ZIP from Sephacryl S-200 HR Sepharose gel filtration 
chromatography Plots o f absorbance at 560nm ( ) and ZIP activity { • - • )  versus elution
volume Protein determined usmg the Enhanced BCA assay as desenbed in section 2 3 4  Fractions 7 
-12 were combined to form the post Sephacryl S-200 HR Sepharose ZIP pool and were stored on ice 
for characterisation studies Sephacryl S-200 HR Sepharose chromatography was performed as 
described in section 2 6 7  * Enzyme activity expressed as fluonmetnc intensities.
83
Purification stage Total protein (mg) Total activity (Units) Specific activity (Umts/mg) Purification factor Recovery (%)
Serum 1,420 5,412 3 81 100 100
Dialysis pH 5 5 1,084 3,950 3 64 0 96 73
SP Sepharose 579 3,852 6 66 1 75 71
Phenyl Sepharose 16 2,132 129 44 33 96 39
Calcium Phosphate Cellulose 01 1,257 11,811 3,098 23
Sephacryl S-200 HR 009 757 8,601 2,256 14
Table 3 3 Purification o f ZIP from bovine serum * Units are expressed as pmoles MCA released per 
minute Pools representing each purification stage were assayed for ZIP activity as outlined in section 
2 8 7 , with 500mM NaCl incorporated into substrate
3 6 8. Alternative Chromatographic Regimes Used to Further
Purify PE 
3 6 81. Q Sepharose Fast Flow Anion Exchange Chromatography
Post-Phenyl Sepharose PE acuvity was dialysed, applied and eluted from Q Sepharose as outlined m 
secuon 2 6 8 1 Figure 3 6 8 1 illustrates the eluuon of PE activity following applicauon of a linear 
increasing salt gradient This Figure also illustrates the failure of Q Sepharose to resolve the PE 
acuvity from contaminating protein
3 6.8.2 Calcium Phosphate Cellulose Chromatography
Figure 3 6  8 2 illustrates attempts made to bind PE acuvity to Calcium Phosphate Cellulose under 
conditions descnbed m section 2 6 82
3 6.8.3. Biogel HT Hydroxylapatite Chromatography
Post-Phenyl Sepharose PE activity was prepared and applied to Biogel HT Hydroxylapaute as outlined 
in secuon 2 6  8 3 Figure 3 6  8 3 illustrates that under these condiUons it was possible to bmd PE 
acuvity However, eluUon of the PE acuvity by applying an increasing phosphate gradient failed to 
resolve PE from contaminating protem
3.6.8.4. Blue Sepharose Fast Flow Chromatography
Figure 3 6  8 4 demonstrates the failure of Bine Sepharose to bmd PE acuvity under the condiUons 
outlined m secuon 2 6 8 4
3.6.8 5. Activated Thiol Sepharose Chromatography
DTT was removed from post-Phenyl Sepharose PE by dialysis as descnbed in secuon 2 6  8 5 1 
Removal of DTT from the enzyme sample was also achieved by de-salung usmg a Sephadex G-25 
column as outlined m section 2 6  8 5 2 Figure 3 6 8.5 1 illustrates the separation of PE activity from 
DTT m post-Sephadex G-25 fractions Failure to bmd PE acUvity to Activated Thiol Sepharose is 
illustrated in Figure 3 6 8 5.2
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Figure 3 6 8 1  Elution of PE from Q Sepharose Illustration o f failure to resolve PE
activity from protein ( ) using a linear increasing NaCl gradient (-------) Q Sepharose
chromatography performed as described in section 2 6  81  * Enzyme activity expressed as
fluonmetnc intensities
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Figure 3 6 8 2  Elution of PE from Calcium Phosphate Cellulose chromatography
Illustration o f failure to bind PE activity (o-m) to Calcium Phosphate Cellulose Calcium Phosphate 
Cellulose chromatography performed as described ui section 2 6 8 2  * Enzyme activity expressed as 
fluonmetnc intensities ( ) Protein concentration, (—•— ) Phosphate concentration
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Figure 3 6 8 3  Elution of PE from HydroxylapatUe Illustration o f failure to resolve PE 
activity f •  -  oj from protein ( ) usmg a linear increasing potassium phosphate gradient (—■ —)
Hydroxylapatite chromatography performed as described in section 2 6  8 3 * Enzyme activity
expressed asfluonmetnc intensities
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Figure 3 6 8 4  Elution of PE from Blue Sepharose Resolution o f PE (0 - 0) from protein 
( ) was achieved with an increasing NaCl gradient however PE activity was severely
affected Blue Sepharose chromatography was performed as desenbed in section 2 6 8 4  * Enzyme 
activity expressed as fluonmetnc intensities
87
HH
a
'ecoO
300 
2 75 
2 50 
2 25 
2 00 
175 
150 
1 25 
100 
0 75 
0 50 
0 25 
000
*
5Z3
<a
i
300
275
250
225
200
175
150
125
100
75
50
25
0
a
"u H
0 15 30 45 60 75 90 105 120 135 150
Elution volume (mL)
Figure 3 6 8 5 1  Elution of PE and DTT from Sephadex G-25 Illustration o f the
removal o f DTT ( ) from PE ( •  - • )  prior to Activated Thiol Sepharose chromatography Sephadex 
G-25 chromatography performed as described in section 2 6 8 5 2  DTT determined according to its 
interference with the Biuret assay as described in section 2 3 2  * Enzyme activity expressed as 
fluonmetnc intensities
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Figure 3 6 8 5 2  Elution of PE from Activated Thiol Sepharose Illustration of failure 
to bind PE activity (*~o) Activated Thiol Sepharose Chromatography was performed as descnbed m
section 2 6 8 5 3  * Enzyme activity expressed as fluonmetnc intensities (-------) DTT concentration,
( ) Absorbance at 280nm
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3.7.  SDS Polyacrylamide Gel Electrophoresis
SDS polyacrylamide gel electrophoresis was performed as outlined in section 2.7. to determine the 
effectiveness of the purification protocols used. Post S-200 PE and Post S-200 ZIP samples were 
prepared as outlined in section 2.7.1. and subjected to electrophoresis on 1mm x 160mm x 160mm 
gels consisting of a 10% resolving gel overlayed with a 3.75% stacking gel. Following eletrophoresis, 
gels were stained with Coomasie Brilliant Blue and Silver Stain. No bands were visualised with the 
Coomassie Brilliant Blue stain. The silver stained gel image was recorded digitally as outlined in 
section 2.7.4. Figure 3.7.1. represents the silver stained gel images for ZIP and PE . Molecular 
weight markers applied to the gels are also presented. The appearance of multiple bands on the silver 
stained gel image for PE prevented positive identification of this protein on the gel.
Major
Band
(b)
Figure 3.7.1. Polyacrylamide Gel Electrophoresis Results. SDS
Polyacrylamide Gel Electrophoresis (SDS-PAGE) was performed as outlined in section 2.7. with the 
silver stained image digitally recorded as described in section 2.7.4. (a) Image illustrates a major band 
obtained when purified ZIP was subjected to electrophoresis with subsequent silver staining. The 
position of this band relative to the positions of the included molecular weight markers indicates that it 
has a molecular weight of approximately 50,000 Da. (b) Image illustrates the appearance of multiple 
bands when partially purified PE was subjected to eletrophoresis with subsequent silver staining. The 
major band corresponds with BSA (66,000) and indicates that this protein is the major contaminant 
present in the PE preparation. The subunit make up of PE could not be determined due to the multiple 
band obtained.
89
3 8 Assay Development for Purified Z-Glv-Pro-MCA Degrading Activities
3 81. Determination of Suitable Solvent for Substrate 
Solubilisation
Stock substrates were prepared as outlined in section 2 8 1 in DMSO, DMF and dioxane- The effects 
of using these solvents in substrate preparation are illustrated in Figures 3 8 11 and 3.8 1.2. for PE and 
ZIP assays respectively Dioxane was chosen as the most suitable solvent for subsequent substrate 
solubilisation
3.8 2 Effect of Dioxane Concentration on Purified Enzymes
Figures 3 8 2 1 and 3 8 2 2 illustrate the effect of increasing dioxane concentration in substrate 
preparations on punfied PE and ZIP activities respectively 2% (v/v) dioxane was chosen as the most 
suitable final dioxane concentration in subsequent substrate preparations for both purified PE and 
punfied ZIP
38  3. Linearity of Enzyme Assays with Respect to Time
Lmeanty of PE and ZIP assays was determined as outlined in section 28  3 Punfied PE activity was 
linear over a 2 hour assay penod m the presence and absence of DTT (Figure 3 83 1.)- Punfied ZIP 
activity was also linear over this penod as illustrated by Figure 3 8 3.2 Assays for both PE and ZIP 
activities working m tandem in serum (Figure 3 8 3 3 ) and ZIP activity working alone in serum 
(Figure 3 8 3 4 )  were linear ova* a 1 hour penod at 37°C
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Figures 3 8 1 1  and 3 8 1 2  Effect of substrate solubilisation solvent on punfied 
enzyme activities Plots o f enzyme activity versus solvent choice lOmM Z-Gly-Pro-MCA stocks 
were prepared m 100% DMSO, DMF or dioxane as outlmed m section 2 8 1  Punfied PE (Figure 
3 8 1 1 )  and punfied ZIP (Figure 3 8 1 2 )  were assayed with 0.1mM ZrGty-Pro-MCA prepared from 
these stocks as outlined in section 2 51 Figure 3 8 1 1  illustrates that DMF was not a suitable 
substrate solvent for detenmmng PE activity Figure 3 8 1 2  illustrates that DMSO was not a suitable 
substrate solvent for determining ZIP activity Dioxane, therefore, was chosen as the single most 
suitable substrate solvent for determining PE and ZIP activities * Enzyme activities expressed as % 
activity obtained m 4% (v/v) DMSO
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Figures 3 8 2 1  and 3 8 2 2  Effect of final dioxane concentration in substrate on 
punfied PE and ZIP activities. Plots o f enzyme activity versus dioxane concentration for 
punfied PE (Figure 3 8 2 1 )  and punfied TIP (Figure 3 8 2 2 )  Investigation performed as desenbed 
in section 2 82  Figures 3 8 2 1  and3 8 2 2  illustrate that assays with substrate containing a dioxane 
concentration of 2% (v/v) produce maximum PE and ZIP activities respectively Increasing dioxane 
concentration to 4% (v/v) reduces apparent sensitivity o f both PE and ZIP assays by greater than 50% 
2% (v/v) dioxane, therefore, was chosen as the most suitable solvent concentration in substrate used to 
detenmne PE and ZIP activities * Enzyme activity expressed as % of activity obtained at a solvent 
concentration of 2% (v/v) f  Dioxane concentration expressed as final solvent concentration in 
substrate (v/v)
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Figures 3.8.3.1. and 3.8.3.2. Linearity o f purified PE and ZIP assays with respect 
to time. Plots of enzyme activity versus assay time for PE (Figure 3.8.3.I.) and ZIP (Figure 3.8.3.2.). 
Assays performed as described in section 2.8.3. where enzyme activity was monitored continuously 
over a 2 hour period in an incubated cuvette at 37°C. Plots demonstrate that both the PE and ZIP 
assays were linear over a period of 2 hours, assuring the linearity o f 1 hour discontinuous assay for  
both enzymes. Figure 3.8.3.1, illustrates linearity o f PE assay in the presence and absence of DTT. * 
Enzyme activity expressed as fluorimetric intensities.
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Figures 3 8 3 3  and 3,8 3 4 Lmeanty of Z-Gly-Pro-MCA degradation m bovine
serum. Plots o f Z-Gty-Pro~MCA degradation versus assay time in the presence (Figure 3 8 3 4 )  and 
absence (Figure 3 8 3 3 )  o f Z-Pro-Prolinal Investigation performed as outlined in section 2 8 3  
Plots detnonstrate that Z-Gly-Pro-MCA degradation in bovine serum is linear for up to 1 hour for PE 
and ZJP activities working m tandem (Figure 3 8 3  3 ) and ZIP activity working alone (Figure 
3 8 3 4 1  assuring the linearity o f a I hour discontinuous assay under similar conditions (—) 
observed velocity ( ) initial velocity * Enzyme activity expressed as fluorunetnc intensities
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3 8 4 Lmeanty of Assays with Respect to Enzyme Concentration
Lmeanty of PE and ZIP assays with respect to enzyme concentration was determined as outlined m 
section 2 8 4 Figure 3 8 4 1 illustrates that the punfied PE assay was linear with respect to enzyme 
concentration Figure 3 8 4 2 demonstrates that the punfied ZIP assay was not linear with respect to 
enzyme concentration under the condiUons descnbed in section 2 8 4 Figure 3 8 4 3 illustrates the 
linear reaction velocity of a 50% ZIP sample monitored over 1 hour as outlined m section 2 8 3 
Inclusion of 200mM KC1 m substrate and diluant produced a linear assay response to enzyme 
concentration (Figure 3 8 4 4 )  Following removal of post-gel filtration KC1 by dialysis as outlined m 
section 28 4 , ZIP produced a linear assay response to enzyme concentration (Figure 3 8 4 5 )  where no 
KC1 was present m substrate or diluant
3.8.5. DTT Activation of Punfied Enzyme Activities
Figure 3 8 5 illustrates that maximal PE activity is obtained when at least 12mM DTT is included in 
the substrate ZIP showed a 30% decrease in observed activity at a DTT concentration of 20mM
3 8 6. Salt Activation of Punfied Enzyme Activities
ZIP demonstrated enhanced activity m the presence of increasing concentrations of NaCl This 
enhanced activity was maximal at a salt concentration of approximately 500mM NaCl as illustrated in 
Figure 3 8 6 while PE demonstrated a 25% decrease in activity at 800mM NaCl
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Figures 3 8 4 1  and 3 8 4 2 . Linearity of punfied enzyme assays with respect to 
enzyme concentration Plots o f observed enzyme activity versus punfied PE (Figure 3 8 4 1 )  or 
purified ZIP (Figure 3 84  2 )  concentration Investigation performed as desenbed in section 2 8 4  
Plots demonstrate that while the PE assay was linear with respect to enzyme concentration, the ZIP 
assay was not Data from a plot o f enzyme activity with respect to ZIP concentration in Figure
3 4 8 2  fitted a second order regression curve better than it did a first order linear regression. * 
Enzyme activity expressed as % o f activity obtained from undiluted enzyme
96
Figure 3.8 4 3 Linearity of a 50% ZIP concentration assay with respect to time
Plot o f enzyme activity versus time Assay performed as outlined in section 2 8 3  with ZIP activity 
being monitored continuously in an incubated cuvette Plot illustrates that dilution o f ZIP activity 
prior to assay does not affect the stability o f the enzyme under assay conditions over a period o f  I 
hour Therefore, the lack o f linearity with respect to ZIP concentration observed in Figure 3 8 4J2. is 
not related to any instability o f the enzyme when in diluted form  * Enzyme activity expressed as 
fluonmetnc intensities
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Figures 3.8.4.4. and 3.8.4.5. Linearity of purified ZIP assays with respect to ZIP 
concentration : The effects o f KCL Plots o f observed ZIP activity versus TIP concentration. 
In Figure S.8.4.4. ZIP activity was diluted and assayed in buffer containing 200mM KCl while in 
Figure 3.8.4.5. ZIP activity, with post gel filtration KCl removed by dialysis, was diluted and assayed 
in buffer containing no KCL Investigation performed as described in section 2.8.4. Both plots are 
linear with respect to ZIP concentration, A salt enhanced activity was elucidated for purified ZIP with 
enzyme activities being increased by a factor c f  2.75 in the presence of200mM KCl. Post gel filtration 
KCl was therefore responsible for non-linearity o f Figure 3.8.42. * Enzyme activity expressed as % 
activity obtained from undiluted dialysed enzyme.
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Figures 3 8 5  and 3 8 6  Effect of DTT and NaCl concentrations on punfied PE 
and ZIP activities Plots o f PE (o-o) and ZIP (* -* ) activities versus DTT concentration (Figure 
3 8 5 )  and NaCl concentration (Figure 3 8.6 ) respectively Figure 3 8  5 illustrates the DTT 
enhanced activity ofpurified PE while ZIP activity is independent o f DTT concentration Figure 3 86 
illustrates the salt enhanced activity o f  ZIP while PE activity is inhibited by 25% at 800mM NaCl 
Maximum enzyme activities were obtained when 12mM DTT or 500mM NaCl are incorporated into 
substrate used to assay PE or ZIP activity respectively * Enzyme activity expressed as % activity o f 
enzyme assayed in the absence ofDTTorNaCL
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3 9 Characterisation of Punfied PE and ZIP Activities
3 91 Relative Molecular Mass Determination
3 9 1,1 Sephacryl S-200 HR Gel Filtration Chromatography
A Sephacryl S-200 gel filtration column was calibrated as outlined in section 2 9 1 1  producing a 
calibration curve for the column which is illustrated in Figure 3 9 1 1  Also included on this plot of 
Log molecular mass versus Ve/V0 are the positions of ZIP and PE, calculated from the calibration
curve equation based on their respective elution volumes The calibration curve obtained was
Log(molecular mass) = -2 82(VeA^0) + 91 
where Ve and V0 are elution volume and void volume (101 5mL) respectively It was deduced from 
this equation that the molecular weights of PE and ZIP are 69,700 Daltons and 184,200 Daltons 
respectively
3.9.1.2. Biosep SEC-3000 High Performance Size Exclusion Liquid 
Chromatography
A Biosep SEC-3000 column was calibrated as outlined in section 2 9 1 2.2 producing a calibration 
curve for the column which is illustrated in Figure 3 9 1 2  Also mcluded on this plot of Log molecular 
mass versus Ve are the positions of ZIP and P E , calculated from the calibration curve equation based 
on their respective elution volumes The calibration curve obtained was
Log(molecular mass) = - 0 27(Ve) + 9 67
It was deduced from this equation that the molecular weights of PE and ZIP are 54,500 Daltons and
191,000 Daltons respectively
3.9.13. SDS Polyacrylamide Gel Electrophoresis
Non-native SDS gels were prepared as outlined in section 2 7 A calibration curve based on the 
relative mobility of the molecular weight standards (Rf) was produced as desenbed m section 2 9 1 3  
and is presented in Figure 3 9 1 3  Also mcluded on this plot of Log molecular weight versus Rf are 
the positions of PE and ZIP calculated from the gel calibration curve equation, based on their 
respective Rf values. The calibration carve obtained was
Log(molecular mass) = -1 0(Rf) + 52 
It was deduced from this equation that the molecular weight of ZIP was 50,000 Daltons and that the 
enzyme was tetramenc The deduced molecular weight of PE could not be determined by this method 
because multiple bands were visualised on the gel
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Figure 3 91.1 Sephacryl S-200 HR Sepharose molecular mass calibration curve
Plot o f Log molecular mass versus V^V0 where Ve is the elution volume o f a molecular mass standard 
(9-m) or enzyme activity (0 )  and V0 is the void volume o f the column used (101 5mL) Ve and V0
were determined as desenbed in sections 2 9 1 1 1  and 2 9 1 1 2  Linear regression analysis o f the 
data obtained from the molecular mass standards produced the following calibration equation
Log(molecular mass) = - 2 82(Ve/V0) + 91  
From this equation the molecular mass o f PE and ZIP were calculated to be 69,700 Daltons and 
184,200 Daltons respectively The positions of PE and ZIP are indicated on the calibration curve
t
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F ig u re  3 9 1 2  B iosep  SEC~3000 m o le c u la r  m ass ca libra tion  curve  Plot o f Log 
molecular mass versus Ve where Ve is the elution volume of a molecular mass standard ( • - • )  or 
enzyme activity ( 0 ) Ve was determined as descnbed in section 2 9 1 2 1  Linear regression analysis
o f the data obtained from the molecular mass standards produced the following calibration equation
Log(molecular mass) = - 0 27(Ve) + 967 
From this equation the molecular mass o f PE and ZIP were calculated to be 54,500 Daltons and
191,000 Daltons respectively The positions o f PE and ZIP are indicated on the calibration curve
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Figure 3 9 1 3  SDS PAGE molecular mass calibration curve Plot o f Log molecular 
mass versus R f R f values were determined as described in section 2 9 1 3  Linear regression 
analysis o f the data obtained from the molecular mass standards ( • - • )  produced the following 
calibration equation
Log(molecular mass) = -1 0(Rp + 52  
From thts equation the molecular mass o f ZIP was calculated to be 50,000 Daltons The molecular 
weight o f PE was not determined The position o f ZIP is indicated on the calibration curve (0)
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3 9 2 Assay Temperature effects on Purified Enzyme Activities
The effects of assay temperature on the punfied enzymes was investigated as outlined in secuon 2 9 2 
Figure 3 9 21 demonstrates that PE has a narrow assay temperature profile with an optimum assay 
temperature of 37°C ZIP acuvity demonstrates a broad assay temperature profile as depicted in Figure 
3 9 2 2 with an optimum assay temperature of 37°C - 45°C
3 9.3 pH Effects on Punfied Enzyme Activities
The effects of vaned pH on purified enzyme acuvmes were investigated as outlined in secuon 29.3 1 
and 2 9 3 2 Figure 3 9 3 1 illustrates that punfied PE exhibits a broad pH acuvity profile with an 
optimum pH, with respect to acuvity, observed at pH 8 0 The enzyme demonstrated a preference for a 
potassium phosphate buffer system Figure 3 9 3 2 illustrates the inacuvauon of punfied PE at pH 
outside the pH range 5 0 to 9 0 Punfied ZIP also exhibits a broad pH activity profile (Figure 3 9 3 3) 
with an optimum pH, with respect to activity, of 8 5, and no preference towards a particular buffer 
system Figure 3 9 3 4 demonstrates that inactivation of ZIP occurs at a pH range outside 4 0 to 9.5
3 9.4. Effect of Functional Reagents on Punfied Enzyme 
Activities
The effects of vanous functional reagents on punfied PE and ZIP activities were determined as 
outlined in section 2 9 4  These results are presented in Tables 3 4 and 3 5 for PE and ZIP activities 
respectively Tables 3 4 and 3 5 present residual PE and ZIP activities following modification with 
functional reagent for 15 minutes at 37°C (section 2 9 4 )  when compared to unmodified enzyme 
(100%) PE activity was inhibited by PCMB (5mM and 0.5 mM), 1,7 Phenanthroline (lOmM) and 
AEBSF (lOmM) by 50% or more Its activity was significantly enhanced by DTT (lOmM and ImM) 
and N-Acetylimidazole (lOmM) ZIP activity was inhibited by PCMB (5mM), 1,7 Phenanthrohne 
(lOmM) and 4,7 Phenanthroline (lOmM) by 50% or more Its activity was enhanced sigmficantiy by 
8-Hydroxyqumohne (lOmM), Trypsin Inhibitor preparation (lmg/mL) and Aprotinm (500|ig/mL)
3 9.5. Effect of Divalent Metal Salts on Purified Enzyme Activities
The effects of vanous divalent metal salts on punfied PE and ZIP activities were determined as 
outlined in section 2 9 5 The results are presented m Table 3 6 where residual PE and ZIP activities 
are expressed as a percentage of unmodified enzyme activity (100%) Both PE and ZIP activities were 
inhibited by greater than 80% by HgSC>4
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Temperature (°C)
Temperature (°C)
Figures 3 9 2 1  and 3 9 2  2 Effect of assay temperature on punfied enzyme 
activities. Plots of enzyme activity versus assay temperature for punfied PE (Figure 3 9 2 1  ) and 
purified ZIP (Figure 3 9 2 2  ) Investigation performed as desenbed in section 2 9 2  Enzymes were 
assayed over periods of 15 minutes (A-A), 30 minutes (o -0) and 45 mmutes Plots illustrate the
comparison between the narrow temperature range of PE and the broad temperature range o f ZIP PE 
was optimally active at 37°C while ZIP was optimally active at 3 7 V  to 45‘C. * Enzyme activity 
expressed as % activity obtained at 37 V
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Figures 3 9  3 1  and 3 93  2 Effect of pH on PE activity. Plots o f PE activity versus pH  
Investigations performed as desenbed m section 2 9  31  and 29  32  Buffer systems used were citrate 
/  phosphate (* - • ) ,  phosphate (0- 0), Tris /  HCl ( 4 - 4 ) and glycine /  NaOH (0 - 0) Figure 3 9 2 1  
represents the pH activity profile o f PE indicating that the enzyme has a broad pH range with an 
optimum pH o f 8 0  PE also demonstrates selectivity towards different buffers with optimum activity 
obtained in potassium phosphate Figure 3 9 2  2 represents the pH inactivation profile o f PE 
illustrating the instability o f PE outside the pH range 5 - 9  * Enzyme activity expressed as % o f  
activity obtained in potassium phosphate, pH 7 4
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Figures 3 9 3 3  and 3 9.3.4 Effect o f pH  on ZIP activity Plots o f ZIP activity versus 
pH Investigations performed as desenbed m section 2 9  31 and 29 3 2 Buffer systems used were 
citrate / phosphate (* - • ) ,  phosphate (0- 0), Tns / HCl (+ - 4) and glycine / NaOH (Q-O) Figure 
3 9 2 1  represents the pH activity profile o f ZIP indicating that the enzyme has a broad pH range with 
an optimum pH o f 8 5  ZIP does not demonstrate selectivity towards different buffer systems Figure 
3 9 3 4  represents the pH inactivation profile o f ZIP illustrating the instability o f  ZIP outside the pH 
range 4 - 9 5  * Enzyme activity expressed as % o f activity obtained in potassium phosphate, pH 7 4
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Residual PE Activity t  (%)
Functional reagent 0 ImM 05mM ImM 5mM lOmM
DTT
DTNB
Iodoacetamide
Iodoacetate
NEM
Leupeptm
2~MercaptoetlianoI
PCMB
EDTA
CDTA
EGTA
Imidazole
8-Hydroxyqmnokne 
1,10 Pbenanthroluie
1.7 Phenanthrolme
4.7 Phenanthrolme 
PMSF
AEBSF
Puromycin
N-Acetfyimidazole
Benzamidine
50
84
113*
110*
94 
81*
92 
92* 
85* 
100
98
95
93 
81* 
80*
96 
100 
75* 
77* 
59* 
84 
106
94
50jig/mL lOOjig/mL 500jig/mL
33
lmg/mL
Trypsin Inhibitor - 74 - 67
Chymotrypsm Inhibitor 80 - 75 -
Pepstatm - - 98 -
Aprotmm 84 - 75 -
Bacitracin - 81 - 73*
N-Decanoyl Co A - - _ 62*
1210
86
80*
88*
60*
103*
84
62*
86
72*
80*
51*
40*
51*
20*
159*
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Table 3 4 Effect o f  functional reagents on punfied PE t  Residual activity is expressed as 
percentage activity remaining following exposure to functional reagent when compared to unmodified 
enzyme (100%) Enzyme was premcubated with each functional reagent for 15 minutes at SVC prior 
to substrate addition. * P < 005 (data analysed statistically using the Paired Student t-Test)
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Residual ZIP Activity t  (%)
Functional reagent 0 ImM 0 5mM ImM 5mM lOmM
DTT
DTNB
Iodoacetamide
Iodoacetate
NEM
Leupeptm
2-Mercaptoethanol
PCMB
EDTA
CDTA
EGTA
Imidazole
8-Hydroxyqumoline 
1,10 Phenanthrolme
1.7 Phenanthrolme
4.7 Phenanthrolme 
PMSF
AEBSF
Puromycin
N-Acetlyimidazole
Benzamidine
113
94
92
64*
103
98
93
84*
102
110
110
97 
96
92
90 
96 
95
91
79*
55*
91*
107
98
93
44*
107 
97 
93* 
69*
108
90*
86*
92
82
86
138*
114
30*
22*
16*
91
95
50jig/mL lOOjig/mL 500|ig/mL lmg/mL
Trypsin Inhibitor - 112* - 131*
Chymotrypsin Inhibitor 112 - 115
Pepstatin - - 111
Aprotmm 111* - 125*
Bacitracm - 91* - 76*
N-Decanoyl Co A - - - 79*
T ab le  3  5  Effect o f functional reagents on purified ZIP t  Residual activity is expressed as 
percentage activity remaining following exposure to Junctional reagent when compared to unmodified 
enzyme (100%) Enzyme was preincubated with each functional reagent for 15 minutes at 37'C pnor 
to substrate addition, * P < 005  (data analysed statistically usmg the Paired Student t-Test)
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Metal salt Concentration^ PE Residual Activity^ ZIP Residual Activity t t
N1SO4 ImM 83* 69*
M11SO4 ImM 87* 71*
Z11SO4 ImM 78* 59
CdS04 ImM 94* 80*
C0SO4 ImM 83 71*
HgS04 ImM 5* 12*
C11SO4 ImM 85* 71*
CaS0 4 ImM 83* 94
MgS04 ImM 86* 77*
Table 3  6 Effect o f divalent metal salts on purified PE and ZIP f  Concentration o f metal solution 
used Actual concentration during preincubation was 500^M and during assay was lOOfjM f t  Residual 
activity is expressed as percentage activity remaining following exposure to divalent metal salt when 
compared to unmodified enzyme (100%) Enzyme was preincubated with each divalent metal salt for 15 
minutes at 37°C pnor to substrate addition * P < 0 0 5  (data analysed statistically using the Paired 
Student t-Test)
39 6 Substrate Specificity Studies on Purified PE and ZIP
Substrate specificity studies on punfied PE and ZIP were performed as descnbed in section 2 9 6 using 
Reverse Phase HPLC and fluonmetnc substrate studies
3.9.6.I. Substrate Specificity Studies Using Reverse Phase HPLC
Reverse Phase HPLC was used to determine whether punfied PE or ZIP activities produced cleavage 
products from vanous peptides listed in Table 2 4 Reactions between the punfied enzymes and 
peptides under investigation were performed as outlined in section 2 9 61 2 and samples were 
analysed by Reverse Phase HPLC as outlined in section 2 9 61 3 Table 3 7 illustrates what peptides 
were and were not cleaved by punfied PE and ZIP activities under conditions outlined in section
2 9 6 1 2  Figures 3 9 6 1  t o 3 9 6 9  represent the spectrophotometnc data obtained from the PDA 
detector (section 2 9 1 2 )  Plots of absorbance at 214nm versus retention time for LHRH, TRH, 
Bradykimn, Substance P and Angiotensin n  are presented Cleavage fragments produced by punfied 
PE and ZIP activities on these peptides are also represented Both PE and ZIP activities produced 
cleavage fragments from LHRH, Bradykimn and Substance P The cleavage product produced by the 
action of ZIP towards LHRH (Figure 3 9 6.2 and insert) coincided with the major cleavage product 
detected following the degradation of LHRH by punfied PE activity (Figure 3 9 6 1 )  This was also the 
case with regards to the cleavage of Bradykimn by PE and ZIP activities (Figures 3 9 6  5 and 3 9 6 6 )  
No cleavage of TRH by PE was detected as illustrated by the failure to detect TRH-OH in Figure
3 9 6 4  There was no similanty between the cleavage products detected for PE and ZIP activities 
towards Substance P
3.9.6.2 Fluonmetnc Substrate Specificity Studies
Cleavage of fluonmetnc substrates by punfied enzyme activities was also investigated as a means of 
elucidating the substrate specificity of PE and ZIP activities Fluonmetnc substrates (Table 2 5 )  were 
prepared and reacted with punfied PE and ZIP activities as outlined in section 29  6 2 MCA released 
from these substrates was determined as descnbed m section 2 9 6 2.2 Table 3 8 presents the results 
obtained from this investigation Punfied enzyme activities towards the vanous substrates are 
expressed as a percentage of their activity towards Z-Gly-Pro-MCA PE demonstrated a high relative 
activity against pGlu-His-Pro-MCA, a fluonmetnc TRH analogue ZIP demonstrated a high relative 
activity against the prolrne ammopeptidase substrate, Pro-MCA
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Cleavage detected following reaction 
with punfied enzyme activity
Peptide PE activity ZIP activity
LHRH Yes Yes
TRH No No
Bradykmin Yes Yes
Substance P Yes Yes
Angiotensin n Yes No
Pro-Gly No No
Z-Pro-Gly No No
Gly-Pro-Ala No No
Gly-Pro ND NX)
Z-Gly-Pro-Ala No No
Gly-Gly-Pro-Ala No No
Gly-Ala-Pbe Yes No
Lys-Ala-Ala No No
Gly-Phe-Ala No No
Z-Pro-Pro No No
Z-Pro-AIa No No
Z-Pro-Leu-Gly No No
Z-Pro No No
Table 3  7  Results from substrate specificity studies usmg Reverse Phase HPLC Investigation 
was performed as described m section 2 9 6 1  Table indicates whether cleavage products were detected 
followmg incubation ofpepttde with purified PE or ZIP activities as outlined m section 2J9 6 1 2  
N D - Not determined No result could be presented for this peptide as it was not detected usmg the 
method desenbed m section 2 9 6 1 3
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Figures 3 9 6.1 and 3 9 62  Cleavage o f LHRH by PE and ZIP activities 
respectively Plots o f absorbance at 214nm versus retention tone Substrate specificity studies 
using Reverse Phase HPLC were earned out as outlined ui section 2 9  61 Plots present data 
obtained from LHRH control ( ) and LHRH following incubation with punfied PE and ZIP
activities (------) The major cleavage product detected m Figure 39  61 coincides with the cleavage
product detected m Figure 3 9 62  (see msen) This indicates that PE and ZIP may share a common 
cleavage sue on LHRH
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Figures 3 9 63  and 3 9.6.4 . Failure to Detect TRH Cleavage by PE Plots o f  
absorbance at 2l4nm versus retention tone. Substrate specificity studies using Reverse Phase HPLC
were carried out as outlined m section 2 9 6 1  In Figure 3 9 6 3  the detection o f TRH (------) and
TRH-OH ( ) as they elute from the Reverse Phase HPLC column is illustrated TRH and TRH-OH
are well resolved by the method desenbed m section 2 9 6 1  3 and are easily distinguishable Figure 
3 9 6 4  illustrates that following the reaction of TRH with PE, no TRH-OH is detected
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Figures 3 9.6 5 and 3 9.6.6 Cleavage of Bradykimn by PE and ZIP activities 
respectively. Plots o f absorbance at 214nm versus retention time Substrate specificity studies 
using Reverse Phase HPLC were earned out as outlined in section 29  61  Plots present data 
obtained from Bradykimn control ( **) and Bradykimn following incubation with purified PE and ZIP 
activities (— —) The major cleavage product detected in Figure 3 961  coincides with the cleavage 
product detected m Figure 3 9 6 2  (set insen) This indicates that PE and ZIP may share a common 
cleavage site on Bradykimn.
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Figures 3.9 6 7 and 3 9 6 8 .  Cleavage of Substance P by PE and ZIP activities 
respectively Plots o f absorbance at 2l4nm versus retention time Substrate specificity studies 
using Reverse Phase HPLC were earned out as outlined m section 2 9 6 1  Plots present data 
obtained from Substance P control ( ) and Substance P following incubation with punfied PE and
ZIP activities (------ ) A minor cleavage product was detected following the action o f ZIP toward
Substance P (Figure 3 9 6  8 insert) but this does not correspond with any cleavage products detected 
following the action o f PE on Substance P (Figure 3 9 6 7 )
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Figure 3 9 6 9  Cleavage of Angiotensin II by PE Plot o f absorbance at 2l4nm versus 
retention time Substrate specificity studies usmg Reverse Phase HPLC were earned out as outlined in 
section 2 9  61  Plot illustrates the elution o f an Angiotensin U control ( ) and the elution o f
Angiotensin II and it cleavage products produced by the action o f punfied PE (----- )
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Substrate
Relative PE activity (%)^ 
( ±s d )
Relative ZIP activity (%)^ 
( ±s d )
Z-Gly-Pro-MCA 100 (±0 8) 100 (±3 3)
Ala-MCA 30 (±5 1) 3 0 (±1 7)
Arg-MCA 40 (±12) 20  (±2 9)
Z-Arg-MCA 1 0 (±6^) 110 (±61)
Pro-MCA 60  (±4 3) 38 0 (±1.5)
pGlu-MCA 10 (±4 6) 00  (±26)
GIu-Phe-MCA 00  (±41) 00  (±2 2)
Gly-Arg-MCA 10 (±1.2) 00  (±10)
Gly-Pro-MCA 20 (±5 2) 10 (±2 6)
Lys-Ala-MCA 00  (±0 5) 1 0 (±1 2)
Z-Arg-Arg-MCA 10 (±14) 7 0 (±2 5)
Z-Phe-Arg-MCA 20  (±80) 4 0 (±2 8)
pGlu-His-Pro-MCA 63.0 (±4 6) 4 0  (±21)
Boc-Val-Leu-Lys-MCA 10 (±1 7) 0 0  (±7 5)
Boc-Val-Pro-Arg-MCA 80 (±11) 3 0 (±0 8)
S uc-Ala-Phe-Lys-MC A 00  (±61) 00  (±7 3)
Z-Phe-Val-Aig-MCA 00  (±5 6) 1 0 (±3 5)
Suc-Gly-Pro-Leu-Gly-Pro-MCA 10 0 (±0.5) 10  (±118).
Table 3 8 Cleavage of fluonmetnc substrates by punfied PE and ZIP activities t  Activities are 
presented as a percentage o f PE and ZIP activities against Z-Gly-Pro-MCA Standard deviations are 
presented in brackets Purified PE activity was highly active against pGlu-His-Pro-MCA, a 
fluorimetric analogue o f TRH whereas ZIP activity was active against Pro-MCA, the proline 
ammopeptidase substrate Substrates cleaved by 10% or greater with respect to the cleavage ofZ-Gfy- 
Pro-MCA (100%) are presented m bold type
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3.9.7. Substrate Specificity Studies on PE and ZIP Based on 
Kinetic Analysis
Kinetic analysis of the interactions of PE and ZIP with vanous substrates was performed as outlined m 
section 2 9 7
3.9 7.1. Determination of Km for Z-GIy-Pro-MCA and punfied PE 
and ZIP Activities
A Km value was determined for the reaction between Z-Gly-Pro-MCA and both punfied enzyme
activities as outlined in section 29  7 1 Figures 3 9 7 1  and 39 7 2 present the data obtained from tins 
study as Lmeweaver-Burk plots The Km values were determined using Michaehs-Menten, 
Lmeweaver-Burk, Eadie-Hofstee, Hanes-Woolf and Direct Linear Plot analyses and the results are 
presented m Table 3 9 Direct Linear Plot analysis is statistically the more reliable of the five analysis 
methods used and accordingly Km values of 94|iM and 267jiM were obtained for PE and ZIP activities
respectively This indicates that the interaction between Z-Gly-Pro-MCA and PE is of a more specific 
nature than that of ZIP and the same substrate
3.9.72 . Determination of Km for pGIu-His-Pro-MCA and purified 
PE
A Km value was determined for the reaction between pGIu-His-Pro-MCA and PE as outlined m 
section 2 9 7 2 Figure 3 97 3 presents the data obtained from this study as a Lmeweaver-Burk plot. 
The Km value was determined usmg Michaehs-Menten, Lmeweaver-Burk, Eadie-Hofstee, Hanes-
i  j,
Woolf and Direct Linear Plot analyses and the results are presented m Table 3 9 A Km value of 69pM 
for the interaction of PE and pGIu-His-Pro-MCA was returned following Direct Lmear Plot analysis*
3.9.7.3. Determination of Kj Values for Proline Containing Peptides r'
The effect of proline containing peptides on the interaction between PE and ZIP and the substrate Z- 
Gly-Pro-MCA was investigated as outlined m section 29 3 Data obtained was analysed usmg the five 
analytical techniques previously mentioned The nature of inhibition observed when proline containing 
peptides were introduced into assays between punfied enzyme activities and the substrate Z-Gly-fro- 
MCA was determined usmg Lmeweaver-Burk, Eadie-Hofstee and Hanes-Woolf plots Figures 39  7 4  
to 3 9 7 8 are Lmeweaver-Burk plots illustrating the competitive or non-competitive nature of PE and 
ZIP inhibition by selected proline containing peptides The K| values for the interactions studied are 
presented in Table 3 10 PE was competitively inhibited by LHRH, TRH, Bradykmin, Angiotensin n  
and Z-Gly-Pro-Ala with K, values of 523^M, 680pM, 136jjM, 113pM and 894f±M respectively ZIP 
was competitively inhibited by LHRH, Bradykmin and Z-Gly-Pro-Ala with Kj values of 475|iM, 
2497pM and 722pM respectively
_ 4
r
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1/Z-Gly-Pro-MCA (jiM'1)
1/Z-Gly-Pro-MCA (jjM '1)
Figures 3 9 7 1  and 3 9 72  Kinetic analysis of PE and ZIP activities respectively
Lineweaver-Burk reciprocal plots o f  reaction velocity versus substrate concentration Data was 
obtained according to the methods described m section 2 9 7 1  Km values are represented by the 
negative intercept on the X-axis Results obtained following kinetic analysis are presented m Table 
3 9 Km values obtained for PE and ZIP interaction with Z-Gly-Pro-MCA were 94jjM and 267jjM  
respectively ♦ Velocities are expressed as fluonmetnc intensities
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1/pGlu-His-Pro-MCA (pM*1)
Figure 3 9 73  Kinetic analysis of PE activity towards pGlu-His-Pro-MCA
Lineweaver-Burk reciprocal plot o f reaction velocity versus substrate concentration Data was 
obtained according to the methods described in section 2 9 72 Km values are represented by the 
negative intercept on the X-axis Results obtained follow mg kinetic analysis are presented in Table 
3 9 The Km value obtained for PE interaction with pGlu-His-Pro-MCA was 69pM * Velocities are 
expressed m fluorunetru: intensities
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Kinetic study
Km obtained following data analysis (jiM) r"
Michaehs-Menten Lineweaver-Buik Eadie-Hofstee Hanes-Woolf Direct Linear Plot
PE + Z-Gly-Pro-MCA 88 151 95 101 94
ZIP + Z-Gly-Pro-MCA 320 300 271 266 267
PE + pGlu-His-Pro-MCA 66 67 66 70 69
Table 3  9 Results obtained from kinetic determinations earned out as desenbed in sections 2 7 1 , 2 7 2  
and 2 7 3  respectively Table illustrates Km determinations for PE and ZIP activities using Z-Gly-Pro-MCA 
as substrate and Km determinations for PE activity using pGlu-His-Pro-MCA (fluorimetrtc TRH analogue) as 
substrate Data from each experiment was analysed using the multiple kinetic model s pre vented PE show s a 
markedly higher affinity for Z-Gly-Pro-MCA than ZIP PF demonstrates a slightly speificty for pGlu-His- 
Pro-MCA than for ZrGly-Pro-MCA
1/Z-Gly-Pro-MCA (pM*1)
1/Z-Gly-Pro-MCA OiM1)
Figures 3 9 7 4  and 3 9 7 5  Kinetic analysis of the effect of prolme containing 
peptides on PE activity towards Z -Gly-Pro-MCA Lineweaver-Burk reciprocal plots o f 
reaction velocity versus substrate concentration. Investigation into the effect o f proline containing 
peptides on the interactions o f PE activity towards Z-Gls-Pro-MCA were earned out as described w 
section 2 9 7 3  Figure 3 9 7 4  illustrates the competitive inhibition of PE by LHRH (o-o)  and TRH 
( V-V) when assayed with X-Gly-Pro-MCA ( Figure 3 9 7 5  illustrates the competitive and non­
competitive inhibition of PE by Bradykimn (O-O) and TRH-OH (A-A) respectively Kt values are 
presented in Table 310 * Reaction velocities are expressed as fluonmetnc intensities
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Figure 3 9 7 6  Kinetic analysis of the effect of Angiotensin II and Z-Gly-Pro-Ala 
on PE activity towards Z-Gly-Pro-MCA Lmeweaver-Burk reciprocal plot o f reaction velocity 
versus substrate concentration. Investigation mto the effect o f proline containing peptides on the 
interactions o f PE activity towards Z-Gly-Pro-MCA were earned out as described m section 2 9  73  
Figure 3 9 7 6  illustrates the competitive inhibition of PE by Angiotensin II (o-o) and Z-Gly-Pro-Ala 
( V-  V) when assayed with ZrGly-Pro-MCA ( Kt values are presented in Table 310 * Reaction 
velocities are expressed as fluonmetnc intensities
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1/Z-Gly-Pro-MCA (pMl)
1/Z-Gly-Pro-MCA (jiM"1)
Figures 3 9 7 7  and 3 9 7 8  Kinetic analysis of the effect of proline containing 
peptides on ZIP activity towards Z-Gly-Pro-MCA Lineweaver-Burk reciprocal plots o f  
reaction velocity versus substrate concentration Investigation into the effect of proline containing 
peptides on the interactions of ZIP activity towards Z-Gly-Pro-MCA were carried out as descnbed m 
section 2 9 7 3  Figure 3 97  7 illustrates the competitive inhibition o f ZIP by LHRH (o-o) ,  
Bradykimn and Z-Gly-Pro-Ala (A-A) when assayed with Z-Gly-Pro-MCA Figure
3 9 7& illustrates the non-competitive inhibition o f ZIP by TRH (V-V)  and TRH-OH (0 - 0) Kt 
values are presented in Table 310 * Reaction velocities are expressed as fluonmetnc intensities
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Inhibition observed
K| QiM) detennmed for PE Kt (nM) determined for ZIP
Peptide Conc (uM) t Inhibtion type MM LB EH HW DLP Inhibition type MM LB EH HW DLP
LHRH
TRH
TRH-OH
Bradykimn
Substance P
Angiotensin II
Z-Pro-GIy
Z-Gly-Pro-AIa
Z-Pro-Pro
Z-Pro-Ala
Z-Pro-Leu-Gly
Z-Pro
400
200
800
175
75
100
800
200
800
800
800
800
Competitive
Competitive
Non-competitive
Competitive
Mixed
Competitive
Mixed
Competitive
Mixed
Mixed
Mixed
Mixed
460
529
508
150
125
726
762
365
282
235
504
815
490
191
153
512
794
480
180
149
977 1073
5 2 3
6 8 0
4 1 2
136
113
8 9 4
Competitive 460 498 478 458 47 5
Non-competitive 317 281 306 315 316
Non-competitive 460 416 446 457 4 6 5
Competitive 3525 1930 2853 3648 2497
Mixed 
Mixed
Mixed - - - - -
Competitive 674 896 642 608 7 2 2
Mixed - - - - -
Mixed - - - - -
Mixed - - - - -
Mixed - - - - -
Table 3 10  Kt values obtained for proline containing peptides when determined for both PE and ZIP activities as outlined in section 29  73  Kt values were 
determined using the apparent Km and apparent Vmax parameters obtained using the following data analysis MM- MichaeliS'Menten, LB - Line weaver-Burk / / /  - 
Eadie-Hofstee, HW  - Hanes-Woolf and DLP - Direct Linear Plot The figures obtained form Direct Linear Plot analysis have been highlighted as they are 
statistically the most reliable = values not determined t  Concentration o f proline containing peptide under assay conditions
3.9 8 Effect of PE Specific Inhibitors on Purified PE and ZIP 
Activities
The effect of vanous PE and proline specific peptidase inhibitors was investigated as desenbed in 
section 2 9 8 Figures 3 9 8 1  t o 3 9 8 1 0  illustrate the effect that these inhibitors exerted on punfied 
PE and ZIP activities Table 3 11 presents the IC50 values determined for each inhibitor with respect 
to PE and ZIP activity PE and ZIP activities were unaffected by Kelatorphan up to a concentration of 
lOmM PE was strongly inhibited by a-Ketobenzotbiazole and Z-Indolinyl Prohnal with IC50 values 
of 4 l x l O ' ^ M  and 4 5xlO_11M respectively ZIP activity was strongly inhibited by a -  
Ketobenzothiazole with an observed IC50 value of 1 5x10"
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Fmoc-Pro-Pro-Nitnle conc (M)
Z-Thiopropyl-Thyoprolmal conc (M)
Figures 3 9 8 1  and 3 9 8.2 The inhibition of PE and ZIP by Fmoc-Pro-Pro- 
N itn le  and Z- Thwpropyl- Thyoprolmal Semi log plots o f residual PE ( • - • )  and TIP (o-o)  
activity versus specific inhibitor concentration Investigations into the effect o f proline specific 
peptidase inhibitors were performed as outlined in section 29  8 Figure 3 9 8 1  illustrates that Fmoc- 
Pro-Pro-Nitrile exhibits no significant inhibitory activity against ZIP but effectively inhibits PE 
activity Figure 3 9 8 2  shows that PE and ZIP are inhibited in a similar manner by ZrThiopropyl- 
Thyoprohnal IC$q values determined for these inhibitors against PE and ZIP activity are presented p i  
Table 3 11 * Enzyme activity expressed as % of uninhibited enzyme (100%)
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Z-Pro-Prolinal conc (M)
<x-Keto-Benzothiazole conc (M)
Figures 3 9 83  and 3 9 84  The inhibition of PE and ZIP by Z-Pro-Prohnal and
OrKetobenzothiazole Semi log plots o f residual PE ( • - • )  and ZIP (o-o)  activity versus specific 
inhibitor concentration Investigations into the effect o f proline specific peptidase inhibitors were 
performed as outlined in section 29  8 Figure 3 9 8 3  illustrates that Z-Pro-Prohnal exhibits no 
significant inhibitory activity against ZIP but is effective against PE activity Figure 39  8 4 shows 
that PE and ZIP are inhibited in a similar manner by a-Ketobenzothiazole IC$o values determined 
for these inhibitors against PE and ZIP activity are presented in Table 311 ♦ Enzme activity 
expressed as % o f uninhibited enzyme (100%)
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Poststatin conc (M)
Z-Phe-Pro-Methylketooe conc (M)
Figures 3 9 8  5 and 3 98  6 The inhibition of PE and ZIP by Poststatm and Z- 
Phe-Pro-Methylketone Semi log plots o f residual PE ( * - • )  and ZIP (o-o)  activity versus 
specific inhibitor concentration Investigations into the effect o f proline specific peptidase inhibitors 
were performed as outlined in section 2 9 8  Figure 3 9 8 5  illustrates that Poststatm exhibits some 
inhibitory activity against ZIP but is a more effective inhibitor o f PE activity Figure 3 9 8 6  shows 
that ZIP is not inhibited by ZrPhe-Pro-Me thy Ike tone which is an effective inhibitor o f PE activity 
IC$o values determined for these inhibitors against PE and ZIP activity are presented in Table 311 * 
Enzyme activity expressed as % of unmhibtted enzyme (100%)
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Z-Cyclohexyl-Prolinal conc. (M)
Z-Indolinyl-Prolinal cooc. (M)
Figures 3.9.8.7. and 3.9.8.8. The inhibition o f PE and ZIP by Z-Cyclohexyl- 
Prolinal and Z-Indolinyl-Prolinal Semi log plots o f residual PE ( • - • )  and ZIP (o-o) activity 
versus specific inhibitor concentration. Investigations into the effect o f proline specific peptidase 
inhibitors were performed as outlined in section 2.9.8. Figure 3.9.8.7. illustrates that Z-Cyclohexyl- 
Prolinal exhibits some inhibitory activity against ZIP but is a more effective inhibitor o f PE activity. 
Figure 3.9.8.8. shows that ZIP is weakly inhibited by Z-Indolinyl-Prolinal in comparison to this 
inhibitors effect on PE activity. IC50 values determined fo r  these inhibitors against PE and ZIP 
activity are presented in Table 3.11. * Enzyme activity expressed as % of uninhibited enzyme (100%)
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Boc-Glu(NHO-Bz)-Pyrr <*>nc. (M)
Kelatorphan conc. (M)
Figures 3.9.8.9. and 3.9.8.10. The inhibition o f PE and ZIP by Boc-Glu(NHO-Bz)- 
Pyrr and Kelatorphan. Semi log plots o f residual PE (• -• )  and ZIP (o-o) activity versus 
specific inhibitor concentration. Investigations into the effect of proline specific peptidase inhibitors 
were performed as outlined in section 2.9.8. Figure 3.9.8.9. illustrates that Boc-Glu(NHO-Bz)-Pyrr 
exhibits inhibitory activity against ZIP and PE activity. Figure 3.9.8.10. shows that Kelatorphan has 
no inhibitory effect on either PE or ZIP activities. IC$q values determined for these inhibitors against 
PE and ZIP activity are presented in Table 3.11. * Enzyme activity expressed as % of uninhibited 
enzyme (100%)
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IC50 (M)
Specific inhibitor PE ZIP
Fmoc-Pro-Pro-Nitnle 3 203xl0-8 ND
Z-Thiopropy 1 -Thy oprolinai 5472xl0‘8 1 882xl0-8
Z-Pro-Prohnal 1 597X10'8 ND
a-Ketobenzothiazole 4 163xl0-11 1 505X10'11
Poststatin 3 509xl0'8 >1 OxlO-3
Z-Phe-Pro-Methylketone 3 099xl0-8 ND
Z-Cyclohexyl-Prohnal 1 450x10-8 >2 0xl0"6
Z-Indolinyl-Prolinal 4 540X10'11 >1 0x10-4
Boc-Glu(NHO-Bz)-Pyrr 1 656x10-7 6 351x10-4
Kelatorphan ND ND
Table 3 11. IC50 values determined for proline specific peptidase inhibitors on PE and ZIP 
activity Investigations into the effect o f specific inhibitors against PE and ZIP activity were 
performed as outlined in section 2 9 8  Results are expressed m M units where IC50 lS tfie 
concentration (M) o f inhibitor needed to inhibit PE or ZIP activity by 50% under the conditions 
desenbedm section2 9 8
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L4. Discussion
4 1 Fluonmetry using 7-Amino-4-Methyl-Coumarin (MCA).
The primary focus of this work centred around the study of two Z-Gly-Pro-MCA degrading activities 
from bovme serum This internally quenched substrate, so called because the attachment of MCA to 
the N-blocked dipeptide compromises its fluorescent activity, was first synthesised and applied to 
prolyl endopepudase (PE) detection by Yoshimoto et a l , (1979) Peptide bond cleavage on the 
carboxyl side of proline releases free MCA, which, under constant exposure to electromagnetic 
radiation at a wavelength of 370nm (excitation), leads to the emission of electromagnetic radianon at a 
wavelength of 440nm Fluonmetnc assays of this type provide greater sensitivity than their 
colonmetnc counterparts In fact Yoshimoto et a l , (1979) reported a 100 fold increase m sensitivity 
when usmg Z-Gly-Pro-MCA, as opposed to a colonmetnc substrate, Z-Gly-Pro-B-napthylamide The 
use of fluonmetnc substrate assays also provide a safer and less labour intensive procednre than 
radiolabelled substrate assays
4 1.1. The Inner Filter Effect
Because fluonmetnc assays rely upon the excitation of a fluorophore by electromagnetic radiation at a 
specific wavelength, and the subsequent detection of emitted electromagnetic radiation at a higher 
specific wavelength, their sensitivity is often compromised by the presence of molecules withm the 
reaction mixture that also absorb at these wavelengths This phenomenon is known as the inner Filter 
effect In the case of MCA based fluonmetnc assays, molecules within the reaction mixture that 
absorb at 370nm will reduce the number of MCA molecules that are excited, leading to a decrease m 
detected fluorescence Also, molecules withm the reaction mixture that absorb at 440nm will prevent 
the detection of emitted radiation from excited MCA molecules In crude biological samples, this 
effect can be quite significant, and lead to inaccurate determination of free MCA concentration withm a 
particular reaction mixture
To overcome this problem, MCA standard curves were constructed m a manner designed to replicate 
assay conditions Specifically, enzyme sample was incorporated into the make up of each standard 
curve (section 2 2 2 ) The effect of this on standard curves is clearly demonstrated in Figures 3 1 1 ,  
3 12 and 313  and in Table 3 1 where serum was incorporated as the enzyme sample The "filtered" 
standard curves demonstrated a reduced slope which is indicative of reduced sensitivity
It was also observed that the percentage reduction in slope vanes m a manner dependent on emission 
slit width As the emission slit width was increased the percentage reduction m slope also increased 
The reduction in slopes fO? ggure 3 1 1 and Figure 3 1 3 were 13 5% and 111% respectively with 
emission slit width settings of lOnm and 2 5nm respectively Expanding the emission slit width merely 
broadens the bandwidth over which the fluonmeter integrates the hght emitted from a particular 
sample With an emission wavelength of 440nm and an emission slit width of 2 5nm, the fluonmeter 
includes light radiated from 438 75mn to 441 25nm as part of the integration calculations for that
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sample If the emission slit width is expanded to lOnm the fiuonmeter then mcludes light radiated 
from 435nm to 445nm as part of its integration calculations It is obvious, therefore, that increasing the 
emission slit width will not only increase sensitivity, but also increase the likelihood of inner filter 
effect interference
One of the more interesting features of the inner filter phenomenon is the effect produced when a 
fluonmetnc assay is used to monitor a protein punfication process Starting material for such a process 
would generally constitute a crude, highly coloured, protein preparation, and as such, is more likely to 
exhibit the inner filter phenomenon than a punfied sample Measurement of the initial activity m the 
starting matenal, without due consideration for the inner filter effect, will reveal lower activities than 
are actually present in the starting matenal Assuming that m a single punfication step, all activity is 
recovered, and all contaminants responsible for the inner filter effect are removed, the yield from this 
step will be considerably higher than 100%, due to the erroneous initial activity determination. It was 
realised therefore, that as part of this work, the preparation of "filtered” standard curves was a useful 
method m ensuring the accuracy of results obtained from fluonmetnc assays
A problem arose, however, based on the need to produce "filtered" standard curves, and the 
practicalities of preparing such curves In order to construct one "filtered*1 standard curve, like those 
presented in Figures 3 1 1 , 3 1 2  or 3 1 3 ,  IOOjiL serum were incorporated as part of each MCA 
concentration m tnplicate and almost 4mL serum were required m total It was unacceptable that 4mL 
of any enzyme sample were used merely to produce "filtered" standard curve A compromise was 
therefore reached with the production of a two point standard curve It was observed from Figures 
3 1 1  - 3 1 3 that the inner filter effect, although reducing the slopes of individual standard curves, did 
not affect their lmeanty On the basis of this observation a "filtered" curve prepared usmg only two 
points m tnplicate, namely a zero point (standard curve ongin) and either a 2jiM or a IOjiM MCA 
point, was used routinely These curves reduced the amount of enzyme sample needed to quantify the 
inner filter effect from 4mL to 600jiL
4 2 Serum Preparation
Serum preparation from whole blood was a simple procedure involving dotting, subsequent clot 
shrinkage, followed by centrifugation Z-Gly-Pro-MCA degrading activities in serum produced m this 
manner remained stable for up to six months when stored at -20 C, by which time the serum batch was 
normally exhausted Some batch to batch variation was observed with regard to levels of Z-Gly-Pro- 
MCA degrading activities, but these variations did not pose specific problems due to the mmrmai 
vanations observed and the fact that these variations did not affect the efficiency of the purification 
protocols
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4.3. Measurement of Z-Glv-Pro-MCA Degrading Activity in Bovine 
Serum
PE activity id  serum was measured according to a modification of the original procedure as desenbed 
m section 2 5 1 and the results are presented in Figure 3 4 1 Z-Gly-Pro-MCA was first synthesised by 
Yoshimoto et al, (1979), and in that report the susceptibility of Z-Gl>-Pro-MCA to non-specific 
degradation was examined These workers reported that the substrate was not degraded b> high 
concentrations of trypsm, a-chymotrypsin, elastase, thrombin, urokinase, leucine ammopeptidase, 
carboxypeptidase A or post-proline dipeptidyl ammopeptidase Therefore, Z-Gly-Pro-MCA 
represented a specific substrate for the detection of PE The synthesis and use of Z-Pro-Prohnal was 
first reported by Wilk et a l , (1983) It was desenbed as a tetrahedral transition state intermediate 
analogue of the PE enzyme-substrate complex At high concentrations, Z-Pro-Prolinal failed to inhibit 
trypsin, chymotrypsin, post-prolme dipeptidyl ammopeptidase, cation-sensitive neutral endopeptidase 
or membrane-bound metalloendopeptidase (enkephalmase) These workers thus concluded that Z-Pro- 
Prolinal was a selective inhibitor of PE The use, therefore, of the specific PE substrate Z-Gly-Pro- 
MCA, coupled with the specific PE inhibitor, Z-Pro-Prolinal, has formed the basis of a definitive assay 
for PE activity over the last decade In this light, the observation that residual PE activity against Z- 
Gly-Pro-MCA (40%) was detected in bovine serum m the presence of Z-Pro-Prolinal was unexpected 
(Figure 3 4 1 )  Increased Z-Pro-Prolinal concentrations (Figure 3 4 2.) and increased preincubation 
times (Figure 3 4 3) failed to reduce this residual PE activity The possibility that there may have been 
a second Z-GIy-Pro-MCA degrading activity m bovine serum was not considered a likely possibility at 
this point Instead, it was thought that incomplete inhibition of PE activity m serum could be explained 
by either, (a), the high levels of protein m serum interfering in some way with the enzyme-inhibitor 
interaction, or (b), the susceptibility of Z-Pro-Prolinal to degradation by aldehyde and alcohol 
dehydrogenases (Fnedman et a l , 1984) may have effectively reduced the concentration of intact Z- 
Pro-Prolinal available to inhibit the enzyme It was decided, therefore, to continue with efforts to 
purify PE from bovine serum
4.4. Purification of Z-Glv-Pro-MCA Degrading Activities from Bovine 
Serum
4.4.1 Ion Exchange Chromatography
Initial attempts to purify PE from bovine serum focused on the use of ion exchange resins Both anion 
and cation exchange resms were considered Figure 3 61 1 is representative of the protein and activity 
profiles that were obtained repeatedly from both cation and anion exchange columns under vanous 
conditions This type of profile, activity binding to the column with a significant amount of activity 
also running through the column (unbound), is normally associated with a binding capacity problem 
which can be related to an insufficiently large column, overloading the column with too much enzyme 
sample, or non-ideal binding and running conditions Increasing the size of the vanous ion exchange 
columns tested, followed by a substantial reduction in the amount of enzyme sample applied to the
136
column, failed lo improve the acuvity binding profile Column configurations and binding conditions 
were also optimised, but failed, without any apparent explanation, to prevent a relentless run through of 
enzyme activity The observation that similar Z-Gly-Pro-MCA degrading activity profiles (bound 
activity and run through activity) were obtained whether the column used was an anion or cation 
exchange resin, was also inexplicable The presence of two distinct Z-GIy-Pro-MCA degrading 
activities in bovine serum now seemed a likely possibility
Confirmation of this was forthcoming when, fractions obtained from an SP Sepharose cation exchange 
column (section 2 61 1), were assayed in the presence and absence of Z-Pro-Prohnal The resulting 
profiles presented in Figure 3 6 1 2  confirmed that there were mdeed two Z-Gly-Pro-MCA degrading 
activities m bovine serum, a PE activity that was totally inhibited by Z-Pro-Prolinal, and a Z-Pro- 
Prohnal insensitive Z-Gly-Pro-MCA degrading peptidase, henceforth designated as ZIP This 
realisation subsequently explained why it was not possible to totally inhibit Z-Gly-Pro-MCA degrading 
activity in bovine serum (Figure 3 4 1 )  Attention now focused on the punfication of both of these 
activities
The SP Sepharose column proved most useful in separating PE and ZIP activities, allowing these 
enzymes to be further punfied independently of one another The applied protein was separated 
roughly into two equal parts, the run through pool containing PE, and the bound pool containing ZIP 
activity Attempts to resolve bound ZIP activity further from bound protein, usmg gradient elution 
techniques, failed to improve activity-protein resolution and the simpler isocratic elution with high salt 
was retamed The recovery of applied PE activity was relatively low (approx 57%) and this was 
thought to be caused by the long term exposure of this activity to low pH The recovery of ZIP activity 
from this column was practically 100%
One final element of the SP Sepharose profile depicted in Figure 3 6 11 should be discussed, the 
apparent "split" or "shouldered" PE and ZIP activity peaks Responsibility for this lay with the non- 
quantitative microplate assay used to determine activities in post-column fractions, descnbed in section 
2 5 3 , and the inner filter effect, which has already been discussed. Figure 4 1 illustrates the light 
paths taken by excited and emitted light through samples that are being fluonmetncally analysed m a 
cuvette or in one well on a 96 well plate A hypothetical fluorophore is placed at a distance farthest 
from the excitation source and the emission detector In the case of the cuvette, the total distance 
travelled through the sample by excitation and emission radiation is 1 4cm, while m the case of the 
well, total distance travelled by radiation through the sample is 2cm. In a cuvette based assay the final 
sample concentration (% v/v) is approximately 6 5%, while in the well assay this percentage is 
approximately 35% The increased exposure of excitation and emission radiation to the enzyme 
sample, coupled with the increased concentration of enzyme sample in the well, amplifies the inner 
filter effect of the assay mixture
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Figure 4 1 Light paths travelled through a glass cuvette and an individual well on a 96 well plate 
demonstrating the increased exposure o f emission and excitation electromagnetic radiation to sample when 
fluorimetric assays are performed m a 9 6  well plate as opposed to a cuvette
This amplification of the inner filter effect was so severe in fractions towards the centre of the run 
through and bound protein peaks of the SP Sepharose column, that the fluonmetnc activity in these 
fractions seemed to decrease, producing '’split" or "shouldered" peaks
4 4 2. Further Purification of PE
The post-SP Sepharose PE pool was salted and applied to a Phenyl Sepharose hydrophobic interaction 
column Elution of PE activity from the column with a decreasing salt gradient produced very good 
resolution between enzyme and contaminating protein, as illustrated m Figure 3 6 2 Recovery of 
applied enzyme activity was 84% and, coupled with a punfication factor of 12 for the column, this step 
proved to be the most successful part of the enure PE punfication
The post-Phenyl Sepharose PE pool was applied to a DEAE Sepharose anion exchange column and 
eluted from that column with an increasing salt gradient, as desenbed in section 2 6 3 , and illustrated 
in Figure 3 6 3 Some resolution of protein was obtained and 60% of the applied activity was 
recovered However, the overall purification factor for the column was only 1 5
The purification strategy for PE is presented m Table 32  The greatest punfication factor obtained was 
29 with an overall yield of 24% This provides some insight into the difficulties encountered during 
the development of the procedure Whether the final aim of a purification is high yield or high levels 
of punty, successful steps must resolve the protein of interest from contaminating proteins without 
senous detrimental effects on the activity or integnty of the protein of interest Sections 2 6 8 and 
3 6 8 document some of the alternative methods attempted to further punfy PE following the 
successful Phenyl Sepharose step Single protocols for each regime attempted are presented m sections 
26  8 and 3 6 8 but many different protocols were attempted usmg each of the resins mentioned The 
failure of these alternative procedures to further punfy PE could be broadly divided mto two 
categones, (a) failure to resolve protein or (b), failure to maintain PE activity
Failure to resolve PE activity from contaminating protein proved to be a difficult problem to overcome 
m order to further punfy PE activity following the Phenyl Sepharose hydrophobic interaction step It 
was possible to bind PE activity to Q Sepharose (Figure 3 6 8 1 ) and Hydroxylapatite (Figure 3 6 8 3) 
columns under conditions outlined in sections 26 81 and 2 6 8 3 respectively Although no reference 
to the use of Q Sepharose anion exchange chromatography could be found in the relevant PE literature, 
Hydroxylapatite has been used by many groups successfully Table 4 1 lists workers that have used 
Hydroxylapatite as an integral part of successful PE purifications However in the case of bovine 
serum PE, under no circumstances was it possible to resolve protem and enzyme activities 
Combinations of low flow rates and shallow phosphate gradients failed to make Hydroxylapatite a 
useful pan of the bovine serum PE punfication strategy
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Author Source Purification Factor Obtained (Fold)
Koida et a l , (1976) Lamb kidney 6
Kmsatschek et a l , (1980) Lamb kidney and pituitary n r
Yoshimoto et a l , (1980) Flavobacterium 3
Monyama et a l , (1988) Porcine muscle 4
Sattar et a l , (1990) Agancus bisporous 2
Kalwant et a l , (1991) Human brain 9
Ohtsuki et a l , (1994) Flesh fly 10
Table 4 1  Use o f Hydroxylapatite in prolyl endopeptidase purifcation These workers published 
Hydroxylapaute punfication steps as successful pans o f PE purification strategies However, Hydroxylapatite 
failed to bind bovine serum PE and could not be used for its purification n r - Not Reported
Q Sepharose, being an anion exchanger, was expected to work in a similar manner to DEAE 
Sepharose, but again, no resolution between protein and activity was forthcoming The resolution 
obtained by using the DEAE Sepharose failed to equal some resolutions obtained by other workers 
usmg this technique (Table 4 2), with the purification factor achieved using this column being a mere 
1 5 fold
There is one possible factor that may be responsible for this lack of resolution Although many of the 
workers presented m Table 4 2 , used animal tissues as their sources, no purification of PE from serum 
has been reported It is obvious that the greatest smgle source of protein contaminant in bovine serum 
is bovine serum albumia With a pi of 5 0, and considering that PE has a similar pi (Wilk, 1983), it 
would be very difficult to separate these proteins on the basis of charge usmg an anion exchange resin
Other techniques used simply failed to bind PE activity Calcium Phosphate Cellulose (Figure 
3 6 8 2), which can be used under similar operating conditions to Hydroxylapatite, failed repeatedly to 
bind PE activity, and in fact, this column failed to bind any of the post-Phenyl Sepharose PE pool 
protein Browne and O’Cuinn, (1983), used Calcium Phosphate Cellulose as part of their purification 
of PE from guinea pig team, but are the only workers m the literature to have done so, or to have 
reported this technique as a successful purification step It is very likely that the Calcium Phosphate 
Cellulose produced m our laboratory had different chromatographic properties to that used by Browne 
and O’Cuinn in 1983 This is a common problem associated with the use of this "home-made” resin.
Assuming that BSA was a major contaminant, it was hoped that Blue Sepharose, a resin used regularly 
for binding albumins as well as NAD+ and NADP* linked enzymes, might help m the purification of 
PE The resin not only failed to bind PE activity, but fractions collected in the wash from the column 
repeatedly displayed high losses of PE activity (Figure 3 6 8 4 )  No reports of the use of Blue 
Sepharose to purify PE activity were found in the literature
One other chromatographic technique was investigated thoroughly as a possible part of the PE 
purification strategy, Activated Thiol Sepharose affinity chromatography Figure 4 2 demonstrates 
how Activated Thiol Sepharose may be used to bind protans The protein sample must be reduced 
with a suitable reducing agent, converting all disulphide bonds to thiols The reducing agent, in this 
case DTT, must then be removed quickly, as it will displace the capping group, and prevent protein 
binding to the column, m the same way that high salt will prevent protein binding to an ion exchange 
resin However, in the absence of DTT, thiols will revert slowly to disulphides, which will not bmd the 
resin It can be a difficult process, but previously it has been used with success in our laboratory 
(Cummins and O'Connor, 1996)
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Author Source Purification Factor Obtained (Fold)
Koida et a /, (1976) Lamb kidney 25
Orlowski et a l , (1979) Rabbit brain 5
Yoshimoto et al t (1981) Lamb brain 34
Browne etal  (1983) Guinea-pig brain 8
Monyama et a l , (1988) Porcine muscle 42
Kalwant et a l , (1991) Human brain 3
Kusuhara et a l , (1993) Rat skin 3
Table 4  2  Use of DEAE anton exchange in prolyl endopeptidase purifcatton. These workers published DEAE 
anion exchange purification steps as successful parts o f PE purification strategies DEAE anion exchange 
chromatography was also used as part o f the bovine serum PE purification strategy, however the efficiency of 
this step was hindered by the presence o f BSA which has a p i equal to that reported fo r  PE
Activated Thiol Sepharose
S S
?
S S E +  S
Covalently bound enzyme
E +RSH
2-Thiopyndone
+E
+  R S S R
RSH = DTT, 2-Mercaptoethanol, Cysteine 
*/ww% = Glutathione spacer arm
F ig u re  4  2 Protein purification strategy using Activated Thiol Sepharose (ATS) (a) Protein in 
reduced form is applied to ATS resin that is capped with 2-Thiopyndone linked to Sepharose via a 
glutathione spacer arm. The protein binds covalently via a disulphide bond to the rtsin, displacing the 
capping group (2-Thiopyndone) (b) Application o f a reducing agent (RSH) such as DTT, reduces the 
disulphide bond, eluting the bound protein from the resm
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Unfortunately, having optimised the removal of DTT usmg Sephadex G-25 as a de-salting column, 
neither PE nor great amounts of contaminating protein bound to the column as illustrated m Figure
3 6 8 5 2 This plot may be somewhat misleading in that the A280nm protein profile seems to suggest 
that quite alot of protein was bound to the column, and under these conditions, the column could have 
been used successfully as a purification step However the A280nm peak bound to the resin is not 
representative of protein Rather, it illustrates the elution of the cappmg group, 2-Thiopyndone, from 
the column following the application of DTT 2-Thiopyndone absorbs maximally at 343nm but 
interferes significantly with A280nm determinations Subsequent analysis of protein in fractions 
obtained from the column indicated that 95% of the applied protein was recovered in the run through 
peak
4 4.3 Further Punfication of ZIP
The separation of the bovine serum Z-Pro-Prohnal insensitive Z-Gly-Pro-MCA degrading peptidase 
(ZIP), from bovine serum PE has already been discussed (Section 44  1)
The second step used m the purification of ZIP was, as for PE, a Phenyl Sepharose hydrophobic 
interaction column This column, when run as desenbed in section 2 6 5 , produced excellent 
resolution between ZIP activity and contaminating protein (Figure 3 6 5) The isocratic elution of ZIP 
activity with distilled water could not be improved upon using gradient elution techniques Indeed, 
gradient elution merely broadened the eluting ZIP peak without any resolution of protein Recovery of 
applied activity (55%) coupled with a punfication factor of 19 for the column, made this step a good 
bulk protein separation step (Table 3 3 )
The post-Phenyl Sepharose ZIP pool could be loaded directly onto a Calcium Phosphate Cellulose 
Column This resin was produced m the lab as outlined m section 2 6 6 As a "home-made" resin, it 
proved to be a very successful punfication tool Used as outlined in section 2 6 6 , it produced 
excellent resolution between contaminating protein and ZIP activity (Figure 3 6 6 )  59% of the
applied ZIP acuvity was recovered, and, coupled with a punfication factor of almost 100 fold for the 
column, this step proved invaluable in the overall ZIP purification strategy (Table 3 3 )
As a final step, the post-Calcium Phosphate Cellulose ZIP pool was concentrated and applied to a 
Sephacryl S-200 HR Sepharose gel filtraUon column The elution profile presented in Figure 3 6 7 , 
shows that further resolution of activity from protein was achieved
The purification strategy for ZIP, presented m Table 3 3„ illustrates the success of the ZIP purification 
It would seem that applicauon of the post-Calcium Phosphate Cellulose ZIP onto the S-200 gel 
filtration column was unwarranted, as the overall purification factor dropped after this column 
However, this drop can be explained by a loss m yield rather than a failure to further punfy the
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enzyme As Figure 3 15 illustrate^ purification of ZIP wa^ achieved by the gel filtration step On this 
basis the gel filtration step was retained as part of the ZIP purification
4 5 Z-Gly-Pro-MCA Degradation Assay Development
Having punfied both enzyme activities, it was decided to re-evaluate the assay procedure descnbed in 
section 2 5 1 This assay was a modification of the procedure of Yoshunoto et a l , (1979) In fact it 
was a modification of a modification of the onginal procedure
Yoshimoto et a l , (1979), first synthesised Z-Gly-Pro-MCA for PE detection Their assay procedure 
involved the addition of 50|iL 0 5mM Z-Gly-Pro-MCA in 100% dioxane to 3mL lOOmM phosphate 
buffer, pH 7 0, followed by the addition of 50pL enzyme solution Thus, the final substrate 
concentration was 0 08mM Z-GlvPro-MCA and the final solvent concentration was 0 16% (v/v) In 
1983, Browne and O'Cuinn modified the onginal procedure addmg 10{xL enzyme sample to 490nL 
0 2mM Z-GIy-Pro-MCA m lOOmM potassium phosphate, pH 7 4, 2mM DTT, 2mM EDTA, m a final 
concentration of 5% (v/v) DMF O’Leary and O’Connor, (1995), made a further modification of this 
procedure O’Leary developed the assay m this laboratory as part of her work here In this procedure, 
400pL 0 ImM Z-Gly-Pro-MCA in lOOmM potassium phosphate, pH 7 4, with a final DMSO 
concentration of 2% (v/v) was added to lOO^L enzyme sample As part of the work presented here, 
problems arose with the preparation of 0 ImM Z-Gly-Pro-MCA m a final DMSO concentration of 2% 
(v/v) At this final DMSO solvent concentration, substrate solubility was quite poor, resulting in an 
unreliable protocol for substrate preparation Initially this problem was overcome by preparing 
substrate in a final DMSO concentration of 4% (v/v), which proved to be more reliable, and this is the 
method descnbed m section 2 5  I To make substrate preparation even more reliable and reproducible 
a further change m the methodology was made Substrate had been prepared by dissolving the required 
amount of Z-Gly-Pro-MCA in lmL DMSO, bringing the volume finally to 50mL with lOOmM 
potassium phosphate buffer at 37‘C This not only had the potential for inaccuracies in weighing out 
the small amounts of substrate needed but also forced the user to make up substrate batches of at least 
50mL to confidently produce a 0 ImM substrate solution, when far less substrate might actually be 
needed The preparation of lOmM Z-Gly-Pro-MCA stock in 100% DMSO, and subsequent 
preparation of lOmL batches of 0 ImM substrate from this stock as descnbed m section 2 5 1 led to an 
easier and more flexible procedure for substrate preparation
The decision to re-evaluate the assay procedure descnbed in section 25  1 was primarily due to the 
discovery of the ZIP activity The assay systems descnbed thus far were designed to detect and 
quantify PE activity It was undear whether they would be sufficient for accurate and reproducible 
determinations of ZIP activity
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4 5 1. Determination of Suitable Solvent for Substrate 
Solubilisation
To re-evaluate the assay the basics were first considered What was the most suitable solvent to be 
used for stock substrate preparation, and what final concentration of this solvent would provide 
optimum solubility, with due consideration to enzyme activity 7 The determination of what was the 
most suitable solvent for stock substrate preparation was mvesugated as desenbed in section 2 8 1 , and 
the results are presented m section 3 81 and Figures 3 8 1 1 and 3 8 1 2 In Figure 3 8 1 1 , although 
no discernible difference may be made between the acnvity of PE when assayed with substrates 
prepared m DMSO or dioxane, DMF adversely affected the activity of the enzyme, reducing the 
sensitivity of the assay by 60% when compared to the other solvents
The same results presented for ZIP in Figure 3 8 12 demonstrated that 20% reduced sensitivity was 
observed when DMSO was used as the substrate solvent Substrate solubility in all three solvents at a 
final concentration of 4% (v/v) was satisfactory On the basis that dioxane produced the lowest 
deletenous effects on assay sensitivity for PE and ZIP, it was chosen as the most suitable solvent to use 
for substrate solubilisation
4.5.2. Effect of Dioxane Concentration on Purified Enzymes
Having decided that dioxane was the best choice of solvent m which to prepare lOmM substrate stock, 
the optimum final concentration of solvent in 0 ImM buffered substrate was mvesugated as outlined in 
section 2 8 2 Section 3 8 2 and Figures 3 8 21 and 3 8 2 2 illustrate the results obtained as part of 
this investigation It was observed that for both PE and ZIP activities, a final solvent concentration of 
2% (v/v) dioxane m substrate produced optimal results Increasing this concentration to 4% (v/v) 
reduced the sensitivity of both assays by greater that 50% Substrate solubility at a final concentration 
of 2% (v/v) dioxane was attained easily m a reproducible manner Therefore the preparation of lOmM 
stock substrate m 100% dioxane, with the use of 0 ImM substrate with a final dioxane concentrauon of 
2% (v/v) was accepted as being the optimum substrate make up for both PE and ZIP acuviues
Once satisfied with substrate make up, the two most important considerauons for developmg a 
quantitative and accurate assay are lmeanty of the assay with respect to (a) time and (b) enzyme 
concentration
4 5.3. Linearity of Enzyme Assays with Respect to Time
Figure 4 3 represents the typical progression of an enzyme-substrate reacUon velocity curve The 
change in reaction velocity over time may be due to substrate depletion, instability of the enzyme under 
assay conditions, or inhibition of the enzyme by product formed Usmg a continuous assay system, 
this decrease in reaction velocity over time may be observed but does not cause any specific problems, 
provided the decrease in reaction velocity is caused by substrate depletion A tangent to the reaction 
curve, drawn through the ongrn, represents the initial rate of reaction, which may be used in
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quantitative activity measurements However, in a discontinuous assay system, where activity 
measurements are only determined at one discrete point along the reaction curve, deviation from 
linearity is not detected, and may lead to inaccurate activity estimates A hypothetical reaction curve is 
presented m Figure 4 3 At 25 minutes, determination of the amount of product formed using either a 
continuous, (represented by initial velocity measurements) or discontinuous assay leads to identical 
results, 1 e 20 units However, at 100 minutes, 45 units are observed when determining the amount of 
product formed using a discontinuous assay, while the initial velocity determination (the true activity 
measurement) is 80 units
I'w '
Assay time
Figure 4 3. Progress of an enzyme-substrate reaction velocity curve Plot o f 
product formed versus assay time Deviation of observed velocity from initial velocity due to 
substrate depletion, enzyme instability or inhibitor production over the assay period
In order to overcome this difficulty with discontinuous assays, the progression of the reaction curve in 
a linear fashion, over the assay period must be confirmed Sections 2 8 3 , 3 8 3 ,  and Figures 3 8 3  1 - 
3 8 3 4 outline how this linearity was confirmed and what results were obtained From Figures 
3 8 3 1 and 3 8  3 2 it is apparent that Z-Gly-Pro-MCA degradation by punfied PE and ZIP s m  linear 
with respect to time for up to two hours Given that the assay desenbed in section 2 5 1 is a one hour 
discontinuous assay, the lineanty of this assay was assured for punfied PE and ZIP activity 
measurements However, Figures 3 8 3 3 and 3 8 3 4 demonstrate that a loss m lmeanty was apparent 
over the two hour penod when Z-Gly-Pro-MCA degradation by PE and ZIP activities m serum, and 
ZIP activity alone m serum, were studied respectively Because the curvature was only observed in the 
crude serum samples, n  was reasonable to assume that this loss in lmeanty was due to enzyme
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depletion caused by proteolysis This curvature did not, however, affect the reaction curve over the 
First sixty minutes, and therefore a one hour discontinuous assay was still valid
4 5 4. Lineanty of Assays with Respect to Enzyme Concentration
A quantitative assay system determining the levels of activity in given enzyme sample should be linear 
with respect to enzyme concentration This aspect of the Z-Gly-Pro-MCA assay was investigated as 
outlined in section 2 8 4 ,  and the results obtained are presented m section 3 8 4  and Figures 3 8 4 1 - 
3 8 4 5 The PE assay was found to be linear with respect to enzyme concentration as illustrated in 
Figure 3 8 41  It was immediately apparent however, that the ZIP assay posed problems m this regard 
Figure 3 84  2 illustrates that activities observed from dilutions of punfied ZIP with phosphate buffer 
were not consistent with ZIP concentration, and in fact the data fitted a second order linear regression 
analysis quite well The lineanty of a 50% purified ZIP sample with respect to time over the assay 
penod was confirmed in Figure 3 84 3 confirming that the lack of lineanty seen in Figure 3 84  2 was 
not due to instability of the enzyme under assay conditions, caused by dilution effects While 
pondenng these results m an attempt to understand why the punfied ZIP assay would not behave 
linearly with respect to enzyme concentration, it was noted that apart from the varying concentration of 
ZIP produced by diluting with phosphate buffer, one other factor was being vaned, the concentration of 
salt m the enzyme sample The punfied ZIP and PE used for these studies were post-Sephacryl S-200 
HR Sepharose gel filtration samples, and as such, contained 200mM KC1 as part of the gel filtration 
running buffer Dilution of ZIP activity with phosphate would produce a pattern of vaned salt 
concentrations for each ZIP concentration Repeating the experiment with the inclusion of 200mM 
KC1 in diluant and substrate, produced a linear response to enzyme concentration (Figure 3 8 4 4 )  
When the experiment was again repeated, with post-gel filtration KC1 first removed by dialysis, and 
with no KC1 included m either diluant or substrate, lmeanty of the punfied ZIP with respect to enzyme 
concentration was again apparent (Figure 3 8 4 5 )  It was also noted that enzyme activity in Figure 
3 8 4 4 ,  when expressed as a percentage of ZIP activity with no salt included, was approximately 2 75 
times that of the dialysed ZIP sample These results not only helped validate the punfied PE and ZIP 
assays, but also revealed a hitherto unobserved enhancement of ZIP activity in the presence of salt
It was apparent from results obtained for the assay lmeanty with respect to enzyme concentration 
investigation (Figures 3 8 4  4 and 3 84  5 ) that the sensitivity of the ZIP assay could be increased by 
incorporating NaCl into the substrate It was also apparent from results obtained for the assay lineanty 
with respect to time investigation (Figure 3 8 3 1 ) that the sensitivity of the PE assay could be 
increased by incorporating DTT into the substrate In order to produce the most sensitive assay for 
each enzyme, investigations were performed as outlined in secuon 2 85 and 2 8 6 to determine the 
effect on observed PE and ZIP acuviues m the presence of increasing concentrauons of DTT and NaCl 
and the results are presented m Figures 3 8 5 and 3 8 6  respecUvely
148
4 5 5 DTT Activation of Purified Enzyme Activities
Figure 3 8 5 illustrates the effect of increasing DTT concentration on PE and ZIP activities ZIP 
activity demonstrated no increased activity in the presence of DTT In fact, at a DTT concentration of 
20mM, the observed ZIP activity was decreased by 30% PE however demonstrated a significant 
increase in observed activity m the presence of low concentrations of DTT At a DTT concentration of 
12mM observed PE activity increased by 12 fold At DTT concentrations of greater than 12mM no 
deleterious effects on observed PE activity were detected indicating that PE could be assayed in the 
presence of excess DTT (greater than 12mM) without affecting the sensitivity of the assay This 
increased PE activity m the presence of DTT agrees with the literature on PE where DTT is normally 
included as part of substrate preparations used to detect this enzyme The extent to which this punfied 
bovine serum PE activity is enhanced by low levels of DTT is quite different however to that 
previously reported Orlowski et a l , (1979) reported a 40% increase in observed activity from PE that 
had been punfied from rabbit brain at a DTT concentration of ImM From Figure 3 8 5 it is clear that 
at a DTT concentration of ImM the observed activity of PE is enhanced by approximately 300% The 
precise nature of the DTT activation of PE is not well understood Reducing agents are normally 
associated as being necessary components of assay systems designed to detect cysteine protease 
activmes The mechanistic class assigned to PE by this work and by the literature will be discussed m 
detail later It is generally accepted, however, that PE is a senne protease with a cysteine residue 
located near the acuve site In the case of cysteine proteases, the presence of reducing agents such as 
DTT, activates the acuve site cysteine residue, increasing its ability to initiate a nucleophilhc attack 
upon a bound substrate In the case of PE, it is possible that activation of the cysteine residue by 
reducing agents may play some role in the binding of substrate, or stabilising the covalent tetrahedral 
intermediate formed dunng the catalysis of pepude bond scission
4 5.6. Salt Activation of Punfied Enzyme Activities
Figure 3 8 6  illustrates the effect of increasing NaCl concentration on punfied PE and ZIP activities 
PE exhibited a decreased observed acuvity m the presence of high concentrations of NaCL At 1M 
NaCl the decrease m observed PE activity was approximately 25% This result is m stark contrast to 
that obtained by Polgar, (1991) where PE activity, punfied from pig muscle, was enhanced in a linear 
fashion up to 0 3-0 5M NaCl at pH 8 0 Polgar also showed that punfied porcine muscle PE 
demonstrated a double sigmoidal pH profile and concluded that two different catalytic forms of the 
enzyme existed at pH 6  0 and at pH 8 0 due to the fact that two p£a values of 5 37 and 6 16 were 
determined for the enzyme This qualified his salt enhanced PE activity results which only occurred at 
pH 8 0 At pH 6  0 no enhanced activity was detected and slight inhibition of PE at low salt 
concentrations were evident It is difficult to reconcile Polgars' observations and those presented here 
because the method used (secuon 2 8 6 ) determined the effect of NaCl on PE activity at a pH of 7 4 
This pH is above both pKa values determined by Polgar and therefore PE would be in the same 
ionisation state at pH 7 4 or at pH 8 0 Orlowski et a l , (1979) reported no effect on punfied rabbit 
brain PE activity when NaCl was mcluded in the substrate
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ZIP activity was enhanced m the presence of NaCl with maximum observed activity being obtained at 
500mM NaCl The increase in activity detected was approximately two fold (Figure 3 8 3 5 ) 
Increased activity in the presence of salts is commonly attributed to increased stability of a protein 
molecule m the presence of such salts Certain salts such as NaCl and ammonium sulphate can reduce 
the solubility of hydrophobic groups on a protein molecule by increasing the ionic strength of the 
solution In addition, these salts enhance the formation of water clusters around the protein which 
causes a loss of the total free energy of the system (Volkin and Khbanov, 1990) The salt itself is 
excluded from the water shell thus formed around the protein This is also known as preferential 
hydration (Tmiasheff and Arakawa, 1990) and causes the protein to become more compact and 
therefore more stable Increased stability, however, does not necessarily account for enhanced activity 
During the discussion on assay lmeanty with respect to time it was obvious that ZIP activity towards 
the substrate Z-Gly-Pro-MCA was stable over the assay penod employed Likewise a 50% ZIP sample 
was stable for a similar penod Polgar, (1995), examined the salt activation of PE with regards to 
stability effects and concluded that NaCl actually de-stabihses PE via a mechanism opposing 
preferential hydration He suggests that NaCl penetrates the zone of preferential hydration and bmds to 
the enzyme at specific sites The binding of NaCl will weaken possible electrostatic forces that may 
stabilise the protein conformation. Polgar also suggests that the reduced water shell surrounding PE m 
the presence of NaCl can account for increased catalytic activity It must be remembered that this is 
Polgars’ account for the activation of PE by NaCl, a result that is not consistent with this study His 
conclusions are presented here as a possible mechanism for the enhanced acuvity of ZIP m the 
presence of NaCl At NaCl concentrations greater than 500mM NaCl no deletenous effects on ZIP 
activity were observed This indicates (as was the case with PE and DTT) that ZIP could be assayed in 
the presence of excess NaCl (>500mM) without affecting the sensitivity of the assay It should be 
noted however that at NaCl concentrations approachmg IM m  lOOmM potassium phosphate, pH 7 4, 
some substrate solubility problems were observed
Having determined the optimal conditions for a sensitive and accurate fluonmetnc assay for PE and 
ZIP usmg the substrate Z-Gly-Pro-MCA, a finalised protocol for such an assay was formulated, and is 
presented in section 2 87
One final question was left unanswered with regard to the salt enhanced activity of ZIP It was 
apparent, for ZIP, that consideration of salt m the design of lmeanty with respect to enzyme 
concentration experiments was necessary, but was salt dependence alone responsible for the second 
order data presented in Figure 3 84  2? Looking closely at Figure 3 8 6 , it is apparent that over a 0 - 
200mM salt range the increase in ZIP activity is linearly enhanced by 0 - 50% Assuming that diluted 
ZIP would respond in a similar fashion Table 4 3 was constructed to estimate activity that would be 
observed when a ZIP sample containing 2G0mM salt was diluted with buffer containing no salt. The 
table was constructed as follows If ZIP (+200mM salt) was diluted with buffer (no salt) m a ratio of 
1 1 then the final enzyme concentration would be 50% of the undiluted ZIP and the final salt
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[ZIP] following Activity [Salt] following Assumed Expected activity +
diluuon (%) expected (%) dilution (mM)’ enhancement (%)** enhancement (%)t
0 0 0 0 0
25 25 50 12 5 28 125
50 50 100 25 62 5
75 75 150 37 5 103 125
100 100 200 50 150
ZIP concentration (%)
Table 4 3 and Figure 4 4. ZIP activities expected when enzyme containing 200mM salt is 
diluted with buffer containing no salt * Salt concentration based on 2QOmM salt present in undiluted 
enzyme sample ** Assumed on the basis that 0 - 200mM salt produces a linear activity increase o f 0 
- 50% (Figure 3 8 6 )  t  Expected activity plus expected activity x  (assumed enhancement) % The 
data obtained is presented graphically m Figure 4 4 , a plot o f ZIP activity versus ZIP concentration, 
clearly illustrating a second order curve (*-o) expected ZIP aam ty (o-o) ZIP activity determined 
according to assumed salt dependence
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concentration would be lOOmM 'Therefore the acuvity expected from the diluted sample would be 
50% of the undiluted ZIP acuvity plus the enhanced acuvm obtained from ZIP m lOOmM salt It is 
assumed that because 0 - 200mM salt produces a linear increase in ZIP acuvity of 0 - 50% (Figure
3 8 6 ) then lOOmM salt will produce an activity increase of 25% Thus the actual acuvity observed 
will be 50% of the undiluted ZIP plus a 25% enhancement, w hich leads to a final acuvity of 62 5% of 
the undiluted enzyme If this logic is applied to a range of dilutions, as is presented in Table 4 3, and 
the data obtained is plotted (Figure 4 4), a second order curve is produced This model therefore 
confinns that salt present in the post gel filtration ZIP was responsible for the data obtained in Figure 
3 8 4 2
4.6. Characterisation of Punfied PE and ZIP Activities 
4 6.1. Relative Molecular Mass Determination
The molecular weight of both PE and ZIP were determined by SEC-HPLC, Gel Filtration 
Chromatography and SDS PAGE as outlined m section 2 91  The results of these invesugauons are 
presented in secuon 3 91  and Figures 3 9 1 1  - 3 9 1 3  The nauve molecular weight of PE was 
estimated to be 69,700Da and 54,500Da by gel filtraUon chromatography (Figure 3 9 1 1 )  and SEC- 
HPLC (Figure 3 9 1 2 )  respecuvely Muluple bands visualised following SDS-PAGE of PE, meant 
that the subunit structure or molecular weight of PE could not be reliably determined by this method. 
The molecular weights obtained agree well with the previously published molecular weights 
determined for PE from vanous sources (Table 4 4 )  In all cases but one, PE was monomenc One 
report suggested that PE had a molecular weight of 115,000Da and that the enzyme was dunenc 
(Koida et a l , 1976) but this result was later corrected (Yoshimoto et a l, 1977) The nadve molecular 
weight of ZIP was estimated to be 184,200 and 191,000 by gel filtrauon chromatography (Figure 
3 9 1 1 )  and SEC-HPLC (Figure 3 9 1.2.) respecuvely Two bands were visualised following SDS 
PAGE usmg Silver Stain (Figure 3 7.2 ), the major of the two having a molecular weight of 50kDa 
(Figure 3 9 1 3 )  This indicates that ZIP exists as a tetrainer of four subunits of equal molecular 
weight The discrepancy between figures obtained from gel filtrauon chromatography on S-200 
Sepharose and SEC-HPLC are difficult to reconcile, though these types of methods for determining 
molecular weight are accurate to approximately 10% (Welling and Welhng-Wester, 1989) The basis 
upon which this value is obtained is not explained by Welling, but one msight into the use of gel 
filtrauon methods for molecular weight determinauon is discussed. As with all quantitative methods, 
the determination of a final result is based on the measurement of a single parameter In the case of gel 
filtrauon methods this parameter is volume (mL) The calibration curve is constructed on the basis of 
volumes at which the molecular mass standards elute from a column and the determination of the 
molecular weight of any unknown molecule is determined based on its eluuon volume from a column 
The calibration curve equations for the S-200 HR Sepharose and Biosep SEC-3000 columns are 
presented in sections 3 9 1 1  and 3 9 1 2  respectively Close* examination of these equations reveal 
that lmL of eluant collected from these columns represents a molecular weight range of 4,000Da for
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the S-200 HR Sepharose column and 30,000Da for the Biosep SEC-3000 column Considering these 
facts coupled with the fraction sizes collected as part of each method, the error m S-200 HR Sepharose 
and Biosep SEC 3000 gel filtration estimation of molecular weights could be as large as 8,000Da and
3 OOODa respecuvely However, careful and precise column calibrauon and determination of elution 
volumes means that gel filtration chromatography as a method for determining molecular weights is 
generally accepted as a reliable procedure
4 6.2 Assay Temperature Effects on Punfied PE and ZIP
The effects of assay temperature on the punfied enzyme activities were investigated as outlined in 
section 2 9 2 and the results are presented in Figures 3 9 2 1 and 3 92  2 It should be noted that the 
method outlined m section 2 9.2 included the premcubation of enzyme and substrate for 10 minutes at 
each temperature tested pnor to substrate addition This protocol, although allowing for the possibility 
of heat denaturauon to occur before the assay was initiated, was necessary to avoid results inconsistent 
with the actual ability of enzyme to tolerate and catalyse substrate hydrolysis at the temperatures under 
investigation Failure to preincubate the enzyme and substrate, resulting in a lack of thermal 
equilibnum, would lead to observed results that were representative of the rate of thermal equilibration 
and the rate of thermal inactivation, particularly at the higher temperatures which would have proven 
difficult, if not impossible, to interpret correctly The limitations of this experimental design lie in the 
fact that results obtained relate specifically to the method employed and may not be extended to form 
further hypotheses on the thermal stability of the enzymes under investigation This method does, 
however, provide useful information into the difference between the punfied PE and ZIP activities In 
Figure 3 9.2 1 the narrow temperature optimum of PE is illustrated This profile is centred narrowly 
about 37°C It is obvious, therefore; that at the two lower temperatures of 4°C and 20°C that there was 
not enough free energy withm the system to allow catalysis to occur The lack of free energy in the 
system caused by lower temperatures can theoretically affect the binding of enzyme to substrate, the 
catalysis of the reaction itself, the dissociation of enzyme and product(s) following catalysis, or 
combinations of all three of these factors The lack of activity at the lower temperatures is not stability 
related as PE was punfied at 4 ‘C and stored on ice pnor to charactensauon experiments No cold- 
labile characteristics were observed for PE At temperatures of 45 °C and greater, it is probable that PE 
underwent heat denaturaaon leading to low or non-existent activities being observed.
ZIP demonstrated a quite different temperature profile, with an optimum assay temperature of 37 C - 
45°C Inactivation does occur, however, at temperatures greater than 45°C The most interesting 
observation was the activity of ZIP at the lower temperatures At 4‘C, punfied ZIP hydrolysed 
substrate at a rate equivalent to 70% of the rate of hydrolysis at 37*C Although no further 
investigations were performed into this aspect of ZIP acuvity against Z-Gly-Pro-MCA, it is apparent 
that lower amounts of free energy are required by the enzyme to hydrolyse Z-Gly-Pro-MCA than those 
required for PE to catalyse the same reaction. Again, this lower energy requirement for the hydrolysis
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of Z-Gly-Pro-MCA by ZIP could be related to substrate binding, catalysis of the reaction or release of 
the products formed
4 6 3 pH Effects on Punfied Enzymes
Investigations into the effects of pH on the activity and stability of punfied PE and ZIP were performed 
as desenbed in section 2 9 3 1 and 2 9 3 2 with results being presented in Figures 3 9 3 1  - 3 9 3 4  
Two distinct investigations were conducted on each punfied enzyme The first, as desenbed in section 
2 9 3 1, determined the pH and buffer system at which optimal enzyme activity could be observed 
The second study, conducted as outlined in section 29  3 2 , demonstrated the pH range over which the 
enzyme remained stable, retaining its ability to hydrolyse substrate This study and the results obtained 
from it were important for the design and implementation of further charactensation work, which may 
have mvolved inadvertent pH changes For example, in the functional reagent studies that will be 
discussed, some compounds used were only slightly soluble in neutral buffers and had to be prepared 
in highly basic or acidic solutions Preincubation of these compounds with punfied enzyme activity 
may have resulted m observed inhibition that was caused solely, or in part, by the pH of the solution 
being tested and not the functional reagent itself The study outlined in section 2 9 3 2 set the pH 
limits that could be successfully used in characterising PE and ZIP activities
Figures 3 9 3 1 and 3 9 3 2 illustrate the pH optimum and pH inactivation profiles for PE respectively 
The cntena upon which the optimum pH for PE activity was determined was based on maximum 
activity observed Thus it was determined that the pH optimum of PE was pH 8 0 in a potassium 
phosphate buffer system On closer examination of the data presented in Figure 3 9 3 1 however, it 
was noted that m a Tns-HCl buffer system, the pH at which maximum PE activity was obtained was 
pH 8 5 Because potassium phosphate buffer could not be used at pH 8 5, the possibility exists that the 
pH optimum for PE is actually 8 5, but that the enzyme retains a preference for phosphate buffer 
Following the discussions where it was concluded that PE activity was not enhanced by the presence of 
NaCl, it is unlikely that this preference for phosphate buffer is related to the ionic strength of the buffer 
systems used In Figure 3 9 3 2 , the pH inactivation profile of PE is presented From this data it was 
determined that PE was inactivated outside the pH range 5 0 - 9 0  It was also observed that greater 
than 50% PE activity could be detected over the pH range 5 0 - 10 0 These results are only relevant 
and reliable under the conditions used to perform the study, 1 e preincubation at each pH for 15 
minutes at 37’C and cannot be extended to longer times or different temperatures The results obtained 
from the investigation mto pH effects on PE activity agree well with previously published information 
(Table 4 4 )
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Source Molecular
weight
Subunit
structure
pH Optimum pH Stability 
Range
Optimum 
Temperature CC)
Reference
Agaricus bisporous 78,000 - 75 5 0 - 9 0 37 Sailaretal (1990)
Flavobacterium 74,000 Mono 7 0 5 0 - 9 0 40 Yoshimoto etal (1980)
E coh 75,000 Mono 9 0 - - Sommer (1993)
Shakashimeji 76,000 Mono 6 8 5 75 - 7 4 37 Yoshimoto et al (1988)
Rat brain 70,000 Mono 7 0 - 8 0 - - Rupnowetal (1979)
Ratbram 70,000 - 7 5 - 8 0 - - Andrews (1980)
Bovine brain 75,000 Mono 75 5 0 - 9 0 40 Yoshimoto etal (1983)
Bovine pituitary 76,000 - 7 4 6 0 - 8 2 40 Knisatschek et al (1979)
Lamb brain 77,000 Mono 7 0 5 5 - 9 0 45 Yoshimoto et al (1981)
Lamb kidney 115,000 Di 7 5 - 8 0 - - Koidaetal (1976)
Porcine liver 72,000 Mono 6 5 6 0 - 7 0 - Monyama and Sasaki (1983)
Rai muscle 69,000 - 7 0 - 7 5 5 0 - 9 0 - Daly etal (1985)
Rat skin 70,000 Mono 5 8 - 40 Kusuharaera/ (1993)
Felsh fly 84,000 Mono 75 - - Ohtsuki et al (1994)
Bovine serum 70,000 - 8 0 5 0  - 9 0 37 This Investigation
Table 4 4 Molecular weighs and subunit make up o f PE from various sources The molecular weights obtained for bovine serum PE agree 
well with the data presented here The dunenc lamb kidney PE was later corrected by Yoshimoto et al (1977) Result for bovine serum (in bold 
type) were obtained as part o f this investigation
The pH optimum and pH macuvation profiles for ZIP are presented in Figures 3 9 3 3 and 3 9 3 4 
respectively The pH at which optimum ZIP activity was observed was 8 5, but in contrast to PE, no 
buffer preference was exhibited by ZIP activity The pH inactivation profile produced for ZIP 
indicates that ZIP activity was stable over a pH rage of 4 5 - 10 5 with greater than 50% of the 
observed activity being retained over the pH range of 3 5 - 10 0 Once more, it should be noted that 
these figures relate only to the method used to investigate these pH effects
4 6.4. Effects of Functional Reagents on Purified PE and ZIP 
Activities
The interaction between enzymes and vanous functional reagents can be used to determined the 
mechanistic class of the enzyme There are four mechanistic classes, senne, cysteine, metallo- and 
aspartic To understand how functional reagent studies help to identify the mechanistic class of a 
particular enzyme, a bnef discussion on enzyme catalysis and the subtle differences between the 
catalytic activities of each mechanistic class is warranted This discussion will focus on the catalysis of 
peptide bond scission by pro teases and peptidases
Peptide bond scission involves the following steps , (a) nucleophiUic attack on the slightly 
electrophillic carbonyl carbon atom, (b) base catalysis to remove the proton from the attacking 
nucleophile, (c) electrophillic assistance which influences the carbonyl oxygen and (d) aad catalysis to 
facilitate the leaving of an amine The difference between the mechanistic classes of proteases lies, not 
in the steps themselves but, in the vanety of groups m the active site that perform each of these 
functions Figure 4 5 illustrates these steps with regard to a senne protease
In the case of senne proteases, oxygen from the hydroxyl side chain of senne initiates the nucleophiUic 
attack, while a neighbouring histidine residue stabilises this interaction A covalent enzyme substrate 
interaction producing a tetrahedral ester intermediate results Cysteine proteases also form a covalent 
intermediate The side cham sulphur of a cysteine residue is the attacking nucleophile, with a 
neighbouring histidine again stabilising the attack The metallo- and aspartic proteases do not initiate 
the nucleophilic attack upon a peptide bond using an active site functional group, and therefore do not 
form covalent intermediates Instead, the metal atom or pair of aspartic acid residues present m the 
active sites of these proteases co-ordinate the nucleophiUic attack on the peptide bond by water 
molecules So it is dear that although there are common steps involved in the catalysis of peptide bond 
scission, each mechanistic class performs these steps in distinct ways It is this specific difference 
between the proteases that can be utilised to determine the mechanistic class to which each protease 
belongs via functional reagent studies (Dunn, 1989)
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Figure 4 5 Schematic representation of the mam steps involved m 
peptide bond scission The figure illustrates the mechanism o f senne protease catalysis
(A) Following substrate binding and formation o f the Michaehs Complex, oxygen, located on the side 
chain or senne, undergoes nucleopfulhc attack on the carbonyl carbon of the substrate peptide bond.
(B) A tetrahedral intermediate is formed The intermediate is stabilised by the removal o f a proton 
from the attacking oxygen by histidine and by electrophilhc assistance offered by hydrogen atoms 
exposed to the enzyme substrate complex (C) Formation of the Acyl Enzyme Intermediate results in 
the leaving o f  the Pi* amine (D) Release o f the bound Pi product via acid catalysis using water, 
results in return of free enzyme
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46 41. Functional Reagent Studies on PE.
Investigations were earned out as descnbed in secuon 2 9 4 and the results illustrating the effect of 
functional reagents on punfied PE, activity are presented in Table 3 4 Those results that are 
significant with regards to the mechanistic classification of PE are as follow s
4.6.4 1.1 Enhanced PE Activity in the Presence of DTT
The activation of punfied PE by increasing concentrations of DTT in substrate have been discussed
(secuon 4 5) In Table 3 5 PE demonstrated a 10 fold increase m observed activity in the presence of
lOmM DTT This DTT enhanced activity has being reported previously and the values presented in 
Table 3 5 agree well with published results (Kato et a l , 1980, Orlowski et a l , 1979, Walter, 1976) 
This DTT enhanced acuvity is normally indicauve of a cysteine protease for reasons which were 
discussed previously An interesting point, with regards to the values presented in Table 3 4 for DTT 
activation of PE acuvity, is that at low DTT concentrauons (ImM), the acuvation of DTT is 
significantly lower than that obtained when DTT was suppbed to the assay mixture by substrate alone 
(Figure 3 8 5 ) This seems to suggest that the preincubation of enzyme with DTT leads to less 
enhanced activity than reduction of the substrate with DTT pnor to assay initiation
4.6 4.1.2. Inhibition of PE by Cysteine Protease Inhibitors
Punfied PE was inhibited by lodoacetamide (lOmM), NEM (lOmM) and PCMB (5mM) by 20%, 40% 
and 70% respectively Of these three compounds PCMB is the most effective and specific cysteine 
protease inhibitor However, all three compounds may interact with cysteine residues that are not 
located in the acuve site of an enzyme (Andrews et a l , 1980) The inhibition of PE by cysteine 
protease inhibitors has been widely reported, the most effective mhibiuon being observed with PCMB 
(Daly et a l , 1985, Mizutam et a l , 1984, Rosen eta l, 1991, Taylor and Dixon, 1976) Andrews et al, 
(1980), having determined that PE was a senne protease, proposed that the inhibition of PE by cysteine 
protease inhibitors was the result of the interaction of these compounds with a non-catalytic cysteine 
residue located near the acuve site This has been previously reported for other senne proteases (Bai 
and Hayashi, 1979) The results presented here agree well with results obtained by Polgar, (1991) He 
related the size of the compounds interacting with the cysteine residue near the acuve site of PE with 
their ability to inhibit the enzymes acuvity Smaller thiol reagents, such as lodoacetamide, were less 
likely to exert steanc effects on the binding of substrate to the active site and therefore were less likely 
to significantly inhibit the enzyme Larger thiol reagents such as NEM* were of sufficient size to 
interfere with the binding of substrate to enzyme and therefore exerted a stronger inhibitory effect 
This increase of inhibitory acuvity with relationship to thiol reagent size was consistent with the 
highest levels of mhibihon being exerted by PCMB
4.6.4.1.3* Inhibition of Punfied PE by Serine Protease Inhibitors
Punfied PE was significantly inhibited by AEBSF (80% inhibition at lOmM) and to a lesser extent by 
PMSF AEBSF is a very specific senne protease inhibitor and its inhibition of HE is indicative that PE
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is a senne protease PE has been confirmed as a senne protease by many authors (Kusuhara et a l , 
1993, Strohmeier et a l , 1994, Yoshimoto ei a l , 1983), however no reports of the use of AEBSF have 
been published AEBSF was chosen as a represented a non-toxic but extremely potent alternative to 
DFP
4 6 41 4 Inhibition of PE by Phenanthrolines
PE was inhibited by lOmM 1,10-, 4,7- and 1,7-phenanthroline by 50%, 50% and 60% respectively 
The inhibition of proteases by the chelator, 1,10-phenanthroline, is normally indicative of a metallo- 
protease However, EDTA and 8-hydroxyquinolme did not inhibit PE activity significantly This, 
coupled with the fact that 1,7- and 4,7-phenanthrohne are not chelators, indicates that the inhibition of 
PE by phenathrohnes was not due to metal chelation, but rather, it was due to some structural similanty 
between these compounds Czekay and Bauer, (1993) reported that pyroglutamyl ammopeptidase type 
II (PAP II) punfied from rat bram was a metallo-protease, but was also inhibited by 4,7- and 1,7- 
phenanthroline They proposed that the inhibition of this enzyme by the phenanthrolines was probably 
due to the non-specific hydrophobic interaction of the enzyme with the aromatic structures shared by 
these compounds They supported this observation with the fact that PAP II interacted strongly with 
phenyl sepharose hydrophobic interaction chromatography media This explanation, therefore, could 
be applied to the effect of the phenanthrolines towards PE activity, as it also interacts strongly with 
phenyl sepharose (Figure 3 6 2 )
4 6.4.2. Functional Reagent Studies on ZIP
The results illustrating the effect of functional reagents on punfied ZIP activity are presented in Table
3 5 and the investigations were earned out as desenbed in section 2 9 4 Those results that are 
significant with regards to the mechanistic classification of ZIP are as follows
4 6.4 2.1. Inhibition of ZIP by Cysteine Protease Inhibitors
Punfied ZIP was inhibited by PCMB (5mM) and NEM (lOmM) by 55% and 30% respectively Unlike 
PE, there was no significant inhibition obtained with the other cysteine pro tease inhibitors Of these 
two compounds PCMB is the most effective However, as with PE, these two compounds may interact 
with cysteine residues that are not located m the active site of an enzyme and ZIP may not be a cysteine 
protease This is supported by the fact that ZIP activity was not enhanced by the presence of reducing 
agents such as DTT or 2-mercaptoethanol (Table 3.5) The steanc effect discussed earlier with regards 
to the inhibition of PE by PCMB and NEM may also apply to ZIP
4 6.4.2.2. Inhibition of Purified ZIP by Serine Protease Inhibitors
Punfied ZIP was significantly inhibited by AEBSF (85% inhibition at lOmM) and to a lesser extent by 
PMSF (45% inhibition at ImM) AEBSF has already been discussed as a specific non-toxic inhibitor 
of senne proteases Its inhibition of ZIP is therefore indicative that ZIP is a senne protease
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4 6 4.2 3 Inhibition of ZIP by Phenanthrohnes
Like PE, ZIP was inhibited by lQmM 1,7- and 4,7-phenanthrolme by 70% and 80% respectively This 
inhibition is probably best explained by the same process whereby the phenanthrolmes inhibited PE 
acuvity (Czekay and Bauer, 1993) The supporting argument made by these authors that the 
interaction of an enzvme with the aromatic structures of the phenanthrolme compounds was 
hydrophobic m nature, is also supported by the interaction of ZIP with phenyl sepharose (Figure
3 6 5) It is interesting to note that ZIP interacted wtth phenyl sepharose m a stronger manner than PE, 
demonstrated by the need to use distilled water to elute the enzyme from the column The increased 
capacity of ZIP for hydrophobic interaction may be responsible for the greater inhibition demonstrated 
by ZIP when exposed ao the phenanthrolmes
4.6 5. The Effect of Divalent Metal Salts on Purified PE and ZIP 
Activities
The effect of divalent metal salts on punfied PE and ZIP activities was determined as desenbed m 
section 29 5 and the results are presented in Table 3 6  Of significance is the fact that both PE and ZIP 
activities were inhib&ed strongly by HgS0 4  (approximately 90% inhibition observed for both 
enzymes) Inactivation by heavy metal poisoning is well documented (Vallee and Ulmer, 1972) 
Heavy metal cations soch as mercury (Hg^+) are known to react with protein sulphydryl groups, 
converting than to meraptides, as well as hisudme and tryptophan residues In addition, disulphide 
bonds can be hydrolytically degraded by the catalytic action of mercury (Volkin and Klibanov, 1990) 
This supports the evidence presented thus far, that interaction with cysteine residues or with sulphydryl 
groups of both PE and ZIP leads to an inhibition of both enzymes The inhibition of PE by Hg^+ is 
well documented in the hterature (Yoshimoto et a l , 1981, Strohmeier et aL, 1994, Sattar et a l , 1990, 
Mizutani et al., 1984) Likewise the inhibition presented for Zn^+ is also in agreement with previous 
reports (Yoshimoto et aL, 1988, Kato et a l , 1980; Kalwant and Porter, 1991) However, these authors 
also reported significant inhibition of PE by Cu^+ and Ni^+ which was not observed in this work ZIP 
activity, although strongly inhibited by only Hg^+, demonstrated a greater sensitivity to inhibition by 
divalent metal salts that PE (Table 3 6 )
4 6.6. Substrate Specificity Studies on Purified PE and ZIP
Substrate specificity studies were earned out as outlined in sections 2 96  and 29  7 and the results are 
presented m section 3-9j6 Three methods of investigation were employed to determine the substrate 
specificity of both PE aod ZIP Reverse Phase HPLC focused on detecting cleavage products produced 
when vanous peptides were incubated with PE or ZIP Fluonmetnc substrates were used to determine 
the ability of berth enzymes m releasing MCA from the carboxyl terminus of a vanety of peptides 
Kinetic analysis of the effect of prolme containing peptides on the release of MCA from Z-Gly-Pro- 
MCA by punfied PE and ZIP activities was also investigated The relevance of results obtained from 
these investigations wiB be discussed with regards to PE and ZIP substrate specificity
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4.6 6 1. Substrate Specificity Studies on Purified PE
Table 3 8 presents the results obtained when PE was incubated with vanous fluonmetnc substrates to 
determine its abilitv to release free MCA from these peptides This not only helped to elucidate the 
substrate specificity of PE but also indicated whether the punfied PE preparation may have contained 
secondary peptidase contaminants PE exhibited activity against the fluonmetnc TRH analogue, pGlu- 
His-Pro-MCA (TRH-MCA) and Suc-Gly-Pro-Leu-Gly-Pro-MCA The release of MCA from TRH- 
MCA poses interesting questions with regards to the specificity of PE towards TRH and its analogues 
PE cleaved this substrate at approximately 60% the rate at which it cleaved Z-Gly-Pro-MC A (Table
3 8 ), yet the cleavage of the natural peptide, pGlu-His-Pro-NH2, was not detected usmg Reverse Phase 
HPLC as illustrated m Figures 3 96 3 and 3 9 6 4  The product expected following the deamidation of 
TRH by PE is TRH-OH Figure 3 9 6 3 illustrated clearly that the HPLC method employed could 
distinguish easily between TRH and TRH-OH It is likely that the failure to detect TRH-OH following 
incubation of TRH with PE is not because TRH was not cleaved by PE, but that the HPLC method was 
not sensitive enough to detect any TRH-OH that was produced The Km determined for PE activity 
towards TRH-MCA was 69pM (Table 3 9 ), however the competitive action of TRH on PE activity 
towards Z-Gly-Pro-MCA produced a Ki of 680jjlM (Table 3 10), illustrating a 10 fold decrease m 
specificity This Kj value suggests that PE might not play an important physiological role with regard 
to TRH The results presented in Table 3 8 indicate that there is no major contaminating peptidase 
acuvity in the punfied PE preparation as no significant cleavage of substrates other than TRH-MCA 
and Suc-Gly-Pro-Leu-Gly-Pro-MCA was observed Reverse Phase HPLC investigations showed that 
PE hydrolysed the bioactive peptides LHRH (Figure 3 9 61) ,  Bradykimn (Figure 3 9 6 5 ) ,  Substance 
P (Figure 3 9 6  7 ) and Angiotensin n  (Figure 3 9 6 9 )  The cleavage of these substrates by PE has 
been previously reported (Bai, 1994, Barelli et a l , 1989, Blumberg et a l , 1980; Chappell et a l , 1990, 
Emson and Williams, 1983) Results obtained from kinetic analysis of the interaction of PE towards 
these peptides are presented in Table 3 10 PE exhibits a low specificity towards LHRH (K, of 
523pM) similar to the figure obtained for TRH However a higher specificity towards Bradykimn (K4 
of 136|iM) and Angiotensin II (Kj of 113|iM) was observed These specifictfies approximate to the 
specificity of PE towards its fluonmetnc substrate, Z-Gly-Pro-MCA (Km of 94^M)
4 6 6 2. Substrate Specificity Studies on Purified ZIP
71P exhibited significant activity against the fluonmetnc substrate Pro-MCA, the substrate commonly 
used to detect proline aminopeptidase activity However, ZIP activity against Z-Gly-Pro-MCA cannot 
be explained by the action of an ammopeptidase activity and therefore the cleavage of Pro-MCA by 
punfied ZIP preparation could represent a contaminating peptidase activity Reverse Phase HPLC 
investigations demonstrated that ZIP cleaved LHRH, Bradykimn and Substance P The cleavage 
products obtained from the action of ZIP towards LHRH and Bradykimn indicate that PE and ZIP may 
share a common cleavage site on each bioactive peptide In both cases, the fragment obtained 
following incubation of LHRH and Bradykimn with ZIP, corresponded to the major fragment observed 
when these substrates were incubated with punfied PE (Figures 3 9 6 1 , 3 9 6 2 , 3 9 6 5  and 3 9 6 6 )
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Kinetic analysis of these interactions (Table 3 10) indicate that ZIP exhibits a similar specificity 
towards LHRH as does PE (Kj of 475^M) but its specificity towards Bradykimn is approximately 20 
fold lower (Kj of2497pM)
4 6 7 The Effects of Proline Specific Peptidase Inhibitors on 
Purified PE and ZIP Activities
The investigation into the effect of prolme specific inhibitors was earned out as outlined m section 
2 9 8 and the results are presented in section 3 9 8 Having first discovered ZIP activity m bovine 
serum and identified its resistance to Z-Pro-Prohnal inhibition (Figures 3 4 2 and 3 4 3 ) other PE and 
prolme specific peptidase inhibitors were sought from vanous international groups This list of 
inhibitors is presented in Table 2 6  The investigation earned out using these inhibitors was simple m 
nature and was implemented solely to determine the similanties or differences obtained when either 
ZIP or PE activities were determined in the presence of these compounds IC50 values were calculated 
to illustrate the differences m sensitivity of both enzymes to inhibition by these compounds, and are 
presented m Table 3 11 All compounds with the exception of kelatorphan inhibited PE activity The 
least effective of these was Boc-Glu(NHO-Bz)-Pyrr with an IC50 value of 1 6xlO"^M This inhibitor 
was synthesised by Demuth et a l , (1993) as part of a senes of ammo dicarboxylic acid pyrrolidide 
inhibitors designed to inhibit prolme specific peptidases such as PE and DAP IV Figure 4 6 (a) shows 
the structural similanty between the inhibitor and the Cys-Pro sequence of residues found m Oxytocin 
and Vasopressin, both natural substrates of PE The most effective inhibitors based on their very low 
IC50 values were a-Ketobenzothiazole and Z-Indohnyl Prolinal The former was obtained from 
Tsutsumi et a l , (1994) and its structure is presented in Figure 4 6  (b) It was synthesised as part of a 
senes of inhibitors produced to inhibit PE activity specifically Tsutsumi et al reported an IC50 value 
of 5 OxlO'^M for the action of this inhibitor against PE activity, in companson to the value presented 
m Table 3 11 of 4xl0‘ 1 Bovine serum PE was therefore 100 times more sensitive to the inhibitory 
action of a-Ketobenzothiazole than that of the partially punfied porcine kidney PE used by Tsutsumi et 
al Z-Indolmyl-Prohnal, supplied by Dr Steven Faraci (Bakker et a ly 1991) demonstrated an IC50 
value of 5 0 x 1 0 ' against PE activity The structure of this compound is illustrated m Fig 4 6 (c) 
Bakker et al desenbed this compound as a slow tight binding inhibitor of PE activity 
ZIP activity was resistant to inhibition by Z-Pro-Prolmal, Foc-Pro-Pro-Nitnle, Kelatorphan and Z-Phe- 
Pro-Me thy Ike tone With the exception of kelatorphan, all of these inhibitors are denvauves of Z-Pro- 
Prolmal ZIP was inhibited to some extent by Z-Indolmyl-Prolinal and Boc-Glu-(NHO-Bz)-Pyrr with 
IC50 values of approximately 1 0x l0~^M Also of interest was that Z-Thiopropyl-Thioprolmal, a 
denvative of Z-Pro-Prolinal (Tsuru et a i , 1988) was a potent inhibitor of ZIP activity (IC50 = 1 8x10“ 
^M) The most potent inhibitory activity observed against ZIP was that of a-Ketobenzothiazole, which 
was also the most potent PE inhibitor tested The IC50 values observed for a-Ketobenzothiazole 
inhibition of PE and ZIP were comparable at 4 1xlO~11M and 1 5x10’ respectively
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F igure  4  6. (a) Structure of BOC-Glu(NHO-Bz)-Pyrr and its relationship to the Cys-Pro bond 
found m oxytocin and vasopressin, natural substrates for PE (b) Structure of the PE inhibitor, a- 
Ketobenzothiazole This inhibitor was the most potent inhibitor tested for both PE and ZIP activities 
(c) Structure o f Z-lndohnyl-Prohnal, a very potent inhibitor o f PE activity
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4 7. General Summary
Two distinct prolrne specific peptidases were detected in bovme serum usmg the substrate Z-Gly-Pro- 
MCA, a reportedly specific fluonmetnc substrate for prolyl endopepudase (PE) One of these 
activities was inhibited by Z-Pro-Prolinal, a PE specific inhibitor, and was subsequently designated PE 
The second activity resisted inhibition by Z-Pro-Prolinal, even at high concentrations and increased 
preincubation times This activity was subsequently designated Z-Pro-Prolinal insensitive Z-Gly-Pro- 
MCA degrading peptidase (ZIP)
Both PE and ZIP activities m bovme serum were successfully separated using SP-Sepharose cation 
exchange chromatography and were subsequently punfied independently of each other
4.7.1. PE - Summary and Conclusions
PE activity was partially punfied, following its separation from ZIP, using Phenyl-Sepharose 
hydrophobic interaction, DEAE-Sepharose anion exchange and Sephacryl S-200 HR gel filtration 
chromatographies, with a final yield of 24% and a final punfication factor of 30 achieved The enzyme 
had a native molecular weight of 70,000 Da, as determined by gel filtration chromatography The 
subunit structure of the enzyme could not be determined by SDS PAGE due to the appearance of 
multiple bands following visualisation of the gel by silver staining
A pH optimum of 8 0, with a preference for phosphate buffer was determined for the partially punfied 
PE. The enzyme was stable over a pH range of 5-9 Optimal activity was obtained from PE at a 
temperature of 37°C with little activity being detected above or below this temperature
PE activity was inhibited by AEBSF indicating that the enzyme may be a member of the senne 
protease family The enzyme was also inhibited by PCMB and activated by DTT, indicating the 
possible presence of an essential cysteine residue close to the active site
PE hydrolysed the substrates Z-GIy-Pro-MCA and pGlu-His-Pro-MCA, with Km values of 94fiM and 
62j±M respectively The enzyme also cleaved a variety of proline containing bioactive peptides 
including LHRH, bradykimn, substance P and angiotensin II These peptides also competitively 
inhibited PE activity towards Z-Gly-Pro-MC A PE demonstrated relatively high specificities towards 
bradykimn and angiotensin II with Kt values of 136{iM and 113|iM respectively
The enzyme was inhibited by a range of PE specific inhibitors with the highest inhibitory activity being 
observed for a-ketobenzothiazole (IC50 = 41picomolar) and Z-Indolinyl Prolmal (IC50 = 45 
picomolar)
In conclusion, bovme serum PE activity, punfied and charactensed during this investigation, has 
revealed itself to be similar to PE activities isolated from other sources with regard to its biophysical
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and biochemical characteristics, and its substrate specificity However, based on its poorly investigated 
acuvity towards proline containing bioacuve peptides, this serum form of PE ma\ play an important 
physiological role in the metabolism of such pepudes
4 7.2 ZIP - Summary and Conclusions
Z-Pro-Prolmal insensitive Z-GIy-Pro-MCA degrading pephdase (ZIP) activity was punfied, following 
its separauon from PE, usmg Phenyl-Sepharose hydrophobic interaction, Calcium Phosphate Cellulose 
and Sephacryl S-200 HR gel filtration chromatographies, with a final yield of 14% and a final 
punfication factor of 2250 achieved The enzyme had a naUve molecular weight of 185,000 Da, as 
determined by gel filtrauon chromatography The subunit structure of ZIP was determined to be 
tetramenc based on the idenuficauon of a major band of 50,000Da by SDS PAGE following 
visualisauon of the gel by silver staining
The enzyme exhibited a pH optimum of 8 5, and was stable over a pH range of 4-9J5 Optimal acuvity 
was obtained from ZIP at a temperature of 3TC- 40 C with significant activities being observed at 4*C 
and 20°C
The enzyme was inhibited by AEBSF indicating that it is probably a member of the senne protease 
family
ZIP hydrolysed the substrate Z-Gly-Pro-MCA with a Km value of 267pM being determined. The 
enzyme also cleaved a vanety of proline containing bioacuve peptides including LHRH, bradykinin 
and substance P These peptides also inhibited ZIP activity towards Z-Gly-Pro-MCA with bradykinin 
and LHRH demonstrating compeuuve values of 2 5mM and 475|iM respectively
The enzyme was inhibited by some of the PE specific inhibitors tested Highest inhibitory activity was 
observed for a-ketobenzothiazole (IC50 =15 picomolar)
The investigation of ZIP activity in bovine serum leads to the following conclusions.
(1) The fluonmetnc assay used to assess PE activity in serum, using the substrate Z-Gly-Pro-MCA, is 
not valid unless the activity observed can be completely inhibited by Z-Pro-ProlinaL
(2) ZIP activity, isolated and charactensed from bovine serum, is proline specific based on its 
inhibition by PE specific inhibitors, particularly those that are based 00 a proline dipeptide structure, 
and its ability to release free MCA from the fluonmetnc substrate, Z-Gly-Pro-MCA.
(3) The biophysical and biochemical charactenstics, determined for ZIP during this investigation, are 
dissimilar to those of any individual proline specific peptidase, previously characterised.
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(4) The ability of ZIP to release free MCA from tbe substrate Z-Gly-Pro-MCA indicates that it might 
be classified as either an endopeptidase or carboxypeptidase activity However, the enzymes ability bo 
cleave LHRH, bradykimn and substance P indicate that it is a prolme specific endopeptidase To date, 
the only reported proline specific endopeptidase activity matching these substrate specifics 
requirements has been prolyl endopeptidase (PE) This investigation has determined that ZIP activm 
in bovine serum is distinct from PE
Therefore, ZIP activity may represent a novel prolme specific endopeptidase localised in serum and 
may, like PE, play an important physiological role m the metabolism of proline containing bioactive 
peptides
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Appendices
A 1. Kinetic Analysis
Data obtained from relevant kinetic investigations were subjected to anahsis based on Micbaehs- 
Menten, Line weaver-Burk, Eadie-Hofstee, Hanes-Woolf and Direct Linear Plot models
A. 1.1 Michaelis-Menten Analysis
The rate equation for the Michaelis-Menten model of enzyme catalysed reaction is as follows
V0 = Vmax[S]/(Km + [S])
where V0 = initial velocity, Vmax = maximal velocity, [S] = substrate concentration and Km is the 
Michaelis-Menten rale constant,
A. 1.2,  Lineweaver-Burk Analysis
A double reciprocal transformation of the Michaelis-Menten rate equation leads to the following
1/V o = Km/V maxtS] + 1/V max
A plot of 1/V0 versus 1/[S] produces a straight line The slope of this line represents Km/Vmax’ the 
Y-axis intercept represents 1/Vmax and the X-axis intercept represents -1/Km
A . 1.3.  Eadie-Hofstee Analysis
This rate equation represents a derivation of the Michaelis-Menten rate equation and is as follows.
Vo/[S] = Vmax/Km - Vo^m
A plot of V0[S] verus VG produces a straight line The slope of the line represents -1/Km, the Y-axis 
intercept represents Vmai/Km and the X-axis intercept represents V m ^
A 1 4. Hanes-Woolf Analysis
This rate equation also represents a derivation of the Michaelis-Menten rate equation and is as follows.
[S]/V o = Km/V max + [S]/Vmax
Plotting [S]/V0 versus [S] produces a straight line The slope of the line represents 1/Vmax, the Y- 
axis intercept represents and the X-axis mtercept represents -Km
Data obtained from kinetic studies was entered into a SigmaPlot worksheet The data was transformed 
to produce the relevant X and Y axis cordmates applicable to each of the four previously mentioned
models Curve fnung protocols, based on the four models, were created and run to determine Km 
values for the data
A 1 5. Direct Linear Plot Analysis
This method is based on plotting substrate concentration and initial velocity values as lines in m 
parameter space rather than as points in observation space Where as in the previously mentioned 
models, substrate concentration and initial velocity values were used to place a point m observation 
space at particular X, Y coordinates, m this model a line is constructed by jommg a point at a distance 
of -[S] from the ongm on the X-axis to a point at a distance V0 from the ongm on the Y-axis and 
extending that line into positive X and Y space Plotting multiple lines usmg multiple substrate 
concentration and initial velocity combinations will lead ideally to a unique intersection point, whose 
X and Y coordinates represent Km and Vmax respectively
In practise, many intersection points are obtained and the Km and Vmax parameters are represented by 
the median values Beacuse the median value of the hst of possible detenmnations is used, the Direct 
Linear Plot is less sensitive to the effects of outliers, making it statistically better than the previous 
models A simple BASIC program was created to take data obtained from kinetic investigations and 
calculate the intesection point of Imes created as described, and to determine the median values
A . 2. Statistical Analysis
Standard deviations were used to express error bar amplitudes chi all plots The mathematics used to 
produce the standard deviation (s d ) from tnphcate detenmnations were as follows.
Mean = (a + b + c)/3 
Variance = (a^  + b^  + c^)/3 * Mean  ^
sd  = Variance 1/2
Where a, b, and c represent the three individual determinations
A-2
